
<html lang="en"     class="pb-page"  data-request-id="01083b2a-dda4-483f-8a9a-6fd7dba14a8b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2008.51.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm701319c"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents†" /></meta><meta name="dc.Creator" content="Mathew P.  Leese" /></meta><meta name="dc.Creator" content="Fabrice L.  Jourdan" /></meta><meta name="dc.Creator" content="Keira  Gaukroger" /></meta><meta name="dc.Creator" content="Mary F.  Mahon" /></meta><meta name="dc.Creator" content="Simon P.  Newman" /></meta><meta name="dc.Creator" content="Paul A.  Foster" /></meta><meta name="dc.Creator" content="Chloe  Stengel" /></meta><meta name="dc.Creator" content="Sandra  Regis-Lydi" /></meta><meta name="dc.Creator" content="Eric  Ferrandis" /></meta><meta name="dc.Creator" content="Anna Di  Fiore" /></meta><meta name="dc.Creator" content="Giuseppina  De Simone" /></meta><meta name="dc.Creator" content="Claudiu T.  Supuran" /></meta><meta name="dc.Creator" content="Atul  Purohit" /></meta><meta name="dc.Creator" content="Michael J.  Reed" /></meta><meta name="dc.Creator" content="Barry V. L.  Potter" /></meta><meta name="dc.Description" content="The synthesis, SAR, and preclinical evaluation of 17-cyanated 2-substituted estra-1,3,5(10)-trienes as anticancer agents are discussed. 2-Methoxy-17β-cyanomethylestra-1,3,5(10)-trien-3-ol (14), but..." /></meta><meta name="Description" content="The synthesis, SAR, and preclinical evaluation of 17-cyanated 2-substituted estra-1,3,5(10)-trienes as anticancer agents are discussed. 2-Methoxy-17β-cyanomethylestra-1,3,5(10)-trien-3-ol (14), but..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 9, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701319c" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701319c" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701319c" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701319c" /></link>
        
    
    

<title>Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701319c" /></meta><meta property="og:title" content="Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents†" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0013.jpeg" /></meta><meta property="og:description" content=" The synthesis, SAR, and preclinical evaluation of 17-cyanated 2-substituted estra-1,3,5(10)-trienes as anticancer agents are discussed. 2-Methoxy-17β-cyanomethylestra-1,3,5(10)-trien-3-ol (14), but not the related 2-ethyl derivative 7, and the related 3-O-sulfamates 8 and 15 display potent antiproliferative effects (MCF-7 GI50 300, 60 and 70 nM, respectively) against human cancer cells in vitro. Investigation of the SAR reveals that a sterically unhindered hydrogen bond acceptor attached to C-17 is most likely key to the enhanced activity. Compound 8 displayed significant in vitro antiangiogenic activity, and its ability to act as a microtubule disruptor was confirmed. Inhibitory activity of the sulfamate derivatives against steroid sulfatase and carbonic anhydrase II (hCAII) was also observed, and the interaction between 15 and hCAII was investigated by protein crystallography. The potential of these multimechanism anticancer agents was confirmed in vivo, with promising activity observed for both 14 and 15 in an athymic nude mouse MDA-MB-231 human breast cancer xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701319c"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701319c">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701319c&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701319c&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701319c&amp;href=/doi/10.1021/jm701319c" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1295-1308</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701247k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701128r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents<a class="ref internalNav" href="#tfn1" aria-label="†">†</a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mathew+P.++Leese">Mathew P. Leese</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrice+L.++Jourdan">Fabrice L. Jourdan</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keira++Gaukroger">Keira Gaukroger</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+F.++Mahon">Mary F. Mahon</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+P.++Newman">Simon P. Newman</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++Foster">Paul A. Foster</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chloe++Stengel">Chloe Stengel</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Regis-Lydi">Sandra Regis-Lydi</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Ferrandis">Eric Ferrandis</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna+Di++Fiore">Anna Di Fiore</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppina++De+Simone">Giuseppina De Simone</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudiu+T.++Supuran">Claudiu T. Supuran</a></span><span class="author-xref-symbol "><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atul++Purohit">Atul Purohit</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Reed">Michael J. Reed</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barry+V.+L.++Potter">Barry V. L. Potter</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div><div class="corresp-fn" id="tfn1">†The X-ray crystal structure of 15 has been deposited with the Cambridge Crystallographic Data Centre as supplementary publication CCDC 658208. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Rd., Cambridge CB2 1 EZ, U.K. (e-mail: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="f59190859a869c81b596969196db969498db9496db809e">[email protected]</a>). Protein crystal data: accession code 3BET.pdb.</div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Tel: +44 1225 386639 . Fax: +44 1225 386114. E-mail: <a href="/cdn-cgi/l/email-protection#ecaec2bac2a0c2bc839898899eac8e8d9884c28d8fc29987"><span class="__cf_email__" data-cfemail="9edcb0c8b0d2b0cef1eaeafbecdefcffeaf6b0fffdb0ebf5">[email protected]</span></a></div><div class="corresp-fn" id="afn1">‡Department of Pharmacy and Pharmacology & Sterix Ltd., University of Bath.</div><div class="corresp-fn" id="afn2">§Department of Chemistry, University of Bath.</div><div class="corresp-fn" id="afn3">∥Imperial College London.</div><div class="corresp-fn" id="afn4">⊥IPSEN System Biology.</div><div class="corresp-fn" id="afn5">#Istituto di Biostrutture e Bioimmagini-CNR.</div><div class="corresp-fn" id="afn6">▽Università degli Studi di Firenze.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701319c&amp;href=/doi/10.1021%2Fjm701319c" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1295–1308</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 9, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 October 2007</li><li><span class="item_label"><b>Published</b> online</span>9 February 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 March 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701319c" title="DOI URL">https://doi.org/10.1021/jm701319c</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1295%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMathew%2BP.%2BLeese%252C%2BFabrice%2BL.%2BJourdan%252C%2BKeira%2BGaukroger%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D5%26contentID%3Djm701319c%26title%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BC-17%2BCyano-Substituted%2BEstratrienes%2Bas%2BAnticancer%2BAgents%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1308%26publicationDate%3DMarch%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701319c"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1170</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701319c" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mathew&quot;,&quot;last_name&quot;:&quot;P. Leese&quot;},{&quot;first_name&quot;:&quot;Fabrice&quot;,&quot;last_name&quot;:&quot;L. Jourdan&quot;},{&quot;first_name&quot;:&quot;Keira&quot;,&quot;last_name&quot;:&quot;Gaukroger&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;F. Mahon&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;P. Newman&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. Foster&quot;},{&quot;first_name&quot;:&quot;Chloe&quot;,&quot;last_name&quot;:&quot;Stengel&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Regis-Lydi&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Ferrandis&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Di Fiore&quot;},{&quot;first_name&quot;:&quot;Giuseppina&quot;,&quot;last_name&quot;:&quot;De Simone&quot;},{&quot;first_name&quot;:&quot;Claudiu&quot;,&quot;last_name&quot;:&quot;T. Supuran&quot;},{&quot;first_name&quot;:&quot;Atul&quot;,&quot;last_name&quot;:&quot;Purohit&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Reed&quot;},{&quot;first_name&quot;:&quot;Barry&quot;,&quot;last_name&quot;:&quot;V. L. Potter&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;1295-1308&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701319c&quot;},&quot;abstract&quot;:&quot;The synthesis, SAR, and preclinical evaluation of 17-cyanated 2-substituted estra-1,3,5(10)-trienes as anticancer agents are discussed. 2-Methoxy-17β-cyanomethylestra-1,3,5(10)-trien-3-ol (14), but not the related 2-ethyl derivative 7, and the related 3-O-sulfamates 8 and 15 display potent antiproliferative effects (MCF-7 GI50 300, 60 and 70 nM, respectively) against human cancer cells in vitro. Investigation of the SAR reveals that a sterically unhindered hydrogen bond acceptor attached to C-17 is most likely key to the enhanced activity. Compound 8 displayed significant in vitro antiangiogenic activity, and its ability to act as a microtubule disruptor was confirmed. Inhibitory activity of the sulfamate derivatives against steroid sulfatase and carbonic anhydrase II (hCAII) was also observed, and the interaction between 15 and hCAII was investigated by protein crystallography. The potential of these multimechanism anticancer agents was confirmed in vivo, with promising activity observed for both 14 and 15 i&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701319c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701319c" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701319c&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701319c" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701319c&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701319c" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701319c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701319c&amp;href=/doi/10.1021/jm701319c" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701319c" /></input><a href="/doi/pdf/10.1021/jm701319c" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701319c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701319c%26sid%3Dliteratum%253Aachs%26pmid%3D18260615%26genre%3Darticle%26aulast%3DLeese%26date%3D2008%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BC-17%2BCyano-Substituted%2BEstratrienes%2Bas%2BAnticancer%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D5%26spage%3D1295%26epage%3D1308%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291983" title="Nitrogen compounds">Nitrogen compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis, SAR, and preclinical evaluation of 17-cyanated 2-substituted estra-1,3,5(10)-trienes as anticancer agents are discussed. 2-Methoxy-17β-cyanomethylestra-1,3,5(10)-trien-3-ol (<b>14</b>), but not the related 2-ethyl derivative <b>7</b>, and the related 3-<i>O</i>-sulfamates <b>8</b> and <b>15</b> display potent antiproliferative effects (MCF-7 GI<sub>50</sub> 300, 60 and 70 nM, respectively) against human cancer cells in vitro. Investigation of the SAR reveals that a sterically unhindered hydrogen bond acceptor attached to C-17 is most likely key to the enhanced activity. Compound <b>8</b> displayed significant in vitro antiangiogenic activity, and its ability to act as a microtubule disruptor was confirmed. Inhibitory activity of the sulfamate derivatives against steroid sulfatase and carbonic anhydrase II (hCAII) was also observed, and the interaction between <b>15</b> and hCAII was investigated by protein crystallography. The potential of these multimechanism anticancer agents was confirmed in vivo, with promising activity observed for both <b>14</b> and <b>15</b> in an athymic nude mouse MDA-MB-231 human breast cancer xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of angiogenesis inhibitors, which block the formation of new blood vessels required by tumors to support their growth,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> offered a novel therapeutic approach to the treatment of cancer and stimulated extensive research in the area.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although a number of potent angiogenesis inhibitors have been discovered, their application as single agent cancer therapies has not shown the hoped for clinical benefits. However, use in combination with conventional cytotoxic agents has produced more encouraging results. This approach, illustrated by the use of bevacizumab,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> a monoclonal antibody against vascular endothelial growth factor (VEGF), in combination with chemotherapy has been shown to improve the survival of patients with colorectal,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> lung, and breast cancer.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The success of this treatment strategy highlights the potential that exists for drugs that can exert an antiangiogenic effect in concert with a second antitumor activity.</div><div class="NLM_p">In previous studies, we detailed the discovery of a number of sulfamoylated 2-substituted estratriene derivatives<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6-9)</a> that, like the endogenous estrogen metabolite 2-methoxyestradiol (<b>1</b>) (2-MeOE2), exhibit antiproliferative activity against cancer cells and also display an antiangiogenic effect.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> Although notable mechanistic differences between the 2-substituted estratriene-3-<i>O</i>-sulfamates <b>2</b> and <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and <b>1</b> have been reported and are discussed in depth elsewhere,<a onclick="showRef(event, 'ref11 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref14 ref15">(11, 14, 15)</a> in essence the antitumor effects of both compound series appear to stem from their ability to disrupt normal microtubule dynamics, which arrests the cell cycle and leads the rapidly dividing cancer cells to undergo apoptosis.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The estratriene sulfamate series is, however, differentiated from the corresponding substituted estradiol derivatives by the enhanced antitumor activity and high oral bioavailability,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which they display and, additionally, by their ability to inhibit both steroid sulfatase (STS<a class="ref internalNav" href="#fn1" aria-label="a">a</a>, irreversibly)<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> and carbonic anhydrase (CA, reversibly).<a onclick="showRef(event, 'ref9 ref19'); return false;" href="javascript:void(0);" class="ref ref9 ref19">(9, 19)</a> STS is a clinical target for the treatment of hormone dependent cancer,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> while the carbonic anhydrase IX isoform, which is highly expressed in a number of tumors, has also been proposed as a target for cancer therapy.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> It should be noted that the activities of these 2-substituted estratriene derivatives are independent of the estrogen receptor, toward which they exhibit negligible affinity. They are thought to bind to the colchicine binding site of α-tubulin.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: EMATE, estrone-3-<i>O</i>-sulfamate; E2MATE, estradiol-3-<i>O</i>-sulfamate; E2bisMATE, estradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate; STS, Steroid sulfatase; CA, carbonic anhydrase; hCAII, human carbonic anhydrase II; ER, estrogen receptor; E2S, estradiol-3-<i>O</i>-sulfate; HDBC, hormone-dependent breast cancer; HIF, hypoxia inducible factor; DMA, <i>N</i>,<i>N</i>-dimethylacetamide.</p></div></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of 2-methoxyestradiol <b>1</b>, 2-MeOE2MATE <b>2</b>, and 2-MeOE2bisMATE <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SAR studies showed that both substitution at C-2 of the steroidal A-ring and an unsubstituted sulfamate group at C-3 are requisite for high antiproliferative activity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Optimal activity was conferred by a C-2 ethyl, methylsulfanyl, or methoxy substituent. Although a number of 2-substituted estradiol derivatives displayed antiproliferative and antiangiogenic activity,<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> these nonsulfamoylated molecules are typically much less potent, as illustrated by the mean activities of <b>1</b> and 2-methoxyestradiol-3-<i>O</i>-sulfamate (<b>2</b>) (2-MeOE2MATE) across the NCI 60 cell line panel (MGM values of 1.3 µM and 110 nM, respectively).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This finding is especially significant in light of the extensive evaluation of <b>1</b> as an anticancer agent in numerous academic studies and ongoing phase II clinical trials. It would seem that the advantages conferred by the incorporation of the 3-<i>O</i>-sulfamate group are manifold, in that this group affords both enhanced antiproliferative activity and resistance to inactivating conjugation of the C-3 hydroxyl group, to which the corresponding estradiol derivatives are subject. Furthermore, estrogen 3-<i>O</i>-sulfamates are also highly active reversible inhibitors of carbonic anhydrase II (CAII), an enzyme that is highly expressed in red blood cells, through a coordination of the monoanionic form of the sulfamate moiety to the zinc atom in the enzyme active site.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This interaction is believed to underlie the high oral bioavailability observed for estradiol-3-<i>O</i>-sulfamate (E2MATE) (which is atypical of estrogen derivatives), wherein reversible uptake by red blood cells and interaction with carbonic anhydrase II results in avoidance of first pass liver metabolism,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and it is plausible to suggest that such a mechanism could well operate advantageously for 2-substituted derivatives of E2MATE.</div><div class="NLM_p">To date, SAR knowledge of these compounds outside the A-ring is limited to variation of the oxidation level of, and/or substitution at, the C-17-position of the estratriene core. 17-Hydroxy, 17-keto, and 17-oximino derivatives at C-17 display similar potency, though the 17-deoxy- and 17α-benzyl derivatives exhibit greatly reduced antiproliferative activity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> An improvement in in vitro antiproliferative activity was achieved by installation of a second <i>O</i>-sulfamate group at C-17, and significantly, this enhanced activity was seen to translate into enhanced in vivo antitumor effects. The C-17 sulfamate group of the 2-substituted estradiol-3,17-<i>O,O</i>-bis-sulfamates thus not only provides for greater activity, by presumably exploiting electrostatic interactions at the site of action unavailable to the smaller oxygen functions of the first generation compounds but also serves to block inactivating metabolism and conjugation reactions to which they (especially the 17-hydroxyl derivatives) are subject. Compound <b>1</b> has been shown to be rapidly metabolized to inactive 2-methoxyestrone (2-MeOE1) by 17β-hydroxysteroid dehydrogenase type II (17β-HSD type II), while the 3,17-<i>O,O</i>-bis-sulfamate derivatives are not subject to 17β-HSD type II metabolism.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The combination of inactivating metabolism with rapid conjugative inactivation through reaction of the hydroxyl groups, to which <b>1</b> is subject, emphasizes the need for molecules with improved pharmacokinetic profiles as well as potency, as amply illustrated by a recent clinical trial where a dose escalation of up to 6 g/day of <b>1</b> was used in an attempt to achieve satisfactory plasma concentrations.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> Pharmacokinetic studies in rats showed that 2-methoxyestradiol-3,17-<i>O,O</i>-bis-sulfamate (<b>3</b>) (2-MeOE2bisMATE), however, displayed 85% bioavailability on oral dosing and was still detectable after 24 h, while identically dosed <b>1</b> was undetectable after just 5 min.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> X-ray crystallography was used to examine the interaction of 2-MeOE2bisMATE with human carbonic anhydrase II (hCAII) and proved, unexpectedly, that the 17-<i>O</i>-sulfamate group of this compound could also interact with the catalytic zinc of the enzyme active site in a manner analogous to that observed for the 3-<i>O</i>-sulfamate group of E2MATE,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> although interaction also of the 3-<i>O</i>-sulfamate in vivo is not necessarily excluded. Thus, it appears that, in addition to the properties discussed above, the 17-<i>O</i>-sulfamate of <b>3</b> may also enhance oral bioavailability by allowing a reversible uptake into red blood cells and through interaction with hCAII affords a mechanism for avoiding first pass liver metabolism.</div><div class="NLM_p last">Encouraged by the high activity and excellent pharmacokinetic profile displayed by the compounds such as <b>3</b>, we explored whether further D-ring modification could afford still greater enhancement in activity. To this end, a series of C-17-carbamate derivatives was synthesized, allowing us to establish that the carbamate function could, in certain cases, successfully function as a bioisostere for the C-17-sulfamate group.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We were thus also drawn to examine further C-17 functional groups that could serve as hydrogen bond acceptors in the hope of discovering even more active compounds and herein report the discovery of 17-cyano-substituted estra-1,3,5(10)-trienes as compounds that exhibit potent antiproliferative and antiangiogenic activity, despite only possessing a single sulfamate group.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Earlier SAR studies demonstrated that a 3-<i>O</i>-sulfamate group is critical for highly potent activity, but that 2-methoxyestradiol-17-<i>O</i>-sulfamate is essentially inactive.<a onclick="showRef(event, 'ref6 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref9">(6, 9)</a> We were, therefore, drawn to examine whether the 17-<i>O</i>-sulfamate group of the 2-substituted estradiol-3,17-<i>O,O</i>-bis-sulfamates could be replaced with a small hydrogen bond-accepting group tethered to C-17, reasoning that a sterically smaller functional group might provide enhanced in vitro antiproliferative activity. In order to mimic the distance between the proposed hydrogen bond acceptor and C-17 of the sulfamate group, a two atom linker would be required between C-17 and the H-bond acceptor. We thus decided to install a cyanomethyl group at C-17 since the alkyl linker would afford a reasonable degree of flexibility, and the cyano group should offer sterically unhindered H-bonding interactions through the terminal nitrogen atom. This is clearly illustrated by computational overlay of bis-sulfamate <b>3</b> and nitrile compound <b>15</b> (vide infra) presented in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. The close spatial proximity of the nitrile nitrogen and 17-<i>O</i>-sulfamate <i>NH<sub>2</sub></i> would suggest that they could function analogously as H-bond acceptors, albeit with differing electronic and steric properties, which might allow the nitrile to interact more strongly with those residues (Asn349 and Val315) around the colchicine binding site of tubulin identified by docking studies as potential H-bond donors to the 17-<i>O</i>-sulfamate group of <b>3</b>.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Computational overlay of minimal energy conformations of 17-<i>O</i>-sulfamoyl <b>3</b> and 17-cyanomethyl <b>15</b> functionalized estra-1,3,5[10]-triene derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A Horner-Wadsworth-Emmons reaction between TBS-protected 2-ethylestrone <b>4</b> and diethylcyanomethyl phosphonate was thus carried out in refluxing THF to give the cyanomethylene derivative <b>5</b> in an excellent 94% yield as a mixture of its <i>E</i>- and <i>Z</i>-isomers (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Hydrogenation of the double bond delivered the 17β-alkane <b>6</b>, which was then desilylated with TBAF in THF to deliver phenol <b>7</b>. Sulfamoylation of <b>7</b> was then achieved by reaction with a solution of sulfamoyl chloride in DMA following the method of Okada and co-workers<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> to give sulfamate <b>8</b>. Desilylation of alkene <b>5</b> was also carried out to deliver the phenol as a mixture of the geometric isomers from which the <i>E</i>-alkene <b>9</b> could be isolated by chromatography. Sulfamoylation of <b>9</b> was then carried out to deliver sulfamate <b>10</b>. The analogous series of reactions was performed in the 2-methoxy series with <b>11</b> being transformed into the respective phenol (<b>14</b> and <b>16</b>) and sulfamate (<b>15</b> and <b>17</b>) derivatives.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0003.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 17-Cyanomethyl and 17-Cyanomethylene Estra-1,3,5(10)-triene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (EtO)<sub>2</sub>POCH<sub>2</sub>CN, NaH, THF; (ii) H<sub>2</sub>, Pd/C, THF/EtOH; (iii) TBAF, THF; (iv) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA.</p></p></figure><div class="NLM_p">An X-ray crystal structure of <b>15</b> was obtained and is presented in Figure <a class="ref internalNav" href="#fig3" aria-label="3">3</a>. This structure confirms the β-stereochemistry of the alkyl substituent C-17 and confirms that the integrity of the chiral centers of the estra-1,3,5(10)-triene core are retained throughout the synthesis. Intermolecular hydrogen bonding between the sulfamate <i>NH<sub>2</sub></i> group and both the nitrile of crystallographically adjacent <b>15</b> and acetone (the crystallization solvent) molecules is observed. The X-ray crystal structure of 2-methoxyestrone-3-<i>O</i>-sulfamate showed no such intermolecular interaction, with the sulfamate appearing instead to hydrogen bond to the adjacent methoxy group in an intramolecular fashion.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The appearance of intra or intermolecular hydrogen bonding may simply derive from the choice of crystallization solvent.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of <b>15</b> displaying the intermolecular hydrogen bonding through the sulfamate <i>NH</i> to the nitrile of the neighboring <b>15</b> and also to the carbonyl oxygen in the solvent of crystallization (acetone). Ellipsoids are represented at 30% probability. Primed labeled atoms were generated via the –1 + <i>x</i>, <i>y</i>, 1 + <i>z</i> symmetry operation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To assess whether the presence of a second cyano group would be beneficial, the (dicyano)methylene and (dicyano)methyl derivatives of 2-ethylestrone were synthesized (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Condensation of <b>4</b> with malononitrile in the presence β-alanine was thus carried out. Although this reaction proved relatively slow, requiring the addition of extra aliquots of malononitrile after 24 and 48 h, the yield of <b>18</b>, however (91%), proved excellent. Sequential desilylation of <b>18</b> and sulfamoylation afforded phenol <b>19</b> and sulfamate <b>20</b>, respectively. Reduction of the Δ-17 double bond of estratetraene <b>18</b> was achieved with sodium borohydride in THF/MeOH to give <b>21</b>, which was then converted to phenol <b>22</b> and sulfamate <b>23</b> as described above.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0005.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 17-(1,1-Dicyano)methyl Estra-1,3,5(10)-triene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) CH<sub>2</sub>(CN)<sub>2</sub>, β-alanine, PhMe; (ii) TBAF, THF; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA; (iv) NaBH<sub>4</sub>, THF/MeOH.</p></p></figure><div class="NLM_p">In order to study further steric effects around C-17, we were drawn to methylate <b>6</b> at C-20. After some investigation, it was determined that deprotonation of the C-20 methylene group could be achieved with 2.2 equivalents of LDA in THF at −78 °C with methyl iodide quench delivering C-20 monomethyl compound <b>24</b> in good yield (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Attempts to introduce a <i>gem</i>-dimethyl group in a one pot procedure directly from <b>6</b> or by lithiation and electrophilic quench of <b>24</b>, however, proved abortive, and we thus decided to inspect an alternate approach to compounds with alkyl substituted side chains. Reaction of benzyl protected 2-ethylestrone <b>25</b> with the lithio-anion of propionitrile afforded the 17α-alkylated estradiol derivative <b>26</b> in reasonable 76% yield, which could then be dehydrated with methanesulfonic acid/triethylamine to give a 95:5 mixture of the Δ-17 and Δ-16 dehydration products with the former, <b>27</b>, being isolated by column chromatography as a single isomer (<i>Z</i>-stereochemistry as assigned by NOE experiments) in 85% yield. Dehydration of <b>26</b> with Burgess reagent<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> delivered spectroscopically identical material. Concurrent debenzylation and double bond hydrogenation delivered 17β-(1-cyano)ethyl phenol (<b>28</b>), which was then sulfamoylated to give <b>29</b>. Reaction of the lithio-anion of isobutyronitrile with benzyl estrone was performed to test the approach to C-20 <i>gem</i>-dimethyl target compounds, and though this reaction proved successful, dehydration of the product alcohol proved intractable.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0006.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 1-(Cyano)ethyl Side Chains at C-17<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LDA, THF, MeI, −78 °C to rt; (ii) EtCN, LDA, THF, −78 °C; (iii) MsOH, Et<sub>3</sub>N, DCM, or Burgess reagent, DMF; (iv) H<sub>2</sub>, Pd/C, THF/EtOH; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA.</p></p></figure><div class="NLM_p">To confirm whether the activities observed for the nitrile series (vide infra) were attributable to their H-bond acceptor capabilities, the isosteric 17β-prop-2-ynyl compound <b>32</b> was synthesized (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). DIBALH reduction of the nitrile group of <b>6</b> was thus carried out to give the aldehyde <b>30</b> in reasonable 61% yield, which could then be reacted with Ohiraʼs reagent<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> to afford the 3-hydroxy alkyne <b>31</b>, as the phenolic TBS group proved unstable to the conditions of the reaction. The desired sulfamate <b>32</b> was then formed by reaction with sulfamoyl chloride in DMA.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0007.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-prop-2-ynyl Estra-1,3,5(10)-triene<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIBALH, PhMe/CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt; (ii) (MeO)<sub>2</sub>POC(N<sub>2</sub>)COMe, MeOH, K<sub>2</sub>CO<sub>3</sub>; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA.</p></p></figure><div class="NLM_p">To assess the effects of direct linkage of the nitrile group to C-17 the cyanohydrin <b>34</b> was formed by reaction of 2-ethyl-3-<i>O</i>-acetyl estrone <b>33</b> with potassium cyanide over 5 days at room temperature (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Dehydration of the cyanohydrin with thionyl chloride in refluxing pyridine gave the Δ-16 product <b>35</b>, which could then be deprotected and sulfamoylated to give <b>40</b> or hydrogenated to give the 17β-cyano derivative <b>36</b>, which was then converted to phenol <b>37</b> and sulfamate <b>38</b> derivatives, as previously described.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0008.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 17-Cyano Estra-1,3,5(10)-triene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) KCN, AcOH, MeOH; (ii) SOCl<sub>2</sub>, pyridine, reflux; (iii) H<sub>2</sub>, Pd/C, THF/MeOH; (iv) NaHCO<sub>3</sub>, MeOH/acetone; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As a first stage predictor of antitumor activity, compounds were assayed for their ability to inhibit the proliferation of a panel of cancer cell lines in vitro. All compounds were screened against DU-145 cells, a human androgen receptor negative (AR−) prostate cancer cell line. The majority of compounds were additionally screened for their ability to inhibit the proliferation of MCF-7 and MDA MB-231 cells (human breast cancer estrogen receptor positive (ER+) and estrogen receptor negative (ER−), respectively). The results obtained from this in vitro screening are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The first striking result in the table is the activity of the 2-methoxy-17-cyanomethyl estra-1,3,5(10)-trien-3-ol (<b>14</b>), which is 2.5-fold more potent against the proliferation of DU-145 cells and ca. 8-fold more potent against the proliferation of both breast cancer cell lines than <b>1</b>. To the best of our knowledge, this is the first time substitution at C-17 alone has provided such an enhancement in antiproliferative activity with respect to the corresponding 17-hydroxy compound, although derivatives of <b>1</b> bearing unsaturation in the D-ring, notably the 14-dehydro derivative, have been reported to have significantly enhanced effects on cancer cell proliferation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In comparison, the corresponding 17-<i>O</i>-sulfamate derivative of <b>1</b> proved less active than <b>1</b> with a GI<sub>50</sub> of >10 µM.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Interestingly, the corresponding 2-ethyl substituted phenol <b>7</b> though 5−10-fold less active than <b>14</b>, was found to be 4-fold more active than 2-ethylestradiol <b>41</b> against DU-145 cells, thus mirroring the beneficial effects of the C-17 cyanomethyl group on antiproliferative activity in the phenol series, an effect that could potentially be used to provide for further enhanced activity if used in conjunction with C-2 substituents, which are reported to deliver enhanced activity in the estradiol series. The 17-(<i>E</i>)-cyanomethylene functionalized phenols <b>9</b> and <b>16</b>, in contrast, displayed no significant activity, a result that suggests that rotation around the C-17-C-20 bond is required to allow either optimal electrostatic interaction or minimize disfavorable steric effects.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antiproliferative Activities of Estratriene Derivatives against Human Cancer Cells in Vitro<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom">No</th><th align="center" valign="bottom">R<sub>1</sub></th><th align="center" valign="bottom">R<sub>2</sub></th><th align="center" valign="bottom">R<sub>3</sub></th><th align="center" valign="bottom" char=".">DU-145 (µM)</th><th align="center" valign="bottom" char=".">MCF-7 (µM)</th><th align="center" valign="bottom" char=".">MDAMB-231 (µM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>1</b></td><td align="left" valign="top">MeO</td><td align="left" valign="top">H</td><td align="left" valign="top">17β-OH</td><td align="char" valign="top" char=".">1.22</td><td align="char" valign="top" char=".">2.35</td><td align="char" valign="top" char=".">0.94</td></tr><tr valign="top"><td align="left" valign="top"><b>2</b></td><td align="left" valign="top">MeO</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">17β-OH</td><td align="char" valign="top" char=".">0.39</td><td align="char" valign="top" char=".">0.36</td><td align="char" valign="top" char=".">0.170</td></tr><tr valign="top"><td align="left" valign="top"><b>3</b></td><td align="left" valign="top">MeO</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">17β-OSO<sub>2</sub>NH<sub>2</sub></td><td align="char" valign="top" char=".">0.34</td><td align="char" valign="top" char=".">0.25</td><td align="char" valign="top" char=".">0.28</td></tr><tr valign="top"><td align="left" valign="top"><b>41</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">17β-OH</td><td align="char" valign="top" char=".">10.3</td><td align="char" valign="top" char=".">10.5</td><td align="char" valign="top" char=".">8.0</td></tr><tr valign="top"><td align="left" valign="top"><b>42</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH <sub>2</sub></td><td align="left" valign="top">17β-OSO<sub>2</sub> NH<sub>2</sub></td><td align="char" valign="top" char=".">0.21</td><td align="char" valign="top" char=".">0.07</td><td align="char" valign="top" char=".">0.21</td></tr><tr valign="top"><td align="left" valign="top"><b>14</b></td><td align="left" valign="top">MeO</td><td align="left" valign="top">H</td><td align="left" valign="top">17β-CH<sub>2</sub>CN</td><td align="char" valign="top" char=".">0.485</td><td align="char" valign="top" char=".">0.3</td><td align="char" valign="top" char=".">0.117</td></tr><tr valign="top"><td align="left" valign="top"><b>15</b></td><td align="left" valign="top">MeO</td><td align="left" valign="top">SO<sub>2</sub> NH <sub>2</sub></td><td align="left" valign="top">17β -CH<sub>2</sub> CN</td><td align="char" valign="top" char=".">0.062</td><td align="char" valign="top" char=".">0.07</td><td align="char" valign="top" char=".">0.071</td></tr><tr valign="top"><td align="left" valign="top"><b>16</b></td><td align="left" valign="top">MeO</td><td align="left" valign="top">H</td><td align="left" valign="top">(<i>E</i>) ═CHCN</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char=".">28</td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>17</b></td><td align="left" valign="top">MeO</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">(<i>E</i>) ═CHCN</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char=".">0.24</td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>7</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">17β-CH<sub>2</sub>CN</td><td align="char" valign="top" char=".">2.5</td><td align="char" valign="top" char=".">3.24</td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>8</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">17β-CH<sub>2</sub>CN</td><td align="char" valign="top" char=".">0.054</td><td align="char" valign="top" char=".">0.06</td><td align="char" valign="top" char=".">0.141</td></tr><tr valign="top"><td align="left" valign="top"><b>9</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">(<i>E</i>) ═CHCN</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>10</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">(<i>E</i>) ═CHCN</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char=".">0.48</td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>19</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">:C(CN)<sub>2</sub></td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">25.9</td><td align="char" valign="top" char=".">20.0</td></tr><tr valign="top"><td align="left" valign="top"><b>20</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">:C(CN)<sub>2</sub></td><td align="char" valign="top" char=".">0.267</td><td align="char" valign="top" char=".">0.21</td><td align="char" valign="top" char=".">0.289</td></tr><tr valign="top"><td align="left" valign="top"><b>22</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">17β-CH(CN)<sub>2</sub></td><td align="char" valign="top" char=".">2.99</td><td align="char" valign="top" char=".">3.9</td><td align="char" valign="top" char=".">2.62</td></tr><tr valign="top"><td align="left" valign="top"><b>23</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">17β-CH(CN)<sub>2</sub></td><td align="char" valign="top" char=".">0.159</td><td align="char" valign="top" char=".">0.33</td><td align="char" valign="top" char=".">0.249</td></tr><tr valign="top"><td align="left" valign="top"><b>29</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">17β-CHMe</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">29.1</td><td align="char" valign="top" char=".">7.50</td></tr><tr valign="top"><td align="left" valign="top"><b>30</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">17β-CHMe</td><td align="char" valign="top" char=".">9.9</td><td align="char" valign="top" char=".">0.32</td><td align="char" valign="top" char=".">10.3</td></tr><tr valign="top"><td align="left" valign="top"><b>31</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">17β-CH<sub>2</sub>CCH</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>32</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">17β-CH<sub>2</sub>CCH</td><td align="char" valign="top" char=".">1.69</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>37</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">17β-CN</td><td align="char" valign="top" char=".">n/a</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td></tr><tr valign="top"><td align="left" valign="top"><b>38</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">17β-CN</td><td align="char" valign="top" char="."><0.5</td><td align="char" valign="top" char=".">0.324</td><td align="char" valign="top" char=".">0.342</td></tr><tr valign="top"><td align="left" valign="top"><b>39</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">H</td><td align="left" valign="top">Δ-16,17-CN</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">57.3</td></tr><tr valign="top"><td align="left" valign="top"><b>40</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">SO<sub>2</sub>NH<sub>2</sub></td><td align="left" valign="top">Δ-16,17-CN</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">75.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Data for compounds <b>1</b>–<b>3</b>, <b>41</b>, and <b>42</b> are taken from the literature.<a onclick="showRef(event, 'ref9 ref30'); return false;" href="javascript:void(0);" class="ref ref9 ref30">(9, 30)</a> GI<sub>50</sub> figures are the mean values obtained from experiments performed in triplicate; s.e.m. = ±7%.</p></div></div></div><div class="NLM_p">The 3-<i>O</i>-sulfamate derivatives bearing the 17-cyanomethyl group in both the 2-methoxy <b>15</b> and 2-ethyl <b>8</b> series proved to be exceptionally potent being, in DU-145 cells, 5.5- and 3.5-fold more active than the 2-methoxy- and 2-ethyl-E2bisMATE compounds (<b>3</b> and <b>42</b>, respectively), which they were designed to mimic. The effects of <b>15</b> and <b>8</b> against breast cancer cell proliferation were similarly profound with 50% growth inhibition obtained in the low nanomolar range. As observed in the phenol series, the 3-<i>O</i>-sulfamoylated 2-methoxy <b>17</b> and 2-ethyl <b>10</b> compounds bearing a C-17 cyanomethylene group were less potent than the corresponding cyanomethyl compounds, with activities against MCF-7 proliferation reduced by 4- and 8-fold, respectively, presumably reflecting the inability of the rigid 17-substituent of these compounds to attain optimal geometry at the site of action.</div><div class="NLM_p">The activities of the remaining compounds in the series serve to characterize the spatial and electronic requirements for high activity. Introduction of a second cyano substituent on the C-17 tethered alkyl group resulted in a slight reduction in antiproliferative activity in the case of both phenol <b>22</b> and sulfamate <b>23</b>, albeit <b>23</b> is of a similar potency to the corresponding bis-sulfamate <b>42</b>. Introduction of a second H-bond acceptor group thus appears only to hinder the key interaction between the C-17 functionality and the site of action. Introduction of a methyl-substituent on the nitrile substituted carbon <b>29</b> caused a reduction in activity similar to that effected by the additional nitrile of <b>23</b>, which would suggest that the increased steric bulk around the hydrogen bond acceptor interferes with attainment of the optimal conformation at the site of action. The rigid dicyano-alkene substitution gave a significant decrease in activity in the phenol series <b>19</b>, although sulfamate <b>20</b> was essentially equipotent with the corresponding alkane <b>23</b>. As we had anticipated, alkyne <b>32</b> wherein the hydrogen bond acceptor nitrogen of <b>8</b> is replaced with with a CH group proved 30-fold less active than the nitrile compound, thus strongly supporting the postulate that the hydrogen bond acceptor group is essential for high antiproliferative activity. By extension, this supports our conclusions on the function of the C-17 sulfamate, principally as a hydrogen bond acceptor, in the bis-sulfamate series. Shortening of the linker group between C-17 and the hydrogen bond acceptor was also found to be deleterious to antiproliferative activity with a 6-fold reduction in activity observed for the 17β-nitrile derivative <b>38</b> relative to the corresponding 17-cyanomethyl compound <b>8</b>. The Δ-16 unsaturated derivatives proved to be essentially inactive as both phenol <b>39</b> and sulfamate <b>40</b>.</div><div class="NLM_p">Thus, it can be seen that C-17 cyanomethyl substitution of 2-substituted estra[1,3,5]-triene-3-<i>O</i>-sulfamates affords a series of molecules with enhanced in vitro antiproliferative activity relative to the C-17 sulfamate series. An enhancement in activity is also evident in the nonsulfamoylated series with <b>7</b> and <b>14</b> found to be more potent than the corresponding estradiol derivatives. The 3-<i>O</i>-sulfamates <b>8</b> and <b>15</b> are the most potent 2-substituted estra[1,3,5]-triene-3-<i>O</i>-sulfamates discovered to date, with <b>15</b> proving to be up to 33-fold more active than <b>1</b> in vitro. Substitution, or deletion, of the CH<sub>2</sub> linker between C-17 and the nitrile group results in reduced activity, while replacement of the hydrogen bond-accepting nitrile group of <b>8</b> with an isosteric ethynyl group (compound <b>32</b>) results in a 30-fold reduction in activity and a more than 40-fold reduction for the unsulfamoylated pair <b>7</b> and <b>31</b>. On the evidence of these results, it appears that the C-17 cyanomethyl substituent most likely affords enhanced antiproliferative activity by functioning as a sterically unhindered hydrogen bond acceptor group, even in the simple 2-methoxyestradiol analogue series, which is positioned at the appropriate distance from C-17 in the biological site of action.</div><div class="NLM_p">A number of the novel 17-cyanomethyl derivatives were screened for antiproliferative activity by the NCI in their 60-cell line assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> Unfortunately, the most active compounds in the series, <b>8</b> and <b>15</b>, were not selected by the NCI for evaluation, though the relative activities of compounds <b>23</b> and <b>29</b> compare favorably with both <b>1</b> and <b>3</b>, for which comparative data are included. Compounds <b>23</b> and <b>29</b> caused >50% growth inhibition in the majority of cell lines at concentrations below 10 nM, with mean growth inhibition (MGM) of 30 and 22 nM, respectively (an MGM of 10 nM is maximal in this case because of the range of concentrations (10 nM to 100 µM) tested and would be achieved only if 50% growth inhibition was observed in all 60 cell lines at 10 nM). The 17-cyanomethyl compounds were thus seen to show slightly greater activity than <b>3</b> and are, notably, 40-fold more active than <b>1</b> across the NCI panel. In comparison, sulfamates <b>40</b> and <b>38</b>, whose cyano-groups are directly linked to C-17, showed greatly reduced activity, while <b>37</b>, the nonsulfamoylated analogue of <b>38</b>, showed no activity. These NCI results confirm the activity observed in our preliminary screens and, furthermore, demonstrate the effects of these compounds against a wide range of cancer phenotypes.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiproliferative Activity of Selected Compounds in the NCI 60-cell Line Panel<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom"> </th><th align="center" valign="bottom" char=".">lung HOP-62</th><th align="center" valign="bottom" char=".">colon HCT-116</th><th align="center" valign="bottom" char=".">CNS SF-539</th><th align="center" valign="bottom" char=".">melanoma UACC-62</th><th align="center" valign="bottom" char=".">ovarian OVCAR-3</th><th align="center" valign="bottom" char=".">renal SN12-C</th><th align="center" valign="bottom" char=".">prostate DU-145</th><th align="center" valign="bottom" char=".">breast MDA-MB-435</th><th align="center" valign="bottom" char=".">MGM (µM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>1</b></td><td align="char" valign="top" char=".">0.7</td><td align="char" valign="top" char=".">0.47</td><td align="char" valign="top" char=".">0.32</td><td align="char" valign="top" char=".">0.36</td><td align="char" valign="top" char=".">0.21</td><td align="char" valign="top" char=".">0.95</td><td align="char" valign="top" char=".">1.8</td><td align="char" valign="top" char=".">0.08</td><td align="char" valign="top" char=".">1.3</td></tr><tr valign="top"><td align="left" valign="top"><b>3</b></td><td align="char" valign="top" char=".">0.051</td><td align="char" valign="top" char=".">0.045</td><td align="char" valign="top" char=".">0.036</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char=".">0.126</td><td align="char" valign="top" char=".">0.083</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char=".">0.087</td></tr><tr valign="top"><td align="left" valign="top"><b>23</b></td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char=".">0.03</td></tr><tr valign="top"><td align="left" valign="top"><b>29</b></td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char=".">NA</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char=".">NA</td><td align="char" valign="top" char="."><0.01</td><td align="char" valign="top" char=".">0.022</td></tr><tr valign="top"><td align="left" valign="top"><b>37</b></td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">>100</td></tr><tr valign="top"><td align="left" valign="top"><b>38</b></td><td align="char" valign="top" char=".">0.512</td><td align="char" valign="top" char=".">0.724</td><td align="char" valign="top" char=".">4.16</td><td align="char" valign="top" char=".">0.588</td><td align="char" valign="top" char=".">14.7</td><td align="char" valign="top" char=".">6.76</td><td align="char" valign="top" char=".">2.69</td><td align="char" valign="top" char=".">3.16</td><td align="char" valign="top" char=".">3.16</td></tr><tr valign="top"><td align="left" valign="top"><b>40</b></td><td align="char" valign="top" char=".">2.63</td><td align="char" valign="top" char=".">4.07</td><td align="char" valign="top" char=".">0.524</td><td align="char" valign="top" char=".">4.07</td><td align="char" valign="top" char=".">3.55</td><td align="char" valign="top" char=".">4.47</td><td align="char" valign="top" char=".">2.51</td><td align="char" valign="top" char=".">2.95</td><td align="char" valign="top" char=".">3.63</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Results are GI<sub>50</sub> values in micromolar. Data for <b>1</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and <b>3</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> are taken from the literature.</p></div></div></div><div class="NLM_p">To assess potential antiangiogenic activity, the compounds were assayed for the ability to inhibit the proliferation of human umbilical vein endothelial cells (HUVECs). The IC<sub>50</sub> values obtained for <b>1</b>, <b>3</b>, and <b>15</b> against HUVEC proliferation were 523, 44, and 30 nM, respectively.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> It can thus be seen that the sulfamate derivatives express their in vitro antiangiogenic effects at far lower concentrations than <b>1</b>. Compound <b>8</b> was also assayed for antiangiogenic activity in an in vitro model of angiogenesis, wherein endothelial cells cocultured in a matrix of human dermal fibroblasts are used to assess antiangiogenic potential (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). When stimulated with VEGF, the endothelial cells proliferate and migrate through the matrix to form tubule-like structures (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b) and the extent of tubule formation can be quantified as described elsewhere.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a, treatment with 20 and 40 nM concentrations of <b>8</b> almost completely inhibits the formation of tubule-like structures. Quantification carried out by calculating total pixel length (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a) reflects the lack of tubule formation, which can be clearly seen in the images of the treated and untreated wells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). We have recently shown that the in vitro antiangiogenic effects of the sulfamoylated 2-substituted estratriene compounds translate well into in vivo activity with compounds including <b>15</b> showing impressive activity upon oral administration in mouse Matrigel plug assay for angiogenic activity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activity of <b>8</b> in an in vitro model of angiogenesis. (a) Plot of quantified tubule length per well in control, VEGF stimulated and <b>8</b> treated wells at 20 and 40 nM. Treated wells are stimulated by 2 ng/mL VEGF. (b) Images of the control, stimulated, and treated wells in this assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have previously established that the antiproliferative and antiangiogenic activities of the 2-substituted estratriene-3-<i>O</i>-sulfamates are derived from their ability to disrupt normal microtubule dynamics<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and wished to confirm that the 17-cyanomethyl series was acting, as we anticipated, at this target. We thus inspected the effects of <b>8</b> on the taxol stimulated polymerization of tubulin (10 µM Taxol and 20 µM <b>8</b>). As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, <b>8</b> causes a substantial inhibition of both the rate and extent of microtubule formation stimulated by Taxol, thus supporting the postulate that these compounds, as in previously studied 2-substituted estra-1,3,5(10)-triene-3-<i>O</i>-sulfamates and the related estradiol derivatives, act as microtubule disruptors. No further investigation on the interaction of these novel ligands with tubulin has yet been made, although it is notable that these ligands, like the previously studied broadly similar 2-substituted estra-1,3,5(10)-triene-3-<i>O</i>-sulfamates, which have been observed to bind tubulin in a competitive manner to radio-labeled colchicine, destabilize the polymerization of tubulin.<a onclick="showRef(event, 'ref11 ref37'); return false;" href="javascript:void(0);" class="ref ref11 ref37">(11, 37)</a></div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>8</b> disrupts microtubule dynamics. The ability of compound <b>8</b> to inhibit paclitaxel-stimulated tubulin stabilization was assessed. In vitro tubulin assembly was measured by turbidity at 350 nm. Tubulin was preincubated with or without compound <b>8</b> (10 µM) for 5 min at 37 °C. Tubulin assembly was then stimulated by adding paclitaxel (10 µM). The change in the absorbance was continuously monitored at 350 nm for 15 min at 37 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having determined that the 17-cyanomethyl compounds act against cancer cell proliferation in vitro, we assayed the compounds for activity against both STS and carbonic anhydrase. It was thought unlikely that the 17β-cyanomethyl substituent would have a profound effect on STS inhibitory activity since the key pharmacophore for inhibition of this enzyme is the phenolic sulfamate group, with activity most strongly influenced by the steric and electronic environment around C-3. Compound <b>15</b> was evaluated for its ability to inhibit the STS mediated conversion of tritiated E1S to E1 in placental microsomes.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> An IC<sub>50</sub> of 130 nM was obtained, thus confirming that 17-cyanomethyl substitution has little detrimental effect on STS inhibitory activity relative to the analogous 17-hydroxy compound, 2-MeOE2MATE (<b>2</b>) (16 nM), or the 17-<i>O</i>-sulfamate compound, 2-MeOE2bisMATE (<b>3</b>) (39 nM). The 2-ethyl compound <b>8</b> was found to be less active as an STS inhibitor with an IC<sub>50</sub> of 1.4 ± 0.4 µM, reflecting the lower activity generally observed for 2-ethyl compounds as inhibitors seen in previous studies.<a onclick="showRef(event, 'ref6 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref9">(6, 9)</a> It is thus evident that in addition to their other anticancer activities, molecules such as <b>15</b>, by functioning as inhibitors of STS, could act against hormone dependent cancers by lowering the levels of circulatory estrogen that stimulate their growth.</div><div class="NLM_p">The ability of estrogen-3-<i>O</i>-sulfamates to reversibly inhibit carbonic anhydrase is well established, with the key interaction being the coordination of the monoanionic form of the sulfamate to the zinc ion of the active site. This reversible interaction of phenolic sulfamates with carbonic anhydrase II could potentially allow an estratriene sulfamate derivative the advantage of sequestration by red blood cells in vivo and consequent avoidance of first pass liver metabolism.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Compound <b>15</b> was thus assayed for inhibitory activity against CAII and was found to have an IC<sub>50</sub> value of 1.5 µM against this enzyme. The activity of <b>15</b> is thus approximately 4-fold lower than the activity of a number of 2-substituted estratriene-3-<i>O</i>-sulfamate derivatives (e.g., 2-methoxyestrone-3-<i>O</i>-sulfamate (2-MeOEMATE), IC<sub>50</sub> of 376 nM and <b>3</b>, IC<sub>50</sub> of 379 nM) and also 3-fold less active than 2-methoxyestradiol-17-<i>O</i>-sulfamate (2-MeOE2–17MATE, IC<sub>50</sub> of 526 nM), which possesses a less acidic alkyl sulfamate group. The detrimental effects of 2-substitution on CA inhibitory effects are known, as estrone-3-<i>O</i>-sulfamate (IC<sub>50</sub> 42nM) is 8-fold more active than 2-MeOEMATE,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and <i>o</i>-bromination of even a simple aryl monosulfamate reduces CAII binding from 27 to 137 nM.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> This reflects, presumably, simple steric constraints close to the sulfamate binding region of the CAII active site. However, we had not previously observed that a 17-substituent, which we would expect to occupy the large lipophilic pocket above the enzyme active site, could have such an effect on inhibitory activity. We were thus drawn to further explore the interaction of <b>15</b> with hCAII to see if we could elucidate the origins of the effect of the C-17 substituent.</div><div class="NLM_p">As can been seen in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b, the sulfamate <i>NH</i> of <b>15</b> coordinates to the catalytic zinc ion (N—Zn<sup>2+</sup> = 2.08 Å) of the enzyme active site displacing the hydroxide ion present in the active site of the uninhibited enzyme. The zinc ion is also coordinated to three histidine residues (His94, His96, and His119) with an overall tetrahedral geometry. Two hydrogen bonds between the sulfamate and Thr 199 through their respective <i>NH</i> and <i>O</i> groups (see Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b) are also apparent, with the steroid nucleus lying in the hydrophobic part of the active site pocket. The presence of the 2-substituent has previously proved to be detrimental to CAII inhibitory activity, and it would thus appear that groups at the 2-position render the interaction between the sulfamate group and the zinc atom less favorable through steric hindrance with the proximal residues of the active site. It is not, however, readily apparent from this structure why <b>15</b> should be 4-fold less active than either 2-MeOEMATE or <b>3</b> as an inhibitor of CAII. The electron density around C-17 is ill defined in this structure, presumably reflecting the rotational freedom of the cyanomethyl group and in turn the absence of substantial energetically beneficial or detrimental interactions with the protein at this site. The structure of <b>3</b>/hCAII did contrast to that of <b>15</b> in two respects, namely, the unexpected coordination of the C-17 sulfamate to the catalytic zinc and the presence of a second binding site for the ligand, not observed in the <b>15</b>/hCAII structure. Given the small difference in inhibitory activity of the respective 3- and 17-<i>O</i>-sulfamate derivatives of <b>1</b> (376 and 526 nM), we believe that the bis-sulfamate derivative can bind through both of its sulfamate groups and that the crystal structure only reflected one of these modes. The presence of a second binding site (ca. 60% occupancy) may, however, be more relevant since it could be possible that the nitrile substituted compound <b>15</b> has lower, or negligible affinity, for this second site, thus resulting in a lower overall affinity between the ligand and enzyme and consequently a reduced inhibitory activity. Given the large size of the pocket above the enzyme active site, it may be possible that occupation of both of the ligand binding sites identified in the <b>3</b>/hCAII structure is required for high activity. Even with a protein crystal structure, it is not possible to draw a definitive conclusion on the origin of the reduced inhibitory activity of <b>15</b> against hCAII relative to other 2-substituted estratriene sulfamate derivatives.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Ribbon diagram of the <b>15</b>−hCAII complex obtained by X-ray crystallography. The inhibitor molecule, metal coordinating residues His94, His96, and His119, and the zinc ion are represented in ball and stick format. (b) Detailed schematic representation of <b>15</b> within the hCAII active site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to evaluate this class of compounds for in vivo antitumor activity, it was decided to test 2-methoxy-17-cyanomethyl estratriene-3-<i>O</i>-sulfamate (<b>15</b>) and the corresponding 3-hydroxy compound <b>14</b> for their ability to inhibit the growth of MDA-MB-231 xenografts in female nude athymic mice (<i>n</i> = 6). The compounds were dosed orally once daily over a period of 28 days as a solution in THF/PG (10%/90%) at doses of 40 and 80 mg/kg (<b>15</b>) and 120 mg/kg (<b>14</b>). As can be seen in Figure<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, promising inhibition of tumor growth was achieved with both compounds. The higher 80 mg/kg dose of sulfamate <b>15</b> proved more effective than the 40 mg/kg dose, with growth inhibitions of 66% and 34% being achieved, respectively. Dosing with the phenol <b>14,</b> albeit at the higher 120 mg/kg dose, caused a 44% inhibition of tumor growth. No toxic effects were observed at these dose levels (data not shown). A dose dependent inhibition of tumor growth was thus observed with <b>15</b> treatment, while significant activity was observed with <b>14</b> treatment. The relative in vivo activities were found to correlate with their relative in vitro activities. It is notable that <b>15</b> proved less active than the corresponding bis-sulfamate, 2-MeOE2bisMATE <b>3</b> which, in the same model, caused tumor regression, although it is 4-fold less potent than <b>15</b> in vitro. The difference in in vitro and in vivo activities observed for <b>15</b> and <b>3</b> may derive from a number of factors. The formulation used for this study has not been rigorously investigated, and we have no information on the oral bioavailability achieved for <b>15</b>. It may also be that the nitrile group of <b>15</b> is subject to rapid metabolism, a factor that could lead to inactivation or accelerated clearance. In contrast, pharmacokinetic studies have shown that <b>3</b> displays high oral bioavailability in rodents (>85%) and does not undergo significant metabolism. As noted above, the relative inhibitory activity of <b>15</b> for carbonic anhydrase is 4-fold less than that observed for <b>3</b>, and this could possibly result in increased exposure to metabolism for <b>15</b> relative to the bis-sulfamate. It is thus clear that, although promising in vivo activity has been observed for <b>15</b>, pharmacokinetic studies would be highly advantageous to establish the in vivo fate of the compound and could direct the development of an enhanced formulation or further structural modification to block potential metabolism. Nevertheless, the structural modification intrinsic to <b>15</b> is clearly worthy of further investigation, particularly that for <b>14</b>, given the problems already noted with 2-MeOE2.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of daily oral administration of <b>14</b> and <b>15</b> on the growth of MDA-MB-231 xenografts in athymic female nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we have discovered that a number of 17-cyanomethyl functionalized 2-substituted estra-1,3,5(10)-triene derivatives display high activity against the proliferation of cancer cells in vitro. Enhanced activity is observed in both the 3-hydroxy and 3-<i>O</i>-sulfamoyl series of compounds, although as observed in previous studies, the sulfamoylated compounds display the most potent antiproliferative effects. SAR studies defined that the C-17 cyanomethyl group most likely functions as a hydrogen bond acceptor and that substitution of the methylene linker between the nitrile and C-17, presumably due to steric factors, is deleterious to activity. Direct linkage of the nitrile group to C-17 and replacement of the nitrile group or replacement an isosteric ethynyl group caused a great reduction in activity. Antiproliferative activity against a wide range of hormone dependent and independent cancer cells was observed, and it appears that this activity, as with previously studied 2-substituted estra-1,3,5(10)-triene-3-<i>O</i>-sulfamates, stems from their ability to interfere with the dynamics of tubulin polymerization. The sulfamate compounds showed activity against the proliferation of HUVECs and in an in vitro model of angiogenesis. Furthermore, the antiangiogenic profiles of these compounds in vivo has recently been established.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In addition, activity of the sulfamoylated molecules against two tumor relevant enzymes, namely, steroid sulfatase (a clinical target for the treatment of HDBC) and carbonic anhydrase was observed. The interaction of <b>15</b> with carbonic anhydrase was studied by protein crystallography revealing, as expected, co-ordination of the 3-<i>O</i>-sulfamate group to the catalytic zinc of the hCAII active site. Confirmation of the potential of these molecules for development as anticancer agents was demonstrated by the significant growth inhibition achieved on treatment of human breast cancer xenografts in mice with two of the novel compounds being orally bioavailable. Further development of antitumor agents based on structural modification of 2-MeOE2 is presently underway.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Materials and Methods</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Chemistry</h4><div class="NLM_p">All chemicals were either purchased from Aldrich Chemical Co. (Gillingham, U.K.), Fluka (Gillingham, U.K.) or Lancaster Synthesis (Morecambe, U.K.). Organic solvents of A.R. grade were supplied by Fisher Scientific (Loughborough, U.K.) and used as supplied. Anhydrous <i>N,N</i>-dimethylformamide (DMF) and <i>N,N</i>-dimethylacetamide (DMA) were purchased from Aldrich and stored under positive pressure of N<sub>2</sub> after use. THF was distilled from sodium with benzophenone indicator. Sulfamoyl chloride was prepared by an adaptation of the method of Appel and Berger<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and was stored in the refrigerator under positive pressure of N<sub>2</sub> as a solution in toluene as described by Woo et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> An appropriate volume of this solution was freshly concentrated in vacuo immediately before use. Estrone was purchased from Sequoia Research Products (Oxford, U.K.). Reactions were carried out at room temperature (rt) unless otherwise stated. Flash column chromatography was performed on silica gel (MatrexC60).</div><div class="NLM_p last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded with a Varian Mercury VX400 NMR spectrometer at 400 and 100 MHz, respectively, and chemical shifts are reported in parts per million (ppm, δ) relative to tetramethylsilane (TMS) as an internal standard. Mass spectra were recorded at the Mass Spectrometry Service Center, University of Bath, U.K. or at the EPSRC National Mass Spectrometry service, Swansea. FAB-MS was carried out using <i>m</i>-nitrobenzyl alcohol (NBA) as the matrix. Elemental analyses were performed by Microanalysis Service, University of Bath. Melting points were determined using a Reichert−Jung Thermo Galen Kofler block and are uncorrected.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Biology</h4><div class="NLM_p last">The effects of compounds on MCF-7, DU-145 and MDA MB-231 cell growth were determined using a microtiter plate assay as described previously.<a onclick="showRef(event, 'ref6 ref30'); return false;" href="javascript:void(0);" class="ref ref6 ref30">(6, 30)</a> STS inhibition was assayed by the method of Purohit et al.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a>, and carbonic anhydrase inhibition was carried out as described elsewhere.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The effects of compound <b>8</b> on in vitro polymerization of purified bovine brain tubulin (Cytoskeleton, Denver, CO) were measured by turbidometry using a previously validated assay.<a onclick="showRef(event, 'ref11 ref37'); return false;" href="javascript:void(0);" class="ref ref11 ref37">(11, 37)</a> Tubulin (1 mg/mL) in MES buffer (0.1 M MES at pH 6.5, 0.5 mM MgCl<sub>2</sub>, 1 M monosodium glutamate, and 1 mM GTP) was preincubated with or without test compounds (10 µM, 1% v/v ethanol) for 5 min at 37 °C. Tubulin assembly was then stimulated by adding paclitaxel (10 µM). The change in the absorbance was continuously monitored at 350 nm for 15 min at 37 °C. Because the amount of tubulin polymerized is directly proportional to the area under the curve (AUC), it was used to determine the extent of tubulin polymerization by different test compounds. The AUC of paclitaxel alone, with a maximal extent of polymerization, was set to 100% polymerization.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> In Vivo Efficacy Studies</h4><div class="NLM_p last">Female MF-1 nu/nu mice from Harlan (Bicester, Oxon, U.K.) were injected subcutaneously (s.c.) in the flank with 2 × 10<sup>6</sup> MDA-MB-231 cells, which resulted in a single tumor per animal. All experiments were carried out under conditions that complied with institutional guidelines. Daily oral administration of <b>15</b> (40 and 80 mg/kg) and <b>14</b> (120 mg/kg) was initiated when the tumors reached approximately 100–150 mm<sup>3</sup> in volume. Dosing was performed for 28 days. Animal weights and tumor measurements were taken weekly using electronic callipers. Tumor volume (V), in mm<sup>3</sup>, was determined using the following equation: length × width<sup>2</sup>/2 (<i>l</i> × <i>w</i><sup>2</sup>/2).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Protein Crystallography</h3><div class="NLM_p last">The hCA II−<b>15</b> complex was obtained by adding a 5-molar excess of the inhibitor to a 10 mg/mL protein solution in 100 mM Tris-HCl at pH 8.5. Crystals of the complex were obtained by the hanging drop vapor diffusion technique at 20 °C. The drops were prepared by mixing 2 µL of the complex solution and 2 µL of the precipitant solution containing 2.8 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 300 mM sodium chloride in 100 mM Tris-HCl (pH 8.4), and 1 mM dithiothreitol to improve the crystal quality. A complete data set was collected at 1.85 Å resolution from a single crystal of about 0.2 mm × 0.3 mm × 0.3 mm. Data collection was carried out at Synchrotron source Elettra in Trieste, using a Mar CCD detector. The crystal belonged to the <i>P</i>2<sub>1</sub> space group with unit cell parameters <i>a</i> = 42.17 Å, <i>b</i> = 41.49 Å, <i>c</i> = 71.58 Å, and β = 104.07°. Diffracted intensities were processed using the HKL crystallographic data reduction package (Denzo/Scalepack).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> A total of 59499 reflections was measured and reduced to 20038 unique reflections. Crystal parameters and data processing statistics are summarized in tabular form in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>. The structure of the complex was analyzed by difference Fourier techniques, using the PDB file <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CA2">1CA2</a><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> as a starting model for refinement. Water molecules were removed from the starting model prior to structure factor and phase calculations. The inspection of the Fourier maps, calculated with 3Fo − 2Fc and Fo − Fc coefficients, revealed prominent electron density features in the active site region. After an initial refinement limited to the enzyme structure, a model for the inhibitor was easily built and introduced into the atomic coordinates set for further refinement, which proceeded to convergence with continuous map inspections and model updates. The refinement was carried out with the program CNS,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and model building and map inspections were performed using the O program.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The final model contains 2068 protein atoms, 28 inhibitor atoms, and 292 water molecules, and has <i>R</i>factor and <i>R</i>free values of 17.0 and 20.3%, respectively. The correctness of stereochemistry was finally checked using PROCHECK.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The statistics for refinement are summarized in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>. Coordinates and structure factors have been deposited in the Brookhaven Protein Data Bank (accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BET">3BET</a>.pdb).</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Crystal Data for 15</h3><div class="NLM_p last">Empirical formula: C<sub>24</sub>H<sub>31</sub>N<sub>2</sub>O<sub>5</sub>S, <i>M</i> = 459.57, <i>T</i> = 150(2) K, λ = 0.71073 Å, monoclinic, space group <i>P</i>2<sub>1</sub>, <i>a</i> = 8.2860(2) Å, <i>b</i> = 13.6050(4) Å, <i>c</i> = 11.2540(1) Å, β = 107.430(1)°, <i>U</i> = 1210.42(6) Å<sup>3</sup>, <i>Z</i> = 2, <i>D</i><sub>c</sub> = 1.261 gcm<sup>−3</sup>, μ = 0.170 mm<sup>−1</sup>; <i>F</i>(000) = 490, crystal size 0.35 × 0.35 × 0.30 mm, unique reflections = 7011 [R(int) = 0.0759], observed <i>I</i> >2σ(<i>I</i>) = 5870, data/restraints/parameters: 7011/3/303, <i>R</i>1 = 0.0470 <i>wR</i>2 = 0.1085 (obs. Data), <i>R</i>1 = 0.0636, <i>wR</i>2 - 0.1162 (all data), max. peak/hole: 0.493 and −0.293 eÅ<sup>−3</sup>, absolute structure parameter = 0.00(6). Data were collected on a Nonius kappaCCD diffractometer.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Ethyl-3-<i>O</i>-(<i>t</i>-butyldimethylsilyl)estrone (<b>4</b>)</h3><div class="NLM_p last">A solution of 2-ethylestrone<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (2.0 g, 6.7 mmol) and imidazole (1.14 g, 16.8 mmol) in DMF (20 mL) was treated with <i>t</i>-butyl-dimethylsilyl chloride (1.11 g, 7.38 mmol) and stirred for 14 h. Ethyl acetate (50 mL) and water (100 mL) were then introduced and the organic layer separated. After washing with water (3 × 50 mL), and brine (50 mL), the organic layer was dried and evaporated to give a colorless oil, which solidified on standing. Crystallization from ethyl acetate/hexane gave a white powder (1.98 g, 72%) with mp 95–97 °C, which showed δ<sub>H</sub> 0.22 (6H, s), 0.91 (3H, s), 1.01 (9H, s), 1.16 (3H, t, <i>J</i> 7.4), 1.32–2.50 (13H, m), 2.56 (2H, q, <i>J</i> 7.4), 2.78–2.88 (2H, m), 6.49 (1H, s) and 7.05 (1H, s); HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 413.2851; C<sub>26</sub>H<sub>41</sub>O<sub>2</sub>Si (M<sup>+</sup> + H) requires 413.2870.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-Ethyl-3-<i>O</i>-(<i>t</i>-butyldimethylsilyl)-17-cyanomethylene Estra-1,3,5(10)-triene (<b>5</b>)</h3><div class="NLM_p last">Sodium hydride (302 mg, 7.6 mmol) was washed with three aliquots of hexane (1 mL each), dried under nitrogen, then treated with THF (10 mL), and then diethyl (cyanomethyl)phosphonate (1.17 mL, 7.3 mmol), at which point vigorous gas evolution was observed. The resultant solution was then treated with a solution of <b>4</b> (1.82 g, 4.4 mmol) in THF (20 mL) and brought to reflux for 18 h. The reaction mixture was then cooled to rt, diluted with ethyl acetate (25 mL), and poured onto water (10 mL); the aqueous layer was separated and the organic layer washed with water (3 × 25 mL) and brine (25 mL), dried, and evaporated. The crude product was purified by column chromatography (3% ethyl acetate/hexane) to give the desired product <b>5</b> as a mixture of isomers. White foam (1.81 g, 4.16 mmol, 94%). δ<sub>H</sub> (selected) 0.21 (6H, s), 0.87 and 0.98 (3H, 2 × s), 0.99 (9H, s), 1.15 (3H, t, <i>J</i> 7.4), 2.55 (2H, q, <i>J</i> 7.4),:CH at 5.12 (app t, <i>J</i> 2.0) and 5.04 (app t, <i>J</i> 2.4), 6.47 (1H, s) and 7.03, 7.04 (1H, 2 × s); MS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 435.3 (M<sup>+</sup>, 100%); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 435.2961, C<sub>28</sub>H<sub>41</sub>ONSi requires 435.2957.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-Ethyl-3-<i>O</i>-(<i>t</i>-butyldimethylsilyl)-17β-cyanomethyl Estra-1,3,5(10)-triene (<b>6</b>)</h3><div class="NLM_p last">Compound <b>5</b> (1.80 g, 4.13 mmol) was dissolved in THF (5 mL) and ethanol (50 mL) then treated with Pd/C (250 mg, 10%). The degassed solution was then stirred under a hydrogen atmosphere for 16 h before filtering through a pad of celite. Evaporation gave the desired product <b>6</b> (1.58 g, 87%) as a white foam. δ<sub>H</sub> 0.21 (6H, s), 0.66 (3H, s), 0.99 (9H, s), 1.16 (3H, t, <i>J</i> 7.4), 1.22–2.42 (16H, m), 2.55 (2H, q, <i>J</i> 7.4), 2.76–2.84 (2H, m), 6.47 (1H, s) and 7.03 (1H, s); MS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 437.4 (M<sup>+</sup>, 100%); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 437.3121; C<sub>28</sub>H<sub>43</sub>OSiN requires 437.3114. Anal. (C<sub>28</sub>H<sub>43</sub>NO<sub>2</sub>Si) C, H, N.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Ethyl-17β-cyanomethyl Estra-1,3,5(10)-trien-3-ol (<b>7</b>)</h3><div class="NLM_p last">A solution of <b>6</b> (1.18 g, 2.70 mmol) in THF (12 mL) was treated with TBAF (4 mL, 1 M in THF). After 1 h, the reaction was diluted with ethyl acetate (25 mL) and then washed with water (3 × 30 mL), brine (30 mL), dried, and evaporated to give a yellowy solid. The crude product was suspended in hot hexane, and the desired product <b>7</b>, a white solid with mp 180–182 °C, was collected by filtration (770 mg, 88%). δ<sub>H</sub> 0.66 (3H, s), 1.15–2.45 (19H, m including 1.21 (3H, t, <i>J</i> 7.6)), 2.58 (2H, q, <i>J</i> 7.6), 2.75–2.85 (2H, m), 4.46–4.56 (1H, br), 6.49 (1H, s) and 7.03 (1H, s); MS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 323.2 (M<sup>+</sup>, 100%); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 323.2252; C<sub>22</sub>H<sub>29</sub>ON requires 323.2249.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-cyanomethyl Estra-1,3,5(10)-triene (<b>8</b>)</h3><div class="NLM_p last">An ice cold solution of sulfamoyl chloride (4.76 mmol) in DMA (5 mL) was added to <b>7</b> (770 mg, 2.38 mmol). After 14 h of stirring, ethyl acetate (25 mL) was added, and the solution was washed with water (3 × 20 mL) and brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated. The crude product was purified by column chromatography (10% acetone in chloroform) to give <b>8</b> as a white crystalline solid with mp 175–177 °C (700 mg, 73%). δ<sub>H</sub> 0.67 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.25–2.42 (16H, m) 2.68 (2H, q, <i>J</i> 7.4), 2.80–2.88 (2H, m), 4.91 (2H, br), 7.07 (1H, s) and 7.17 (1H, s); MS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 402.0 (M<sup>+</sup>, 100%); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 402.1975; C<sub>22</sub>H<sub>30</sub>O<sub>3</sub>N<sub>2</sub>S requires 402.1977. Anal. (C<sub>22</sub>H<sub>30</sub>N<sub>2</sub>O<sub>3</sub>S).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>E</i>-2-Ethyl-17-cyanomethylene Estra-1,3,5(10)-trien-3-ol (<b>9</b>)</h3><div class="NLM_p last">A solution of <b>5</b> (540 mg, 1.24 mmol) in THF (10 mL) was reacted with TBAF (3 mL, 3 mmol) as described for the synthesis of <b>7</b>. Column chromatography (20% ethyl acetate/hexane) afforded the desired phenol <b>9</b> as a pale yellow oil (284 mg, 0.882 mmol, 71%). Crystallization from ethyl acetate/hexane gave white crystals with mp 168–170 °C. δ<sub>H</sub> 0.88 (3 H), 1.22 (3 H, t, <i>J</i> 7.4), 1.25–2.45 (11 H, m), 2.59 (2 H, q, <i>J</i> 7.4), 2.63–2.84 (4 H, m), 4.53 (1 H, s), 5.04 (1 H, t, <i>J</i> 2.3), 6.49 (1 H, s) and 7.02 (1 H, s); MS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 321.3 (M<sup>+</sup>, 100%); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 321.2088; C<sub>22</sub>H<sub>27</sub>ON requires 321.2093. Anal. (C<sub>21</sub>H<sub>25</sub>NO<sub>2</sub>) C, H, N.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>E</i>-2-Ethyl-3-<i>O</i>-sulfamoyl-17-cyanomethylene Estra-1,3,5(10)-triene (<b>10</b>)</h3><div class="NLM_p last">Compound <b>9</b> (110 mg, 0.34 mmol) was reacted with sulfamoyl chloride (2 equiv) in DMA (1.5 mL) as described for the synthesis of <b>8</b>. Column chromatography (10% acetone in chloroform) gave the desired product as a white foam (86 mg, 63%). δ<sub>H</sub> 0.87 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.23–1.63 (6H, m), 1.90–1.99 (3H, m), 2.20–2.29 (1H, m), 2.39–2.46 (1H, m), 2.58–2.82 (4H, m, including 2.69 (2H, q, <i>J</i> 7.4)), 2.83–2.89 (2H, m), 5.00 (2H, br), 5.05 (1H, t, <i>J</i> 2.6), 7.09 (1H, s) and 7.18 (1H, s); MS [ES<sup>−</sup>] <i>m</i>/<i>z</i> 399.5 (M<sup>+</sup> − H, 100%). Anal. (C<sub>21</sub>H<sub>28</sub>N<sub>2</sub>O<sub>4</sub>S) C, H, N.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Methoxy-3-<i>O</i>-(<i>t</i>-butyldimethylsilyl)estrone (<b>11</b>)</h3><div class="NLM_p last">2-Methoxyestrone<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (1.5 g, 5 mmol) and imidazole (408 mg, 6 mmol) in DMF (20 mL) was reacted with <i>t</i>-butyl-dimethylsilyl chloride (829 mg) as described for the synthesis of <b>4</b>. The resultant crude oil was purified by chromatography (9:1 hexane/EtOAc) to give a white powder (1.5 g, 73%) with mp 162–64 °C, which showed δ<sub>H</sub> 0.15 (6H, s), 0.92 (3H, s), 0.99 (9H, s), 1.38–2.54 (13H, m), 2.75–2.83 (2H, m), 3.77 (3H, s), 6.56 (1H, s), 6.76 (1H, s); MS [ES<sup>−</sup>] <i>m</i>/<i>z</i> 413.3 (70%, M<sup>+</sup> − H); HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 415.2660; C<sub>25</sub>H<sub>39</sub>O<sub>3</sub>Si (M<sup>+</sup> + H) requires 415.2663.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Methoxy-3-<i>O</i>-(t-butyldimethylsilyl)-17-cyanomethyleneEstra-1,3,5(10)-triene (<b>12</b>)</h3><div class="NLM_p last">Sodium hydride (204 mg, 5.1 mmol) in THF (10 mL) was reacted with diethyl (cyanomethyl)phosphonate (776 µL, 4.8 mmol) and 2-methoxy-3-<i>O</i>-<i>t</i>-butyldimethylsilyl estrone (1.82 g, 4.4 mmol) in THF (10 mL) as described for the synthesis of <b>5</b>. The crude product was purified by column chromatography (4% ethyl acetate/hexane) to give the desired product <b>12</b> (a 3:2 mixture of <i>E</i>- and <i>Z</i>-isomers) as a white solid (1.04 g, 79%). δ<sub>H</sub> (selected) 0.13 (6H, s), 0.98 (9H, s), 0.99, 0.88 (3H, 2 × s), 3.77 (3H, s), 5.12, 5.04 (1H, 2 × m, :CH, both isomers), 6.54 (1H, s) and 6.75, 6.74 (1H, 2 × s); MS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 438.1 [(M + H)<sup>+</sup>, 50%] and 380.1 (100%); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 437.2731; C<sub>27</sub>H<sub>39</sub>NO<sub>2</sub>Si requires 437.2750.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Methoxy-3-<i>O</i>-(t-butyldimethylsilyl)-17β-cyanomethyl Estra-1,3,5(10)-triene (<b>13</b>)</h3><div class="NLM_p last">A solution of <b>12</b> (0.98 g, 2.24 mmol) in THF (15 mL) and ethanol (100 mL) was reacted with Pd/C (200 mg, 5%) and hydrogen over 48 h as described for the synthesis of <b>6</b>. The desired product <b>13</b> was isolated as a white solid (0.92 g, 94%) with mp 149–151 °C. δ<sub>H</sub> 0.14 (6H, s), 0.68 (3H, s), 0.98 (9H, s), 1.24–2.42 (16H, m), 2.70–2.76 (2H, m), 3.76 (3H, s), 6.53 (1H, s) and 6.75 (1H, s). Anal. (C<sub>27</sub>H<sub>41</sub>NO<sub>2</sub>Si) C, H, N.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Methoxy-17β-cyanomethyl Estra-1,3,5(10)-trien-3-ol (<b>14</b>)</h3><div class="NLM_p last">A solution of <b>13</b> (0.92 g, 2.09 mmol) in THF (20 mL) was reacted with TBAF (3 mL, 1 M in THF) as described for the synthesis of <b>7</b>. The desired phenol <b>14</b> was crystallized from ethyl acetate/hexane to give colorless crystals (600 mg,88%) with mp 172–174 °C. δ<sub>H</sub> 0.68 (3H, s), 1.24–2.42 (16H, m), 2.72–2.80 (2H, m), 3.85 (3H, s), 5.42 (1H, s), 6.63 (1H, s) and 6.77 (1H, s); MS [ES<sup>−</sup>] <i>m</i>/<i>z</i> 309 ((M<sup>+</sup> −H)<sup>−</sup>, 100%). Anal. (C<sub>21</sub>H<sub>27</sub>NO<sub>2</sub>) C, H, N.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Methoxy-3-<i>O</i>-sulfamoyl-17β-cyanomethyl Estra-1,3,5(10)-triene (<b>15</b>)</h3><div class="NLM_p last">Compound <b>14</b> (570 mg, 1.75 mmol) was reacted with sulfamoyl chloride and DMA as described for the synthesis of <b>8</b>. Column chromatography (chloroform/aceone 9:1) followed by recrystallization from acetone/hexane afforded the sulfamate as a white crystalline solid (<b>15</b>) (590 mg, 83%) with mp 183–185 °C. δ<sub>H</sub> 0.69 (3H, s), 1.20–2.50 (16H, m, alkyl H), 2.74–2.84 (2H, m), 3.87 (3H, s), 5.06 (2H, s), 6.92 (1H, s) and 7.04 (1H, s); MS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 404.1 (M<sup>+</sup>, 100%); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 404.1767; C<sub>21</sub>H<sub>28</sub>O<sub>4</sub>N<sub>2</sub>S requires 404.1770. Anal. (C<sub>21</sub>H<sub>28</sub>O<sub>4</sub>N<sub>2</sub>S) C, H, N.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>E-</i>2-Methoxy-17-cyanomethylene Estra-1,3,5(10)-trien-3-ol (<b>16</b>)</h3><div class="NLM_p last">A solution of <b>12</b> (400 mg, 0.95 mmol) in THF (10 mL) was reacted with TBAF (3 mL) as described for the synthesis of <b>7</b>. Column chromatography (10% ethyl acetate in hexane) afforded two fractions, the first being a mixture of the two isomers as a white powder (91 mg, 30%) and the second <i>E</i>-isomer <b>16</b> as a white solid with mp 183–185 °C (115 mg, 0.36 mmol, 37%). δ<sub>H</sub> (CDCl<sub>3</sub>) 0.89 (3H, s), 1.25–2.39 (11H, m), 2.56–2.82 (4H, m), 3.86 (3H, s), 5.05 (1 H, t, <i>J</i> 2.7), 5.43 (1H, s), 6.65 (1H, s), 6.77 (1H, s); MS (FAB<sup>+</sup>) <i>m</i>/<i>z</i> 323.1 (M<sup>+</sup>, 100%); HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 324.1961; C<sub>21</sub>H<sub>26</sub>O<sub>2</sub>N (M<sup>+</sup>+H) requires 324.1958. Anal. (C<sub>22</sub>H<sub>27</sub>NO) C, H, N.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Methoxy-3-<i>O-</i>sulfamoyl-17-cyanomethylene Estra-1,3,5(10)-triene (<b>17</b>)</h3><div class="NLM_p last">Compound <b>16</b> (40 mg, 0.124 mmol) was treated with sulfamoyl chloride (1.5 mmol) in DMA (1.5 mL) as described for the synthesis of <b>8</b>. Flash column chromatography (hexane/ethyl acetate 4:1) afforded the desired sulfamate <b>17</b> as white needles with mp 202–204 °C (36 mg, 72%). δ<sub>H</sub> (<i>d</i><sub>6</sub>-acetone) 0.95 (3H, s), 1.25–2.66 (12H, m), 2.74–2.84 (3H, m), 3.84 (3H, s), 5.27 (1H, t, <i>J</i> 2.3), 6.90 (2H, s), 7.02 (1H, s), 7.04 (1H, s); MS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 402.0 (M<sup>+</sup>, 100%); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 402.1611; C<sub>21</sub>H<sub>26</sub>O<sub>4</sub>N<sub>2</sub>S requires 402.1613. Anal. (C<sub>22</sub>H<sub>28</sub>N<sub>2</sub>O<sub>3</sub>S) C, H, N.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Ethyl-3-<i>O</i>-(<i>t</i>-butyldimethylsilyl)-17-(1,1-dicyano)methylene Estra-1,3,5(10)-triene (<b>18</b>)</h3><div class="NLM_p last">A solution of <b>4</b> (830 mg, 2 mmol), malononitrile (0.38 mL, 10 mmol), and β-alanine (535 mg, 6 mmol) in toluene (150 mL) and acetic acid (30 mL) was refluxed for 3 days with extra aliquots of malononitrile (0.13 mL, 2 mmol) added after 24 and 48 h. The solution was then cooled to rt, the solvents evaporated, and the residual solid stirred with water (50 mL). The mixture was then extracted with ethyl acetate (2 × 100 mL), and the resultant organic layer was washed with water and brine, then dried, and evaporated. Column chromatography (hexane/ethyl acetate 5:1) gave the desired alkene <b>18</b> as a white powder with mp 168–169 °C (840 mg, 91%). δ<sub>H</sub> 0.21 (6H, s), 1.00 (9H, s), 1.06 (3H, s), 1.15 (3H, t, <i>J</i> 7.4), 1.40–2.26 (9H, m), 2.45–3.05 (m, 7H), 6.40 (1H, s) and 7.02 (1H, s); MS [ES<sup>−</sup>] <i>m</i>/<i>z</i> 459.4 (M<sup>+</sup> − H)<sup>−</sup>, 100%); HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 461.2985; C<sub>29</sub>H<sub>41</sub>N<sub>2</sub>OSi (M<sup>+</sup>+H) requires 461.2983.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Ethyl-3-<i>O</i>-hydroxy-17-(1,1-dicyano)methylene Estra-1,3,5(10)-triene (<b>19</b>)</h3><div class="NLM_p last">A solution of <b>18</b> (230 mg, 0.5 mmol) in THF (50 mL) was cooled to 0 °C and treated with TBAF (0.6 mmol, 0.6 mL) in a dropwise manner. After 2 h at 0 °C, the reaction was allowed to come to rt and then treated with water (10 mL) and ethyl acetate (80 mL). The resultant organic layer was separated, washed with water and brine, then dried, and evaporated. The residual solid was purified by column chromatography (hexane/ethyl acetate 5:1 to 2:1) to give phenol <b>19</b> as a white solid with mp 269–270 °C (125 mg, 72%). δ<sub>H</sub> 1.06 (3H, s), 1.21 (3H, t, <i>J</i> 7.5), 1.39–2.52 (10H, m), 2.61 (2H, q, <i>J</i> 7.5), 2.63–3.02 (5H, m), 4.52 (1H, s), 6.50 (1H, s) and 7.02 (1H, s); HPLC: 98.9%, MS [APCI<sup>−</sup>] <i>m</i>/<i>z</i> 345.4 ((M<sup>+</sup> − H)<sup>−</sup>, 100%).</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17-(1,1-dicyano)methylene Estra-1,3,5(10)-triene (<b>20</b>)</h3><div class="NLM_p last">Compound <b>19</b> (69 mg, 0.2 mmol) was reacted with sulfamoyl chloride (0.6 mmol) in DMA (2 mL) as described for the synthesis of <b>8</b>. Column chromatography (hexane/ethyl acetate 5:1 to 3:1) gave the desired sulfamate <b>20</b> as a white powder with mp 227–228 °C (62 mg, 73%). δ<sub>H</sub> 1.06 (s, 3H), 1.20 (3H, t, <i>J</i> 7.4), 1.44–2.55 (10H, m), 2.69 (2H, q, <i>J</i> 7.4), 2.75–3.04 (5H, m), 5.03 (2H, s), 7.09 (1H, s) and 7.16 (1H, s); HPLC 100%. Anal. (C<sub>23</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub>S) C, H, N.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Ethyl-3-<i>O</i>-<i>t</i>-butyldimethylsilyl-17β-(1,1-dicyano)methyl Estra-1,3,5(10)-triene (<b>21</b>)</h3><div class="NLM_p last">A solution of <b>18</b> (460 mg, 1 mmol) in methanol (50 mL) and THF (5 mL) was cooled to −10 °C, then treated with NaBH<sub>4</sub> (76 mg, 2 mmol) in a portionwise manner. After 4 h of stirring, water (50 mL) was added, and then sufficient ammonium chloride was added to acidify the solution. The mixture was then extracted with ethyl acetate (2 × 60 mL) and the combined organics washed with water and brine, dried, and evaporated. Column chromatography (hexane/ethyl acetate 5:1) gave the desired product <b>21</b> as a white powder with mp 161–162 °C (380 mg, 83%). δ<sub>H</sub> 0.22 (6H, s). 0.80 (3H, s), 1.00 (9H, s), 1.16 (3H, t, <i>J</i> 7.5), 1.33–2.40 (14H, m), 2.55 (2H, q, <i>J</i> 7.5), 2.78 (2H, m), 3.56 (1H, d, <i>J</i> 9.9), 6.47 (1H, s) and 7.03 (1H, s); MS [ES<sup>−</sup>] <i>m</i>/<i>z</i> 461.3 ((M<sup>+</sup> − H)<sup>−</sup>, 100%); HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 463.3152; C<sub>29</sub>H<sub>43</sub>N<sub>2</sub>OSi (M<sup>+</sup>+H) requires 463.3139.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Ethyl-17β-(1,1-dicyano)methyl Estra-1,3,5(10)-trien-3-ol (<b>22</b>)</h3><div class="NLM_p last">A solution of <b>21</b> (230 mg, 0.5 mmol) in THF (50 mL) was reacted with TBAF (0.6 mmol, 0.6 mL) as described for the synthesis of <b>6</b>. Column chromatography (hexane/ethyl acetate 5:1 to 2:1) gave <b>22</b> as a white solid with mp 247–248 °C (124 mg, 71%). δ<sub>H</sub> 0.80 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.30–2.41(14H, m), 2.59 (2H, q, <i>J</i> 7.4), 2.81 (2H, m), 3.56 (1H, d, <i>J</i> 9.9), 4.51 (1H, br), 6.49 (1H, s) and 7.02 (1H, s); MS [APCI<sup>−</sup>] <i>m</i>/<i>z</i> 347.4 (M<sup>+</sup> − H)<sup>−</sup>, HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 349.2264; C<sub>23</sub>H<sub>29</sub>N<sub>2</sub>O (M<sup>+</sup> + H) requires 349.2274. Anal. (C<sub>23</sub>H<sub>28</sub>N<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-dicyanomethyl Estra-1,3,5(10)-triene (<b>23</b>)</h3><div class="NLM_p last">A solution of <b>22</b> (0.2 mmol) was reacted with sulfamoyl chloride (0.6 mmol) in DMA (2 mL) as described for the synthesis of <b>8</b>. Column chromatography (hexane/ethyl acetate 5:1 to 3:1) gave the desired sulfamate <b>23</b> (170 mg, 80%) as a white powder with mp 169–170 °C. δ<sub>H</sub> 0.80 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.32–2.38 (14H, m), 2.68 (2H, q, <i>J</i> 7.4), 2.83 (2H, m), 3.57 (1H, d, <i>J</i> 9.9), 4.91 (2H, br), 7.08 (1H, s) and 7.16 (1H, s); MS [FAB<sup>−</sup>] <i>m</i>/<i>z</i> 347.4 ((M<sup>+</sup> − H)<sup>−</sup>, 100%). Anal. (C<sub>23</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>S) C, H, N.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Ethyl-3-<i>O</i>-(<i>t</i>-butyldimethylsilyl)-17β-(1-cyanoethyl) Estra-1,3,5(10)-triene (<b>24</b>)</h3><div class="NLM_p last">A stirred −78 °C solution of <b>6</b> (220 mg, 0.5 mmol) in THF (50 mL) was treated with LDA (1.2 mL, 1.2 mmol, 1 M in THF) in a dropwise manner, and then after a further 0.5 h, methyl iodide (212 mg, 1.5mmol) was added. The mixture was stirred for 4 h at −78 °C and 12 h at rt before the addition of ethyl acetate (100 mL) and water (30 mL). The organic layer was then separated, washed with water and brine, dried, and evaporated. The crude yellow oil was purified by column chromatography (hexane/ethyl acetate 20:1) to give the desired product <b>24</b> as a colorless oil (176 mg, 78%) as a 1:1 mixture of diastereoisomers. δ<sub>H</sub> (selected) 0.23 (6H, s), 0.76 and 0.78 (3H, 2 × s), 1.01 (9H, s), 1.17 (2H, t, <i>J</i> 7.4), 1.25–1.96 (13H, m), 2.05–2.50 (3H, m), 2.57 (2H, q, <i>J</i> 7.4), 2.66–2.88 (4H, m), 6.48 and 6.50 (1H, 2 × s), 7.03 and 7.06 (1H, 2 × s); HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 452.3349; C<sub>29</sub>H<sub>46</sub>OSi (M<sup>+</sup> + H) requires 452.3347.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Ethyl-3-<i>O</i>-benzyl Estrone (<b>25</b>)</h3><div class="NLM_p last">A mixture of 2-ethyl estrone<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (5.6 g, 18.8 mmol) and potassium carbonate (5.19 g, 37.5 mmol) in DMF (100 mL) was treated with benzyl chloride (2.81 mL) and then heated to 120 °C for 4 h. The reaction was then cooled to rt prior to the addition of sufficient water to dissolve the potassium carbonate then precipitate the product. The resultant beige powder was removed by filtration then resuspended in hot methanol to remove colored impurities. The product was then collected by filtration to give <b>25</b> as a white powder (6.1 g, 84%) with mp 169–171 °C, which showed 0.90 (3H, s), 1.20 (3H, t, <i>J</i> 7.4), 1.34–2.56 (13H, m), 2.66 2H, q, <i>J</i> 7.4), 2.83–2.92 (2H, m), 5.04 (2H, s), 6.64 (1H, s), 7.10 (1H, s) and 7.28–7.45 (5H, m); HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 389.2466; C<sub>27</sub>H<sub>33</sub>O<sub>2</sub> (M<sup>+</sup> + H) requires 389.2475. Anal. (C<sub>27</sub>H<sub>32</sub>O<sub>2</sub>) C, H.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Ethyl-3-<i>O</i>-benzyl-17α-hydroxy-17β-(1-cyanoethyl) Estra-1,3,5(10)-triene (<b>26</b>)</h3><div class="NLM_p last">A −78 °C solution of propionitrile (50 mmol) in dry THF (50 mL) was treated with LDA (50 mmol) in a dropwise manner, and then stirred for 1 h prior to the addition of <b>25</b> (8 mmol) in THF (20 mL) over 3 h. The reaction was then stirred for an additional 3 h prior to ammonium chloride quench. The mixture was then extracted into ethyl acetate and the organic layer washed with water and brine, dried, and evaporated. The crude oil was purified by column chromatography (hexane/ethyl acetate gradient 10:1 to 4:1) to give the desired alcohol <b>26</b> (2.70 g, 76%) as a white powder with mp 75–77 °C, which showed δ<sub>H</sub> 0.97 (3H, s), 1.20 (3H, t, <i>J</i> 7.6), 1.25–2.49 (16H, m), 2.66 (2H, q, <i>J</i> 7.6), 2.77–2.91 (3H, m), 5.04 (2H, s), 6.62 (1H, s), 7.09 (1H, s) and 7.28–7.46 (5H, m). MS [ES<sup>+</sup>] <i>m</i>/<i>z</i> 466.36 (M<sup>+</sup> + Na)<sup>+</sup>, 100%).</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-Ethyl-3-<i>O</i>-benzyl-17-(1-cyano)ethylene Estra-1,3,5(10)-triene (<b>27</b>)</h3><div class="NLM_p">Methane sulfonic acid (0.1 mL, 1.4 mmol) was added dropwise to a solution of <b>26</b> (500 mg, 1.1 mmol) in triethylamine (5 mL) and DCM (50 mL), and then stirred at 0 °C for 4 h. The reaction mixture was poured onto ice/water (20 mL), and the organics were extracted with ethyl acetate (2 × 50 mL). The organic layer was washed with water then brine, dried, and evaporated to give a crude oil containing a mixture of the two possible dehydration products (Δ17:Δ16 ratio ca. 95:5 as measured by NMR). Column chromatography (hexane/ethyl acetate 10:1) gave the desired Δ-17 alkene <b>27</b> (400 mg, 85%) as a white powder with mp 63–64 °C, which showed δ<sub>H</sub> 0.95 (3H, s), 1.21 (3H, t, <i>J</i> 7.3), 1.30–1.71 (6H, m), 1.84 (3H, s), 1.85–2.51 (6H, m), 2.64 (2H, q, <i>J</i> 7.3), 2.75–2.90 (3H, m), 5.04 (2H, s), 6.63 (1H, s), 7.10 (1H, s) and 7.28–7.48 (5H, m); MS [ES<sup>−</sup>] <i>m</i>/<i>z</i> 424.35 ((M<sup>+</sup> − H)<sup>−</sup>, 100%); HRMS [ES<sup>+</sup>] <i>m</i>/<i>z</i> found 426.2788, C<sub>30</sub>H<sub>37</sub>NO (M<sup>+</sup>+H) requires 426.2791.</div><div class="NLM_p last">Alternatively, a solution of <b>26</b> (220 mg, 0.5 mmol) and Burgess reagent (358 mg, 1.5 mmol) in DMF (5 mL) was stirred at rt for 1 day. After the addition of water, the organics were extracted with ethyl acetate, the organic layer washed with water and brine, dried, and evaporated. The resultant yellow oil (230 mg) was purified by chromatography (hexane/EtOAc 20:1 to 15:1) to give <b>27</b> as a white powder (165 mg, 78%), which was spectroscopically identical to that described above.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-Ethyl-3-hydroxy-17β-(1-cyano)ethyl Estra-1,3,5(10)-triene (<b>28</b>)</h3><div class="NLM_p last">A solution of <b>27</b> (430 mg, 1mmol) in methanol (45 mL) and THF (5 mL) was treated with 5% Pd/C (50 mg) and then was stirred under an atmosphere of H<sub>2</sub>. After standard workup column chromatography (hexane/ethyl acetate 10:1 to 1:1), recrystallization (hexane/ethyl acetate 5:1) gave the desired phenol <b>28</b> as a white powder with mp 235–236 °C (225 mg, 67%). δ<sub>H</sub> 0.76 (3H, s), 1.20 (3H, t, <i>J</i> 7.4), 1.24–1.69 (13H, m), 1.71–2.48 (4H, m), 2.57 (2H, q, <i>J</i> 7.3), 2.71 (1H, m), 2.78 (2H, m), 4.47 (1H, br), 6.49 (1H, s) and 7.03 (1H, s); MS [ES<sup>−</sup>] <i>m</i>/<i>z</i> 336.3 ((M<sup>+</sup> − H)<sup>−</sup>, 100%). Anal. (C<sub>23</sub>H<sub>31</sub>NO) C, H, N.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-(1-cyano)ethyl Estra-1,3,5(10)-triene (<b>29</b>)</h3><div class="NLM_p last">Compound <b>28</b> (100 mg, 0.3mmol) was reacted with a solution of sulfamoyl chloride (0.8 mmol) in DMA (2 mL) as described for the synthesis of <b>8</b>. Column chromatography (hexane/ethyl acetate 5:1 to 2:1), then recrystallization (hexane/ethyl acetate 5:1) gave the desired sulfamate <b>29</b> as a white powder with mp 171–172 °C (86 mg, 69%). δ<sub>H</sub> 0.76 (3H, s), 1.20 (3H, t, <i>J</i> 7.4), 1.22–1.64 (11H, m), 1.75–2.35 (6H, m), 2.66 (2H, q, <i>J</i> 7.3), 2.68 (1H, m), 2.84 (2H, m), 4.92 (2H, br), 7.07 (1H, s) and 7.16 (1H,s); MS [ES<sup>−</sup>] <i>m</i>/<i>z</i> 415.4 ((M<sup>+</sup> − H)<sup>−</sup>, 100%). Anal. (C<sub>23</sub>H<sub>32</sub>N<sub>2</sub>O<sub>3</sub>S) C, H, N.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-Ethyl-3-<i>O</i>-<i>t</i>-butyldimethylsilyl-17β-(2′-oxoethyl) Estra-1,3,5(10)-triene (<b>30</b>)</h3><div class="NLM_p last">A 0 °C solution of <b>6</b> (550 mg, 1.26 mmol) in dichloromethane (7 mL) and toluene (15 mL) was treated with DIBALH (1.26 mL, 1.26 mmol, THF solution) and then allowed to warm to room temperature. Further aliquots of DIBALH (1 and 0.5 mL) were added (after 1 h and 1.5 h) until TLC analysis showed that no starting material remained. A solution of Rochelleʼs salt (20 mL, sat.) was then added, and the reaction was stirred for a further 0.5 h before extracting with ethyl acetate (3 × 30 mL). The combined organic layers were then washed with water and brine, then dried, and evaporated. The resulting oil was purified by column chromatography (hexane/ ethyl acetate to 19:1) to afford the desired aldehyde <b>30</b> as a white powder with mp 78–80 °C (340 mg, 61%). δ<sub>H</sub> 0.25 (6H, s), 0.66 (3H, s), 1.02 (9H, s), 1.19 (3H, t, <i>J</i> 7.4), 1.23–2.56 (16H, m), 2.58 (2H, q, <i>J</i> 7.4), 2.74–2.88 (2H, m), 6.50 (1H, s), 7.07 (1H, s) and 9.81 (1H, t, <i>J</i> 2.2). MS [APCI<sup>+</sup>] <i>m</i>/<i>z</i> 441.4 (100%, (M<sup>+</sup> + H)).</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Ethyl-17β-prop-2-ynyl Estra-1,3,5(10)-trien-3-ol (<b>31</b>)</h3><div class="NLM_p last">A mixture of (1-diazo-2-oxo-propyl)-phosphonic acid dimethyl ester<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (0.19 g, 1.0 mmol) and dry K<sub>2</sub>CO<sub>3</sub> (138 mg, 1.0 mmol) in anhydrous methanol (2.5 mL) was stirred under nitrogen and cooled to 0 °C, then treated with a solution of <b>30</b> (130 mg, 0.3mmol) in DCM (1 mL). The mixture was stirred for 24 h at room temperature after which water (10 mL) and DCM (50 mL) were added to the solution. The organic layer was washed with water and brine, dried, and evaporated. The resulting oil was purified by flash chromatography (gradient hexane/ethyl acetate 40:1 to 10:1) to give the desired alkyne <b>31</b> as a colorless oil (60 mg, 62%), which showed δ<sub>H</sub> 0.63 (3H, s), 1.21 (3H, t, <i>J</i> 7.3), 1.20–2.31 (17H, m), 2.57 (2H, q, <i>J</i> 7.3), 2.78 (2H, m), 4.58 (1H, s), 6.45 (1H, s) and 7.04 (1H, s); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 322.2288; C<sub>23</sub>H<sub>30</sub>O requires 322.2296. NB: A 7% yield of the TBDMS protected alkyne product was also isolated.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-prop-2-ynyl Estra-1,3,5(10)-triene (<b>32</b>)</h3><div class="NLM_p last">Compound <b>31</b> (50 mg, 0.16 mmol) was reacted with sulfamoyl chloride (0.3 mmol) in DMA (1 mL) as described for the synthesis of <b>8</b>. Column chromatography (hexane/ethyl acetate 10:1 to 7:1) gave the desired sulfamate <b>32</b> as a colorless oil (40 mg, 62%), which showed δ<sub>H</sub> 0.61 (3H, s), 1.18 (3H, t, <i>J</i> 7.3), 1.20–2.30 (17H, m), 2.66 (2H, q, <i>J</i> 7.3), 2.79 (2H, m), 4.97 (2H, br), 7.03 (1H, s) and 7.15 (1H, s); HRMS [FAB<sup>−</sup>] <i>m</i>/<i>z</i> found 400.1937; C<sub>23</sub>H<sub>30</sub>NO<sub>3</sub>S requires 400.1946.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-Ethyl-3-<i>O</i>-acyl Estrone (<b>33</b>)</h3><div class="NLM_p last">A solution of 2-ethyl estrone<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (0.89 g, 3 mmol) in DCM (20 mL) and TEA (1 mL, 7.2 mmol) was stirred and cooled to 0 °C. Acetyl chloride (0.29 mL, 4 mmol) was added in a dropwise manner, and the mixture was stirred at 0 °C for an hour. After the addition of DCM (20 mL) and water (20 mL), the organic layer was separated, washed with water and brine, dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude white powder was purified by flash chromatography (hexane/EtOAc 20/1 to 10:1) to afford the desired acetate <b>33</b> (880 mg, 88%) as a white powder with mp 138–139 °C. δ<sub>H</sub><sup>1</sup>H NMR (CDCl<sub>3</sub>, 270 MHz): 0.89 (3H, s, CH<sub>3</sub>), 1.16 (3H, t, <i>J</i> 7.4 Hz), 1.38–1.68 (6H, m), 1.92–2.25 (5H, m), 2.30 (3H, s), 2.38–2.54 (4H, m), 2.83–2.88 (2H, m), 6.72 (1H, s) and 7.15 (1H, s); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> 341.2098; C<sub>22</sub>H<sub>29</sub>O<sub>3</sub> requires 341.2111. Anal. (C<sub>22</sub>H<sub>28</sub>O<sub>2</sub>) C, H.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Ethyl 3-<i>O</i>-acyl-17-hydroxy-17-cyano Estra-1,3,5(10)-triene (<b>34</b>)</h3><div class="NLM_p last">A solution of <b>33</b> (1.7 g, 5 mmol) and KCN (3.26 g, 50mmol) in methanol (20 mL) and acetic acid (5 mL) was stirred at room temperature for 5 days. Ice–water (50 mL) was then added to the mixture, and the resulting precipitate was separated by filtration. The residue was washed with copious amounts of water and then dissolved in ethyl acetate (100 mL). The resultant solution was then washed with water and brine, dried, and evaporated to give <b>34</b> as a white solid with mp 147–148 °C (1.6 g, 87%). δ<sub>H</sub> 0.85 (3H, s), 1.16 (3H, t, <i>J</i> 7.4), 1.33–2.06 (11H, m), 2.30 (3H, s), 2.25–2.58 (4H,m), 2.70 (2H, q, <i>J</i> 7.4), 2.82 (2H, m), 6.71 (1H, s) and 7.15 (1H, s); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 368.2229; C<sub>23</sub>H<sub>30</sub>NO<sub>3</sub> (M<sup>+</sup> + H) requires 368.2220. Anal. (C<sub>23</sub>H<sub>29</sub>NO<sub>3</sub>) C, H, N.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-Ethyl-3-<i>O</i>-acyl-17-cyano Estra-1,3,5(10),16-tetraene (<b>35</b>)</h3><div class="NLM_p last">A solution of <b>34</b> (1.47 g, 4 mmol) in dry pyridine (10 mL) was treated with SOCl<sub>2</sub> (1.46 mL, 20 mmol) in a dropwise manner. The solution was brought to reflux for 1 h, then cooled to 0 °C before bringing to pH 1 with HCl (5 M aqueous). After extraction into ethyl acetate (3 × 30 mL), the combined organic layers were washed with water and brine, then dried and evaporated to give a dark brown oil. Column chromatography (hexane/ethyl acetate 8:1 to 6:1) gave <b>35</b> (500 mg, 36%) as a white powder with mp 176–177 °C, which showed δ<sub>H</sub> 0.94 (3H, s), 1.16 (3H, t, <i>J</i> 7.4), 1.36–2.26 (9H, m), 2.30 (3H, s), 2.39–2.52 (4H, m), 2.86 (2H, m), 6.65 (1H, dd, <i>J</i> 3.5 and 2.0), 6.72 (1H, s) and 7.14 (1H, s); HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 350.2115; C<sub>23</sub>H<sub>28</sub>NO<sub>2</sub> requires 350.2115. Anal. (C<sub>23</sub>H<sub>28</sub>NO<sub>2</sub>.0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-Ethyl-3-<i>O</i>-acyl-17β-cyano Estra-1,3,5(10)-triene (<b>36</b>)</h3><div class="NLM_p last">A solution of <b>35</b> (350 mg, 1 mmol) in THF (5 mL) and methanol (30 mL) was reacted with 5% Pd/C (50 mg) under an atmosphere of hydrogen for 24 h as described for the synthesis of <b>6</b>. Column chromatography (hexane/ethyl acetate 8:1 to 3:1) gave <b>36</b> as a white powder with mp 195–196 °C (330 mg, 94%). δ<sub>H</sub> 0.99 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.22–2.32 (12H, m), 2.35 (3H, s), 2.38–2.47 (2H, m), 2.53 (2H, q, <i>J</i> 7.4), 2.88 (2H, m), 6.76 (1H, s) and 7.19 (1H, s); MS [APCI<sup>−</sup>] <i>m</i>/<i>z</i> 350.11 (M<sup>+</sup> − H)<sup>−</sup>.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-Ethyl-17β-cyano Estra-1,3,5(10)-trien-3-ol (<b>37</b>)</h3><div class="NLM_p last">A solution of <b>36</b> (280 mg, 0.8 mmol) in acetone (10 mL) and methanol (10 mL) was treated with NaHCO <sub>3</sub> (0.34 g, 4 mmol) then stirred for 24 h. Solids were then removed by filtration and the filtrate evaporated. The resulting solid was treated with 2 M aqueous HCl to pH 1, and the solution was extracted with ethyl acetate (3 × 25 mL). The combined organics were then washed with water and brine, then dried, and evaporated. The resulting solid was purified by chromatography (hexane/ethyl acetate 8:1 to 6:1) and then recrystallized from hexane/ethyl acetate (4:1) to give <b>37</b> as a white powder with mp 284–285 °C (210 mg, 85%). δ<sub>H</sub> 0.95 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.30–2.42 (14H, m, 2.58 (2H, <i>J</i> 7.4), 2.78 (2H, m), 4.50 (1H, s), 6.49 (1H, s) and 7.03 (1H, s); MS [APCI<sup>−</sup>] <i>m</i>/<i>z</i> 308.29 (M<sup>+</sup> − H)<sup>−</sup>. Anal. (C<sub>21</sub>H<sub>27</sub>NO) C, H, N.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-cyano Estra-1,3,5(10)-triene (<b>38</b>)</h3><div class="NLM_p last">Compound <b>37</b> (125 mg, 0.4 mmol) was reacted with sulfamoyl chloride (0.8 mmol) in DMA (2 mL) as described for the synthesis of <b>8</b>. Column chromatography (hexane/ethyl acetate 5:1) followed by crystallization (hexane/ethyl acetate 5:1) gave the desired sulfamate <b>38</b> as a white powder (135 mg, 86%) with mp 193–194 °C, which showed δ<sub>H</sub> 1.00 (3H, s), 1.25 (3H, t, <i>J</i> 7.4), 1.28–2.42 (14H, m), 2.73 (2H, q, <i>J</i> 7.4), 2.88 (2H, m), 4.99 (2H, s), 7.13 (1H, s) and 7.23 (1H, s); MS [APCI<sup>−</sup>] <i>m</i>/<i>z</i> 387.31 (M<sup>+</sup> − H)<sup>−</sup>. Anal. (C<sub>21</sub>H<sub>28</sub>N<sub>2</sub>O<sub>3</sub>S) C, H, N.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-Ethyl-17-cyano Estra-1,3,5(10),16-tetraen-3-ol (<b>39</b>)</h3><div class="NLM_p last">A solution of <b>35</b> (210 mg, 0.6 mmol) in acetone (10 mL) and methanol (10 mL) was reacted with NaHCO<sub>3</sub> (150 mg, 1.8 mmol) as described for the synthesis of <b>37</b>. Column chromatography (hexane/ethylacetate 8:1 to 6:1) followed by recrystallization (hexane/ethyl acetate 6:1) gave the desired phenol <b>39</b> as a white powder (165 mg, 90%) with mp 213–214 °C, which showed δ<sub>H</sub> 0.88 (3H, s), 1.16 (3H, t, <i>J</i> 7.5), 1.31–2.41 (11H, m), 2.53 (2H, q, <i>J</i> 7.5), 2.70–2.84 (2H, m), 4.48 (1H, s), 6.44 (1H, s), 6.60 (1H, dd, <i>J</i> 3.3 and 1.8) and 6.97 (1H, s); MS [APCI<sup>−</sup>] <i>m</i>/<i>z</i> 306.21 (M<sup>+</sup> − H)<sup>−</sup>. Anal. (C<sub>21</sub>H<sub>25</sub>NO) C, H, N.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17-cyano Estra-1,3,5(10),16-tetraene (<b>40</b>)</h3><div class="NLM_p last">Compound <b>39</b> (75 mg, 0.25 mmol) was reacted with sulfamoyl chloride (0.5 mmol) in DMA (1 mL) as described for the synthesis of <b>8</b>. Column chromatography (hexane/ethyl acetate 5:1) followed by crystallization (hexane/ethyl acetate 5:1) gave the desired sulfamate <b>40</b> as a white powder (70 mg, 73%) with mp 212–213 °C, which showed δ<sub>H</sub> 0.99 (3H,s), 1.26 (3H, t, <i>J</i> 7.5), 1.41–2.54 (11H, m), 2.74 (2H, q, <i>J</i> 7.5), 2.92 (2H, m), 5.03 (2H, s), 6.71 (1H, dd, <i>J</i> 3.3 and 1.9), 7.13 (1H, s) and 7.22 (1H, s); MS [APCI<sup>−</sup>] <i>m</i>/<i>z</i> 385.23 (M − H)<sup>−</sup>; HRMS [FAB<sup>+</sup>] <i>m</i>/<i>z</i> found 386.1653; C<sub>21</sub>H<sub>23</sub>O<sub>3</sub>N<sub>2</sub>S requires 386.1664. Anal. (C<sub>21</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub>S) C, H, N.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57"><a href="/doi/suppl/10.1021/jm701319c">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Table of elemental analyses, 13C NMR data and crystallographic data for the hCA II/<b>15</b> complex. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701319c/suppl_file/jm701319c-file001.pdf">jm701319c-file001.pdf (334.32 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701319c" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barry V. L. Potter</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2c6e027a0260027c435858495e6c4e4d5844024d4f025947"><span class="__cf_email__" data-cfemail="90d2bec6bedcbec0ffe4e4f5e2d0f2f1e4f8bef1f3bee5fb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathew P. Leese</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrice L. Jourdan</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keira Gaukroger</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary F. Mahon</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon P. Newman</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. Foster</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chloe Stengel</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Regis-Lydi</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Ferrandis</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Di Fiore</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppina De Simone</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudiu T. Supuran</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atul Purohit</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Reed</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology & Sterix Ltd., and Department of Chemistry, University of Bath, Bath BA2 7AY, U.K., Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Maryʼs Hospital, London W2 1NY, U.K., IPSEN System Biology, 91966 Les Ulis, France, Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Sterix Ltd., a member of the IPSEN Group. We thank Sincrotrone Trieste CNR/Elettra for the opportunity to collect data at the Crystallographic Beamline, Ms. Alison Smith and Dr. James Robinson for technical support, and the NCI DTP program for providing in vitro screening resources.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiatt, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshaw, E.</span><span> </span><span class="NLM_article-title">Tumor angiogenesis: therapeutic implications</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_year" style="font-weight: bold;">1971</span> <span class="NLM_volume">285</span> <span class="NLM_fpage">1182</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1056%2FNEJM197108122850711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=4938153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1971&pages=1182-1186&author=J.+Folkmanauthor=M.+Bachauthor=J.+W.+Roweauthor=F.+Davidoffauthor=P.+Lambertauthor=C.+Hirschauthor=A.+Goldbergauthor=H.+H.+Hiattauthor=J.+Glassauthor=E.+Henshaw&title=Tumor+angiogenesis%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor angiogenesis: therapeutic implications</span></div><div class="casAuthors">Folkman J</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1182-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA0C6odtE1LPxQvRxYU81tfW6udTcc2eZefSJURnVwJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D&md5=efdddcba0c04be542edd51fef2ef27b9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM197108122850711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197108122850711%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DM.%26aulast%3DRowe%26aufirst%3DJ.%2BW.%26aulast%3DDavidoff%26aufirst%3DF.%26aulast%3DLambert%26aufirst%3DP.%26aulast%3DHirsch%26aufirst%3DC.%26aulast%3DGoldberg%26aufirst%3DA.%26aulast%3DHiatt%26aufirst%3DH.%2BH.%26aulast%3DGlass%26aufirst%3DJ.%26aulast%3DHenshaw%26aufirst%3DE.%26atitle%3DTumor%2520angiogenesis%253A%2520therapeutic%2520implications%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26spage%3D1182%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerbel, R. S.</span><span> </span><span class="NLM_article-title">Angiogenesis as a therapeutic target</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">438</span> <span class="NLM_fpage">967</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fnature04483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=16355214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSksrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=967-974&author=N.+Ferraraauthor=R.+S.+Kerbel&title=Angiogenesis+as+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis as a therapeutic target</span></div><div class="casAuthors">Ferrara, Napoleone; Kerbel, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">7070</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inhibiting angiogenesis is a promising strategy for treatment of cancer and several other disorders, including age-related macular degeneration.  Major progress towards a treatment has been achieved over the past few years, and the first antiangiogenic agents have been recently approved for use in several countries.  Therapeutic angiogenesis (promoting new vessel growth to treat ischemic disorders) is an exciting frontier of cardiovascular medicine, but further understanding of the mechanisms of vascular morphogenesis is needed first.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdP_T905faXLVg90H21EOLACvtfcHk0liNnMfO-DH7PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSksrnI&md5=05a90bd29a0fb34f9c20a825f899d04c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature04483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04483%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DKerbel%26aufirst%3DR.%2BS.%26atitle%3DAngiogenesis%2520as%2520a%2520therapeutic%2520target%26jtitle%3DNature%26date%3D2005%26volume%3D438%26spage%3D967%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">391</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fnrd1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=15136787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=391-400&author=N.+Ferraraauthor=K.+J.+Hillanauthor=H.+P.+Gerberauthor=W.+Novotny&title=Discovery+and+development+of+bevacizumab%2C+an+anti-VEGF+antibody+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span></div><div class="casAuthors">Ferrara, Napoleone; Hillan, Kenneth J.; Gerber, Hans-Peter; Novotny, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular supply to nourish a growing tumor, was postulated many decades ago, although the identification and isolation of these factors proved elusive.  Now, vascular endothelial growth factor (VEGF), which was identified in the 1980s, is recognized as an essential regulator of normal and abnormal blood vessel growth.  In 1993, it was shown that a monoclonal antibody that targeted VEGF results in a dramatic suppression of tumor growth in vivo, which led to the development of bevacizumab (Avastin; Genentech), a humanized variant of this anti-VEGF antibody, as an anticancer agent.  The recent approval of bevacizumab by the US FDA as a first-line therapy for metastatic colorectal cancer validates the ideas that VEGF is a key mediator of tumor angiogenesis and that blocking angiogenesis is an effective strategy to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaLbfhdBKOLVg90H21EOLACvtfcHk0liNnMfO-DH7PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D&md5=4b1f647db4dfe2a24449cdf59b874e7c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1381%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DGerber%26aufirst%3DH.%2BP.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DDiscovery%2520and%2520development%2520of%2520bevacizumab%252C%2520an%2520anti-VEGF%2520antibody%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hurwitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehrenbacher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartwright, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabbinavar, F.</span><span> </span><span class="NLM_article-title">Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">350</span> <span class="NLM_fpage">2335</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1056%2FNEJMoa032691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=15175435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2335-2342&author=H.+Hurwitzauthor=L.+Fehrenbacherauthor=W.+Novotnyauthor=T.+Cartwrightauthor=J.+Hainsworthauthor=W.+Heimauthor=J.+Berlinauthor=A.+Baronauthor=S.+Griffingauthor=E.+Holmgrenauthor=N.+Ferraraauthor=G.+Fyfeauthor=B.+Rogersauthor=R.+Rossauthor=F.+Kabbinavar&title=Bevacizumab+plus+irinotecan%2C+fluorouracil%2C+and+leucovorin+for+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer</span></div><div class="casAuthors">Hurwitz, Herbert; Fehrenbacher, Louis; Novotny, William; Cartwright, Thomas; Hainsworth, John; Heim, William; Berlin, Jordan; Baron, Ari; Griffing, Susan; Holmgren, Eric; Ferrara, Napoleone; Fyfe, Gwen; Rogers, Beth; Ross, Robert; Kabbinavar, Fairooz</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2335-2342</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclin. and clin. activity against metastatic colorectal cancer, particularly in combination with chemotherapy.  Of 813 patients with previously untreated metastatic colorectal cancer, we randomly assigned 402 to receive irinotecan, bolus fluorouracil, and leucovorin (IFL) plus bevacizumab (5 mg per kg of body wt. every two weeks) and 411 to receive IFL plus placebo.  The primary end point was overall survival.  Secondary end points were progression-free survival, the response rate, the duration of the response, safety, and the quality of life.  The median duration of survival was 20.3 mo in the group given IFL plus bevacizumab, as compared with 15.6 mo in the group given IFL plus placebo, corresponding to a hazard ratio for death of 0.66 (P<0.001).  The median duration of progression-free survival was 10.6 mo in the group given IFL plus bevacizumab, as compared with 6.2 mo in the group given IFL plus placebo (hazard ratio for disease progression, 0.54; P<0.001); the corresponding rates of response were 44.8 % and 34.8 % (P = 0.004).  The median duration of the response was 10.4 mo in the group given IFL plus bevacizumab, as compared with 7.1 mo in the group given IFL plus placebo (hazard ratio for progression, 0.62; P = 0.001).  Grade 3 hypertension was more common during treatment with IFL plus bevacizumab than with IFL plus placebo (11.0 % vs. 2.3 %) but was easily managed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5r6uP5oxZU7Vg90H21EOLACvtfcHk0liNnMfO-DH7PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gjt74%253D&md5=6a1289cdbf1501f121eb0482e5a1f536</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa032691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa032691%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DH.%26aulast%3DFehrenbacher%26aufirst%3DL.%26aulast%3DNovotny%26aufirst%3DW.%26aulast%3DCartwright%26aufirst%3DT.%26aulast%3DHainsworth%26aufirst%3DJ.%26aulast%3DHeim%26aufirst%3DW.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DA.%26aulast%3DGriffing%26aufirst%3DS.%26aulast%3DHolmgren%26aufirst%3DE.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DFyfe%26aufirst%3DG.%26aulast%3DRogers%26aufirst%3DB.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DKabbinavar%26aufirst%3DF.%26atitle%3DBevacizumab%2520plus%2520irinotecan%252C%2520fluorouracil%252C%2520and%2520leucovorin%2520for%2520metastatic%2520colorectal%2520cancer%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D2335%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, J. S.</span><span> </span><span class="NLM_article-title">Lessons from phase III clinical trials on anti-VEGF therapy for cancer</span> <span class="citation_source-journal">Nat Clin. Pract. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">24</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fncponc0403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=16407877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVynsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=24-40&author=R.+K.+Jainauthor=D.+G.+Dudaauthor=J.+W.+Clarkauthor=J.+S.+Loeffler&title=Lessons+from+phase+III+clinical+trials+on+anti-VEGF+therapy+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from phase III clinical trials on anti-VEGF therapy for cancer</span></div><div class="casAuthors">Jain, Rakesh K.; Duda, Dan G.; Clark, Jeffrey W.; Loeffler, Jay S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-40</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In randomized phase III trials two anti-vascular endothelial growth factor (VEGF) approaches have yielded survival benefit in patients with metastatic cancer.  In one approach, the addn. of bevacizumab, a VEGF-specific antibody, to std. chemotherapy improved overall survival in colorectal and lung cancer patients and progression-free survival in breast cancer patients.  In the second approach, multitargeted tyrosine kinase inhibitors that block VEGF receptor and other kinases in both endothelial and cancer cells, demonstrated survival benefit in gastrointestinal stromal tumor and renal-cell-carcinoma patients.  By contrast, adding bevacizumab to chemotherapy failed to increase survival in patients with previously treated and refractory metastatic breast cancer.  Furthermore, addn. of vatalanib, a kinase inhibitor developed as a VEGF receptor-selective agent, to chemotherapy did not show a similar benefit in metastatic colorectal cancer patients.  These contrasting responses raise crit. questions about how these agents work and how to combine them optimally.  We summarize three of the many potential mechanisms of action of anti-VEGF agents, and also discuss progress relating to the identification of potential biomarkers for anti-VEGF-agent efficacy in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzdONgbUWNUrVg90H21EOLACvtfcHk0lhNq8u9d5_agQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVynsL0%253D&md5=dfcfbf8ab8060df6b65c359b0bf8ef77</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fncponc0403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc0403%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DDuda%26aufirst%3DD.%2BG.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DLoeffler%26aufirst%3DJ.%2BS.%26atitle%3DLessons%2520from%2520phase%2520III%2520clinical%2520trials%2520on%2520anti-VEGF%2520therapy%2520for%2520cancer%26jtitle%3DNat%2520Clin.%2520Pract.%2520Oncol.%26date%3D2006%26volume%3D3%26spage%3D24%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">A-ring substituted estrogen sulfamates: Potent multi-targeted anti-cancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">48</span> <span class="NLM_fpage">5243</span> <span class="NLM_lpage">5256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5243-5256&author=M.+P.+Leeseauthor=H.+A.+M.+Hejazauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+Reedauthor=B.+V.+L.+Potter&title=A-ring+substituted+estrogen+sulfamates%3A+Potent+multi-targeted+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm050066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050066a%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DA-ring%2520substituted%2520estrogen%2520sulfamates%253A%2520Potent%2520multi-targeted%2520anti-cancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5243%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumor agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">3135</span> <span class="NLM_lpage">3138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3135-3138&author=M.+P.+Leeseauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Alkylsulfanyl+estrogen+derivatives%3A+synthesis+of+a+novel+class+of+multi-targeted+anti-tumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Alkylsulfanyl%2520estrogen%2520derivatives%253A%2520synthesis%2520of%2520a%2520novel%2520class%2520of%2520multi-targeted%2520anti-tumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3135%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-<i>O</i>-sulfamates</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">94</span> <span class="NLM_fpage">239</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2Fj.jsbmb.2005.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=15862971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=239-251&author=M.+P.+Leeseauthor=B.+Leblondauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Anti-cancer+activities+of+novel+D-ring+modified+2-substituted+estrogen-3-O-sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates</span></div><div class="casAuthors">Leese, Mathew P.; Leblond, Bertrand; Newman, Simon P.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">239-251</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulfamoylated derivs. of the endogenous estrogen metabolite 2-methoxyestradiol [2-MeOE2 (I)], such as 2-methoxy-3-O-sulfamoylestrone [2-MeOEMATE (II)], display greatly enhanced activity against the proliferation of human cancer cells and inhibit steroid sulfatase (STS), another current oncol. target.  We explore here the effects of steroidal D-ring modification on the activity of such 2-substituted estrogen-3-O-sulfamates in respect of inhibition of tumor cell proliferation and steroid sulfatase.  The novel 17-deoxy analogs of 2-MeOEMATE and the related 2-Et and 2-methylsulfanyl compds. showed greatly reduced inhibition of MCF-7 proliferation.  Introduction of a 17α-benzyl substituent to such 2-substituted estrogen sulfamates also proved deleterious to anti-proliferative activity but could, in one case, enhance STS inhibition with respect to the parent substituted estrone sulfamate.  In contrast, selected 17-oxime derivs. of 2-MeOEMATE displayed an enhanced anti-proliferative activity.  These results illustrate that enhanced in vitro anti-cancer activity can be achieved in the 2-substituted estrogen sulfamate series and highlight, in particular, the importance of potential hydrogen bonding effects around the steroidal D-ring in the activity of these mols.  The SAR parameters established herein will assist the future design of anti-proliferative and anti-endocrine agents as potential therapeutics for both hormone dependent and independent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC4Cz4Pgw94bVg90H21EOLACvtfcHk0lhNq8u9d5_agQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLs%253D&md5=0bc448776d6e96d5ee9f562de51eabb4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2005.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2005.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DAnti-cancer%2520activities%2520of%2520novel%2520D-ring%2520modified%25202-substituted%2520estrogen-3-O-sulfamates%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D94%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography, and in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">7683</span> <span class="NLM_lpage">7696</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060705x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7683-7696&author=M.+P.+Leeseauthor=B.+Leblondauthor=A.+Smithauthor=S.+P.+Newmanauthor=A.+Di+Fioreauthor=G.+de+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-substituted+estradiol+bis-sulfamates%2C+multitargeted+antitumor+agents%3A+Synthesis%2C+in+vitro+SAR%2C+protein+crystallography%2C+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm060705x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060705x%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3Dde%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-substituted%2520estradiol%2520bis-sulfamates%252C%2520multitargeted%2520antitumor%2520agents%253A%2520Synthesis%252C%2520in%2520vitro%2520SAR%252C%2520protein%2520crystallography%252C%2520and%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7683%26epage%3D7696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effect of 2-methoxyoestrone-3-<i>O</i>-sulphamate on the growth of breast cancer cells and induced mammary tumours</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">85</span> <span class="NLM_fpage">584</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=10699934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=584-589&author=A.+Purohitauthor=H.+A.+M.+Hejazauthor=L.+Waldenauthor=L.+MacCarthy-Morroghauthor=G.+Packhamauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effect+of+2-methoxyoestrone-3-O-sulphamate+on+the+growth+of+breast+cancer+cells+and+induced+mammary+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours</span></div><div class="casAuthors">Purohit A; Hejaz H A; Walden L; MacCarthy-Morrogh L; Packham G; Potter B V; Reed M J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">584-9</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">2-Methoxyoestrogens are emerging as a new class of drug that can inhibit tumour growth and angiogenesis.  As sulphamoylation of oestrogens enhances their potency and bioavailability we have synthesized 2-methoxyoestrone-3-O-sulphamate (2-MeOEMATE) and compared its ability to inhibit the proliferation of breast cancer cells with that of 2-methoxyoestrone (2-MeOE1). 2-MeOEMATE (1 microM) inhibited the growth of oestrogen receptor positive MCF-7 breast cancer cells by 52% whereas 2-MeOE1 had little effect at this concentration. 2-MeOEMATE also inhibited the growth of oestrogen receptor negative MDA-MB-231 breast cancer cells.  Exposure of cells to 2-MeOEMATE caused them to round up and become detached suggesting that this compound may induce cells to undergo apoptosis.  Cell cycle analysis revealed that 2-MeOEMATE caused cells to arrest in the G(2)/M phase with the increase in G(2)/M arrested cells being detectable by 12 hr.  Exposure of MCF-7 cells to 2 L-MeOEMATE for 24 hr followed by culture in drug-free medium for 24 hr did not reverse the arrest of cells in the G(2)/M phase.  TUNEL analysis confirmed that 2-MeOEMATE induced apoptosis in a significant proportion of treated MCF-7 cells.  In an in vivo study, employing nitrosomethylurea-induced mammary tumours in intact rats, 2-MeOE1 (20mg/kg/d, p.o. for 11 days) had little effect on tumour growth.  In contrast, the same dose of 2-MeOEMATE resulted in the almost complete regression of 2/3 tumours over an 11-day period.  We conclude that 2-MeOEMATE should have considerable therapeutic potential for the treatment of breast tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqkhlCxw4mrynGiHuhFGv8fW6udTcc2ebyHgMRXOuFN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D&md5=75a9c5a896a1a00886a9c17cf2cbe241</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000215%252985%253A4%253C584%253A%253AAID-IJC22%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DWalden%26aufirst%3DL.%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effect%2520of%25202-methoxyoestrone-3-O-sulphamate%2520on%2520the%2520growth%2520of%2520breast%2520cancer%2520cells%2520and%2520induced%2520mammary%2520tumours%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26spage%3D584%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">Differential effects of estrone and estrone-3-<i>O</i>-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">60</span> <span class="NLM_fpage">5441</span> <span class="NLM_lpage">5450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=11034086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1ehtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5441-5450&author=L.+MacCarthy-Morroghauthor=P.+A.+Townsendauthor=A.+Purohitauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=Differential+effects+of+estrone+and+estrone-3-O-sulfamate+derivatives+on+mitotic+arrest%2C+apoptosis%2C+and+microtubule+assembly+in+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span></div><div class="casAuthors">MacCarthy-Morrogh, Lucy; Townsend, Paul A.; Purohit, Atul; Hejaz, Hatem A. M.; Potter, Barry V. L.; Reed, Michael J.; Packham, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5441-5450</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">There is considerable interest in the potential use of estrogen derivs. for the treatment and prevention of breast cancer.  We demonstrated previously that the sulfamoylated estrone deriv. 2-methoxyestrone-3-O-sulfamate (2-MeOEMATE) induced G2-M cell cycle arrest and modest levels of apoptosis in breast cancer cells in vitro, whereas the parent estrone deriv., 2-methoxyestrone, did not, 2-MeOEMATE also induced breast tumor regression in vivo in intact rats.  To further explore the significance of sulfamoylation on the anticancer activity of estrone derivs. and to elucidate their mechanism of action, we synthesized two addnl. agents, 2-ethylestrone and 2-ethylestrone-3-O-sulfamate (2-EtEMATE).  2-MeOEMATE and 2-EtEMATE inhibited the growth of a panel of estrogen receptor-neg. and -pos. breast cancer cell lines in vitro, induced mitotic arrest and apoptosis, and suppressed the long-term clonogenic potential of MCF7 and CAL51 breast cancer cells.  In each assay, the sulfamoylated estrone derivs. were > 10-fold more potent than their parent compds.  The sulfamoylated estrone derivs. were also significantly more potent inhibitors of cell growth than the previously studied endogenous estradiol metabolite 2-methoxyestradiol.  2-MeOEMATE and 2-EtEMATE functioned as antimicrotubule agents and inhibited the ability of paclitaxel to promote tubulin assembly in vitro.  Like other antimicrotubule agents, the sulfamoylated estrone derivs. induced BCL-2 and BCL-XL phosphorylation and increased p53 expression.  2-MeOEMATE and 2-EtEMATE are novel antimicrotubule agents that have potent anticancer activity in breast cancer cells in vitro and may be beneficial as anticancer agents in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwuuBiQck6dLVg90H21EOLACvtfcHk0lisJaYrnKjONw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1ehtr8%253D&md5=07ffe177df9adffa388318cc283891ff</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DTownsend%26aufirst%3DP.%2BA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3DDifferential%2520effects%2520of%2520estrone%2520and%2520estrone-3-O-sulfamate%2520derivatives%2520on%2520mitotic%2520arrest%252C%2520apoptosis%252C%2520and%2520microtubule%2520assembly%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5441%26epage%3D5450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of <i>in vitro</i> angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">109</span> <span class="NLM_fpage">533</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1002%2Fijc.20045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=14991574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXislCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=533-540&author=S.+P.+Newmanauthor=M.+P.+Leeseauthor=A.+Purohitauthor=D.+R.+C.+Jamesauthor=C.+E.+Rennieauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+in+vitro+angiogenesis+by+2-methoxy-+and+2-ethyl-estrogen+sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates</span></div><div class="casAuthors">Newman, Simon P.; Leese, Mathew P.; Purohit, Atul; James, David. R. C.; Rennie, Catherine E.; Potter, Barry V. L.; Reed, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-540</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Sulfamoylation of 2-methoxyestrone (2-MeOE1) was shown previously to enhance its potency as an anti-proliferative agent against breast cancer cells.  We have examd. the ability of a series of 2-methoxyestradiol (2-MeOE2) and 2-ethylestradiol (2-EtE2) sulfamates to inhibit angiogenesis in vitro.  2-MeOE2 bis-sulfamate and 2-EtE2 sulfamate were potent inhibitors of human umbilical vein endothelial cell (HUVEC) proliferation with IC50 values of 0.05 μM and 0.01 μM, resp.  A novel co-culture system, in which endothelial cells were cultured in a matrix of human dermal fibroblasts, was also used to assess the anti-angiogenic potential of these drugs.  In this system endothelial cells proliferate and migrate through the culture matrix to form tubule structures.  Whereas 2-MeOE2 (1.0 μM) caused a small redn. in tubule formation, both 2-MeOE2 bis-sulfamate (0.1 μM) and 2-EtE2 sulfamate (0.1 μM) almost completely abolished tubule formation.  2-MeOE2 bis-sulfamate and 2-EtE2 sulfamate both induced BCL-2 phosphorylation, p53 protein expression and apoptosis in HUVECs.  Microarray anal. of a limited no. of genes known to be involved in the angiogenic process did not show any gross changes in cells treated with the 2-substituted estrogens.  The sulfamoylated derivs. of 2-MeOE2 and 2-EtE2 are potent inhibitors of in vitro angiogenesis and both compds. should have therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjobqvR13TBLVg90H21EOLACvtfcHk0lisJaYrnKjONw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXislCisro%253D&md5=483da21487f348462926eb1b2b11caad</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fijc.20045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20045%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DD.%2BR.%2BC.%26aulast%3DRennie%26aufirst%3DC.%2BE.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520in%2520vitro%2520angiogenesis%2520by%25202-methoxy-%2520and%25202-ethyl-estrogen%2520sulfamates%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D109%26spage%3D533%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">1368</span> <span class="NLM_lpage">1376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=17426705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1368-1376&author=S.+K.+Chanderauthor=P.+A.+Fosterauthor=M.+P.+Leeseauthor=S.+P.+Newmanauthor=B.+V.+L.+Potterauthor=A.+Purohitauthor=M.+J.+Reed&title=In+vivo+inhibition+of+angiogenesis+by+sulphamoylated+derivatives+of+2-methoxyoestradiol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol</span></div><div class="casAuthors">Chander, S. K.; Foster, P. A.; Leese, M. P.; Newman, S. P.; Potter, B. V. L.; Purohit, A.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1368-1376</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs that inhibit growth of tumors and their blood supply could have considerable therapeutic potential.  2-Methoxyestradiol-3,17-O,O-bis-sulfamate (2-MeOE2bisMATE) has been shown to inhibit the proliferation of MCF-7 (ER+) breast cancer cells and angiogenesis in vitro.  2-MeOE2bisMATE and its analog, 17-Cym-2-MeOE2MATE, were investigated for their ability to inhibit in vivo angiogenesis and tumor growth.  The mouse Matrigel plug assay for angiogenesis was used to investigate the effect of compds. on neovascularization and was quantified using a FITC-dextran injection technique.  Nude mice bearing tumors derived from MCF-7 cells were used to assess efficacy on tumor growth.  Tumor sections were stained for VEGFR-2 and Ki67 to assess tumor angiogenesis and cell proliferation resp.  Matrigel plugs supplemented with basic fibroblast growth factor resulted in increased neovascularization over 7 days.  Oral administration of 2-MeOE2bisMATE for 7 days at 10 or 50 mg kg-1 significantly reduced neovascularization to or below control levels resp.  17-Cym-2-MeOE2MATE at 20 mg kg-1 was equally effective.  2-MeOE2bisMATE, dosed daily for 21 days, caused a 52% redn. in tumor growth at 5 mg kg-1 and 38% regression at 20 mg kg-1.  17-Cym-2-MeOE2MATE (20 mg kg-1) reduced tumor growth by 92%.  Immunohistochem. revealed a redn. in angiogenesis and proliferation.  Matrigel plug and tumor imaging after FITC-dextran injection indicated that 2-MeOE2bisMATE caused a marked disruption of vasculature.  These sulfamoylated estrogen derivs. have been shown to be potent inhibitors of angiogenesis in vivo.  This, together with their ability to inhibit tumor growth, indicates the potential of this new class of drugs for further development for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqermbvXLYR8LVg90H21EOLACvtfcHk0lhDkd-6XC3YrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslyisro%253D&md5=a589de69ba3adc8e5ca93cff2cda1ede</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520angiogenesis%2520by%2520sulphamoylated%2520derivatives%2520of%25202-methoxyoestradiol%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D1368%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wood, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouzakiti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">323</span> <span class="NLM_lpage">332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=323-332&author=L.+Woodauthor=M.+P.+Leeseauthor=A.+Mouzakitiauthor=A.+Purohitauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=2-MeOE2bisMATE+induces+caspase-dependent+apoptosis+in+CAL51+breast+cancer+cells+and+overcomes+resistance+to+TRAIL+via+cooperative+activation+of+caspases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DL.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMouzakiti%26aufirst%3DA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3D2-MeOE2bisMATE%2520induces%2520caspase-dependent%2520apoptosis%2520in%2520CAL51%2520breast%2520cancer%2520cells%2520and%2520overcomes%2520resistance%2520to%2520TRAIL%2520via%2520cooperative%2520activation%2520of%2520caspases%26jtitle%3DApoptosis%26date%3D2004%26volume%3D9%26spage%3D323%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutill, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">The role of 17β-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">324</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=324-330&author=S.+P.+Newmanauthor=C.+R.+Iresonauthor=H.+J.+Tutillauthor=J.+M.+Dayauthor=M.+F.+C.+Parsonsauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=The+role+of+17%CE%B2-hydroxysteroid+dehydrogenases+in+modulating+the+activity+of+2-methoxyestradiol+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DTutill%26aufirst%3DH.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DParsons%26aufirst%3DM.%2BF.%2BC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%252017%25CE%25B2-hydroxysteroid%2520dehydrogenases%2520in%2520modulating%2520the%2520activity%2520of%25202-methoxyestradiol%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D324%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-<i>bis</i>-sulphamate <i>in vivo</i> in rodents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">90</span> <span class="NLM_fpage">932</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fsj.bjc.6601591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=14970876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=932-937&author=C.+R.+Iresonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=S.+Pereraauthor=S.+P.+Newmanauthor=D.+Parishauthor=M.+P.+Leeseauthor=A.+C.+Smithauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Pharmacokinetics+and+efficacy+of+2-methoxyoestradiol+and+2-methoxyoestradiol-bis-sulphamate+in+vivo+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span></div><div class="casAuthors">Ireson, C. R.; Chander, S. K.; Purohit, A.; Perera, S.; Newman, S. P.; Parish, D.; Leese, M. P.; Smith, A. C.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">932-937</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Methoxyoestradiol (2-MeOE2) is an endogenous estrogen metabolite that inhibits the proliferation of cancer cells in vitro, and it is also antiangiogenic.  In vivo 2-MeOE2, when administered at relatively high doses, inhibits the growth of tumors derived from breast cancer cells, sarcomas and melanomas.  Sulphamoylated derivs. of 2-MeOE2 are more potent inhibitors of in vitro breast cancer cell growth than 2-MeOE2.  In the present study, the authors have compared the pharmacokinetic profiles and metab. of 2-MeOE2 and its sulfamoylated deriv., 2-methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE), in adult female rats.  Their ability to inhibit tumor growth was compared in nude mice bearing xenografts derived from MDA-MB-435 (estrogen receptor neg.) melanoma cancer cells.  After a single oral 10 mg kg-1 dose of 2-MeOE2bisMATE, significant concns. of this compd. were still detectable at 24 h.  In contrast, no 2-MeOE2 or metabolites were detected in plasma at any time after a 10 mg kg-1 oral dose.  Thus, the bioavailability of 2-MeOE2 is very low, whereas for 2-MeOE2bisMATE it was 85%.  No significant metabolites of 2-MeOE2bisMATE were detected in plasma after oral or i.v. dosing, showing that this drug is resistant to metab.  In the tumor efficacy model, oral administration of 2-MeOE2bisMATE, at 20 mg kg-1 day-1 daily for 28 days, almost completely inhibited tumor growth.  Inhibition of tumor growth was maintained for a further 28 days after the cessation of dosing.  At this dose level, 2-MeOE2 did not inhibit tumor growth.  The resistance to metab. shown by 2-MeOE2bisMATE and its ability to inhibit tumor growth in vivo suggest that this compd. should have considerable potential for development as a novel anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogMoiaDGhPlLVg90H21EOLACvtfcHk0lhDkd-6XC3YrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D&md5=e92f1f7f94f9d2fdb3afad25cc41903d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601591%26sid%3Dliteratum%253Aachs%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520efficacy%2520of%25202-methoxyoestradiol%2520and%25202-methoxyoestradiol-bis-sulphamate%2520in%2520vivo%2520in%2520rodents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26spage%3D932%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: Molecular biology, regulation and inhibition</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">26</span> <span class="NLM_fpage">171</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1210%2Fer.2004-0003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=15561802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=171-202&author=M.+J.+Reedauthor=A.+Purohitauthor=S.+P.+Newmanauthor=B.+V.+L.+Potter&title=Steroid+sulfatase%3A+Molecular+biology%2C+regulation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulfatase: Molecular biology, regulation, and inhibition</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Woo, L. W. L.; Newman, S. P.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-202</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Steroid sulfatase (STS) is responsible for the hydrolysis of aryl and alkyl steroid sulfates and therefore has a pivotal role in regulating the formation of biol. active steroids.  STS is widely distributed throughout the body, and its action is implicated in physiol. processes and pathol. conditions.  The crystal structure of STS has been resolved, but relatively little is known about what regulates its expression or activity.  Research into the control and inhibition of this enzyme has been stimulated by its important role in supporting the growth of hormone-dependent tumors of the breast and prostate.  STS is responsible for the hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate to estrone and dehydroepiandrosterone, resp., both of which can be converted to steroids with estrogenic properties (i.e., estradiol and androstenediol) that can stimulate tumor growth.  STS expression is increased in breast tumors and has prognostic significance.  The role of STS in supporting tumor growth prompted the development of potent STS inhibitors.  Several steroidal and nonsteroidal STS inhibitors are now available, with the irreversible type of inhibitor having a phenol sulfamate ester as its active pharmacophore.  One such inhibitor, 667 COUMATE, has now entered a phase I trial in postmenopausal women with breast cancer.  The skin is also an important site of STS activity, and deficiency of this enzyme is assocd. with X-linked ichthyosis.  STS may also be involved in regulating part of the immune response and some aspects of cognitive function.  The development of potent STS inhibitors will allow investigation of the role of this enzyme in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvDkv9jdOyZ7Vg90H21EOLACvtfcHk0li1AtKJIZ7dBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D&md5=5ea6cff3a5f23b3f31d08506c724df06</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0003%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulfatase%253A%2520Molecular%2520biology%252C%2520regulation%2520and%2520inhibition%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D171%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">The development of steroid sulphatase inhibitors</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">9</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=9-23&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potter&title=The+development+of+steroid+sulphatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DThe%2520development%2520of%2520steroid%2520sulphatase%2520inhibitors%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D1996%26volume%3D3%26spage%3D9%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">305</span> <span class="NLM_fpage">909</span> <span class="NLM_lpage">914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=909-914&author=Y.+T.+Hoauthor=A.+Purohitauthor=N.+Vickerauthor=S.+P.+Newmanauthor=J.+J.+Robinsonauthor=M.+P.+Leeseauthor=D.+Ganeshapillaiauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+carbonic+anhydrase+II+by+steroidal+and+non-steroidal+sulphamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVicker%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DJ.%2BJ.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520carbonic%2520anhydrase%2520II%2520by%2520steroidal%2520and%2520non-steroidal%2520sulphamates%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D305%26spage%3D909%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Stanway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sufi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigushin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczyk, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulinkaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, R. C.</span><span> </span><span class="NLM_article-title">Phase I study of STX64 (667 Coumate) in breast cancer patients: The first study of a steroid sulfatase inhibitor</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">1585</span> <span class="NLM_lpage">1592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1158%2F1078-0432.CCR-05-1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=16533785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1585-1592&author=S.+J.+Stanwayauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=S.+Sufiauthor=D.+Vigushinauthor=R.+Wardauthor=R.+Wilsonauthor=F.+Z.+Stanczykauthor=N.+Dobbsauthor=E.+Kulinkayaauthor=M.+Elliottauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=R.+C.+Coombs&title=Phase+I+study+of+STX64+%28667+Coumate%29+in+breast+cancer+patients%3A+The+first+study+of+a+steroid+sulfatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: the First Study of a Steroid Sulfatase Inhibitor</span></div><div class="casAuthors">Stanway, Susannah J.; Purohit, Atul; Woo, L. W. Lawrence; Sufi, Saulat; Vigushin, David; Ward, Rebecca; Wilson, Richard H.; Stanczyk, Frank Z.; Dobbs, Nicola; Kulinskaya, Elena; Elliott, Moira; Potter, Barry V. L.; Reed, Michael J.; Coombes, R. Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1585-1592</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Inhibition of steroid sulfatase (STS), the enzyme responsible for the hydrolysis of steroid sulfates, represents a potential novel treatment for postmenopausal women with hormone-dependent breast cancer.  Estrone and DHEA are formed by this sulfatase pathway and can be converted to steroids (estradiol and androstenediol, resp.), which have potent estrogenic properties.  Exptl. Design: STX64 (667 Coumate), a tricylic coumarin-based sulfamate that irreversibly inhibits STS activity, was selected for entry into the first phase I trial of a STS inhibitor in postmenopausal women with breast cancer.  STX64 was administered orally (nine patients at 5 mg and five patients at 20 mg) as an initial dose followed 1 wk later by 3 x 2 weekly cycles, with each cycle comprising daily dosing for 5 days followed by 9 days off treatment.  Blood and tumor tissue samples were collected for the assessment of STS activity and serum was obtained for steroid hormone measurements before and after treatment.  Results: The median inhibition of STS activity by STX64 was 98% in peripheral blood lymphocytes (PBL) and 99% in breast tumor tissue at the end of the 5-day dosing period.  As expected, serum concns. of estrone, estradiol, androstenediol, and DHEA all decreased significantly from pretreatment levels.  Unexpectedly, androstenedione and testosterone concns. also decreased.  Four patients, all of whom had previously progressed on aromatase inhibitors, showed evidence of stable disease for 2.75 to 7 mo.  The drug was well tolerated with only minor drug-related adverse events recorded.  Conclusion: STX64 is a potent, well-tolerated STS inhibitor.  It inhibits STS activity in PBLs and tumor tissues and causes significant decreases in serum concns. of steroids with estrogenic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvfOgizqc5GLVg90H21EOLACvtfcHk0li1AtKJIZ7dBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGmsL0%253D&md5=91b2349eac6d0b3f27073e7b894b7b6d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1996%26sid%3Dliteratum%253Aachs%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSufi%26aufirst%3DS.%26aulast%3DVigushin%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DStanczyk%26aufirst%3DF.%2BZ.%26aulast%3DDobbs%26aufirst%3DN.%26aulast%3DKulinkaya%26aufirst%3DE.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DCoombs%26aufirst%3DR.%2BC.%26atitle%3DPhase%2520I%2520study%2520of%2520STX64%2520%2528667%2520Coumate%2529%2520in%2520breast%2520cancer%2520patients%253A%2520The%2520first%2520study%2520of%2520a%2520steroid%2520sulfatase%2520inhibitor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1585%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Stanway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delavault, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurieau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: a new target for the endocrine therapy of breast cancer</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">370</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=370-374&author=S.+J.+Stanwayauthor=P.+Delavaultauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=C.+Thurieauauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Steroid+sulfatase%3A+a+new+target+for+the+endocrine+therapy+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DDelavault%26aufirst%3DP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DThurieau%26aufirst%3DC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DSteroid%2520sulfatase%253A%2520a%2520new%2520target%2520for%2520the%2520endocrine%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D370%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hussain, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perunovic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, D. H.</span><span> </span><span class="NLM_article-title">Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">104</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fsj.bjc.6603530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=17213826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1KnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=104-109&author=S.+A.+Hussainauthor=R.+Ganesanauthor=G.+Reynoldsauthor=L.+Grossauthor=A.+Stevensauthor=J.+Pastorekauthor=P.+G.+Murrayauthor=B.+Perunovicauthor=M.+S.+Anwarauthor=L.+Billinghamauthor=N.+D.+Jamesauthor=D.+Spoonerauthor=C.+J.+Pooleauthor=D.+W.+Reaauthor=D.+H.+Palmer&title=Hypoxia-regulated+carbonic+anhydrase+IX+expression+is+associated+with+poor+survival+in+patients+with+invasive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer</span></div><div class="casAuthors">Hussain, S. A.; Ganesan, R.; Reynolds, G.; Gross, L.; Stevens, A.; Pastorek, J.; Murray, P. G.; Perunovic, B.; Anwar, M. S.; Billingham, L.; James, N. D.; Spooner, D.; Poole, C. J.; Rea, D. W.; Palmer, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-109</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor hypoxia is a microenvironmental factor related to poor response to radiation, chemotherapy, genetic instability, selection for resistance to apoptosis, and increased risk of invasion and metastasis.  Hypoxia-regulated carbonic anhydrase IX (CA IX) has been studied in various tumor sites and its expression has been correlated with the clin. outcome.  The purpose of this study was to investigate the correlation of CA IX expression with outcome in patients with invasive breast cancer.  We conducted a retrospective study examg. the effects of carbonic anhydrase IX (CA IX) on survival in patients with breast cancer.  To facilitate the screening of multiple tissue blocks from each patient, tissue microarrays were prepd. contg. between two and five representative samples of tumor per patient.  Immunohistochem. was used to examine expression of CA IX in patients with breast cancer.  The study includes a cohort of 144 unselected patients with early invasive breast cancer who underwent surgery, and had CA IX expression and follow-up data available for anal.  At the time of anal., there were 28 deaths and median follow-up of 48 mo with 96% of patients having at least 2 years of follow-up.  CA IX was neg. for 107 patients (17 deaths) and pos. for 37 patients (11 deaths).  Kaplan-Meier survival curves show that survival was superior in the CA IX-neg. group with a 2-yr survival of 97% for negatives and 83% for positives (log-rank test P=0.01).  Allowing for potential prognostic variables in a Cox regression anal., CA IX remained a significant independent predictor of survival (P=0.035).  This study showed in both univariate and multivariate anal. that survival is significantly inferior in patients with tumor expressing CA IX.  Prospective studies are underway to investigate this correlation in clin. trial setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIslWBGCU0lbVg90H21EOLACvtfcHk0lgZwLpV80hvIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1KnsQ%253D%253D&md5=4bf6d73ab8551ce706272ebed8d33aa4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603530%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DS.%2BA.%26aulast%3DGanesan%26aufirst%3DR.%26aulast%3DReynolds%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DL.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DPastorek%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DP.%2BG.%26aulast%3DPerunovic%26aufirst%3DB.%26aulast%3DAnwar%26aufirst%3DM.%2BS.%26aulast%3DBillingham%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DN.%2BD.%26aulast%3DSpooner%26aufirst%3DD.%26aulast%3DPoole%26aufirst%3DC.%2BJ.%26aulast%3DRea%26aufirst%3DD.%2BW.%26aulast%3DPalmer%26aufirst%3DD.%2BH.%26atitle%3DHypoxia-regulated%2520carbonic%2520anhydrase%2520IX%2520expression%2520is%2520associated%2520with%2520poor%2520survival%2520in%2520patients%2520with%2520invasive%2520breast%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D104%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachdeva, Y. P.</span><span> </span><span class="NLM_article-title">Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">40</span> <span class="NLM_fpage">2323</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9700833" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2323-2334&author=M.+Cushmanauthor=H.+M.+Heauthor=J.+A.+Katzenellenbogenauthor=R.+K.+Varmaauthor=E.+Hamelauthor=C.+M.+Linauthor=S.+Ramauthor=Y.+P.+Sachdeva&title=Synthesis+of+analogs+of+2-methoxyestradiol+with+enhanced+inhibitory+effects+on+tubulin+polymerization+and+cancer+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9700833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9700833%26sid%3Dliteratum%253Aachs%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DH.%2BM.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DVarma%26aufirst%3DR.%2BK.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DRam%26aufirst%3DS.%26aulast%3DSachdeva%26aufirst%3DY.%2BP.%26atitle%3DSynthesis%2520of%2520analogs%2520of%25202-methoxyestradiol%2520with%2520enhanced%2520inhibitory%2520effects%2520on%2520tubulin%2520polymerization%2520and%2520cancer%2520cell%2520growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2323%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Klauber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parangi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DʼAmato, R. J.</span><span> </span><span class="NLM_article-title">Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">57</span> <span class="NLM_fpage">81</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=8988045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK2sXjvFOmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=81-86&author=N.+Klauberauthor=S.+Parangiauthor=E.+Flynnauthor=E.+Hamelauthor=R.+J.+D%CA%BCAmato&title=Inhibition+of+angiogenesis+and+breast+cancer+in+mice+by+the+microtubule+inhibitors+2-methoxyestradiol+and+taxol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol</span></div><div class="casAuthors">Klauber, Nancy; Parangi, Sareh; Flynn, Evelyn; Hamel, Ernest; D'Amato, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-86</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">2-Methoxyestradiol (2-ME), an endogenous estrogen metabolite which disrupts microtubule function, has been shown to inhibit proliferating cells in vitro and suppress certain murine tumors in vivo.  In vitro screening has detd. that breast cancer cell lines are most sensitive to inhibition by 2-ME.  Addnl., 2-ME has been shown to inhibit angiogenesis in vitro.  We tested whether 2-ME suppresses cytokine-induced angiogenesis in vivo and inhibits growth of a human breast carcinoma in severe combined immunodeficient mice.  A model of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF)-induced corneal neovascularization in C57BL/6 mice was used to evaluate the antiangiogenic effects of 2-ME and other microtubule inhibitors such as Taxol, vincristine, and colchicine.  2-ME (150 mg/kg p.o.) inhibited bFGF and VEGF-induced neovascularization by 39% and 54%, resp.  Taxol (6 mg/kg i.p.) inhibited bFGF and VEGF-induced neovascularization by 45% and 37%, resp.  Vincristine (0.2 mg/kg i.p.) and colchicine (0.25 mg/kg i.p.) had no effect.  Treatment with 2-ME (75 mg/kg p.o.) for 1 mo suppressed the growth of a human breast carcinoma in mice by 60% without toxicity.  Recognition of the antiangiogenic and antitumor properties of 2-ME and taxol may be crucial in planning clin. applications to angiogenesis-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbq_DgfUImq7Vg90H21EOLACvtfcHk0lgZwLpV80hvIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvFOmtw%253D%253D&md5=88fbe8611dfdb66530160abe5318c2d7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlauber%26aufirst%3DN.%26aulast%3DParangi%26aufirst%3DS.%26aulast%3DFlynn%26aufirst%3DE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DD%25CA%25BCAmato%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520angiogenesis%2520and%2520breast%2520cancer%2520in%2520mice%2520by%2520the%2520microtubule%2520inhibitors%25202-methoxyestradiol%2520and%2520taxol%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D81%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">38</span> <span class="NLM_fpage">2041</span> <span class="NLM_lpage">2049</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00012a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=2041-2049&author=M.+Cushmanauthor=H.+M.+Heauthor=J.+A.+Katzenellenbogenauthor=C.+M.+Linauthor=E.+Hamel&title=Synthesis%2C+antitubulin+and+antimitotic+activity%2C+and+cytotoxicity+of+analogs+of+2-methoxyestradiol%2C+an+endogenous+mammalian+metabolite+of+estradiol+that+inhibits+tubulin+polymerization+by+binding+to+the+colchicine+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00012a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00012a003%26sid%3Dliteratum%253Aachs%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DH.%2BM.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DSynthesis%252C%2520antitubulin%2520and%2520antimitotic%2520activity%252C%2520and%2520cytotoxicity%2520of%2520analogs%2520of%25202-methoxyestradiol%252C%2520an%2520endogenous%2520mammalian%2520metabolite%2520of%2520estradiol%2520that%2520inhibits%2520tubulin%2520polymerization%2520by%2520binding%2520to%2520the%2520colchicine%2520binding%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D2041%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Abbate, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">231</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=231-234&author=F.+Abbateauthor=J.+Y.+Winumauthor=B.+V.+L.+Potterauthor=A.+Casiniauthor=J.+L.+Monteroauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors%3A+X-ray+crystallographic+structure+of+the+adduct+of+human+isozyme+II+with+EMATE%2C+a+dual+inhibitor+of+carbonic+anhydrases+and+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbate%26aufirst%3DF.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DJ.%2BL.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors%253A%2520X-ray%2520crystallographic%2520structure%2520of%2520the%2520adduct%2520of%2520human%2520isozyme%2520II%2520with%2520EMATE%252C%2520a%2520dual%2520inhibitor%2520of%2520carbonic%2520anhydrases%2520and%2520steroid%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D231%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddersen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B.</span><span> </span><span class="NLM_article-title">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">55</span> <span class="NLM_fpage">395</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2F0960-0760%2895%2900214-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=8541236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=395-403&author=W.+Elgerauthor=S.+Schwarzauthor=A.+M.+Heddenauthor=G.+Reddersenauthor=B.+Schneider&title=Sulfamates+of+various+estrogens+are+prodrugs+with+increased+systemic+and+reduced+hepatic+estrogenicity+at+oral+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span></div><div class="casAuthors">Elger, Walter; Schwarz, Sigfrid; Hedden, Annemarie; Reddersen, Gudrun; Schneider, Birgitt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">395-403</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oral therapy with natural or synthetic estrogens, like ethinylestradiol, suffers from low, suboptimally defined bioavailability and excess hepatic estrogen actions.  N,N-alkylated and non-alkylated sulfamates of ethinylestradiol, estradiol and estrone overcome these deficiencies.  Ovariectomized Wistar rats (-7/group) were orally treated for 7 days, and killed on day 8, plasma was gained on days 0, 4, and 8.  Systemic estrogenicity was quantified by assessment of uterine wt., vaginal cornification, and measurement of gonadotropins by homologous RIA.  Estrogenicity in the liver was analyzed.  Angiotensinogen was estd. by RIA of angiotensin-I after incubation of EDTA-plasma with porcine renin.  Total and high-d. cholesterol were measured by enzymic methods.  Preliminary biotransformation studies were performed after oral administration of 10 μg, 5 μ Ci [2,4,6,7-3H]estradiol sulfonate.  Ethinylestradiol led to distinct elevation of angiotensin-I and dramatic depression of cholesterol fractions, reflecting hepatic estrogen effects, already at doses with marginal systemic effects.  Estradiol and estrone had systemic and hepatic estrogenic activity at much higher doses only.  Estrogen sulfamates had systemic estrogen activity 10-90-fold above that of their parent estrogen.  Non-alkylated sulfamates of given estrogens were more active than N-alkylated ones.  Elevation of systemic estrogen activity was always combined with a dramatic redn. of hepatic estrogenicity.  Estradiol sulfamate had a 90-fold elevated systemic estrogen activity vs. estradiol, but lacked hepatic activity including the 30-fold dose inducing vaginal response.  Three hours after administration no unchanged estradiol sulfamate was detectable in plasma.  Rather peaks, probably representing estradiol and estrone, were found.  Estrogen sulfamates are considered prodrugs of their parent estrogen, which do not interact with any liver function during the first-pass.  They represent a new strategy of oral hormone administration.  Their main potential seems to be the systemic generation of natural estrogen when used in oral contraceptives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq93WhQsNTWFbVg90H21EOLACvtfcHk0liS_3YxMPRqyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D&md5=60ff9ba569eb4001a4a023073e8737e0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900214-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900214-6%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DHedden%26aufirst%3DA.%2BM.%26aulast%3DReddersen%26aufirst%3DG.%26aulast%3DSchneider%26aufirst%3DB.%26atitle%3DSulfamates%2520of%2520various%2520estrogens%2520are%2520prodrugs%2520with%2520increased%2520systemic%2520and%2520reduced%2520hepatic%2520estrogenicity%2520at%2520oral%2520application%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D55%26spage%3D395%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dahut, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparreboom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span> </span><span class="NLM_article-title">Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">22</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.4161%2Fcbt.5.1.2349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=16357512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVSntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=22-27&author=W.+L.+Dahutauthor=N.+J.+Lakhaniauthor=J.+L.+Gulleyauthor=P.+M.+Arlenauthor=E.+C.+Kohnauthor=H.+Kotzauthor=D.+McNallyauthor=A.+Parrauthor=D.+Nguyenauthor=S.+X.+Yangauthor=S.+M.+Steinbergauthor=J.+Venitzauthor=A.+Sparreboomauthor=W.+D.+Figg&title=Phase+I+clinical+trial+of+oral+2-methoxyestradiol%2C+an+antiangiogenic+and+apoptotic+agent%2C+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors</span></div><div class="casAuthors">Dahut, William L.; Lakhani, Nehal J.; Gulley, James L.; Arlen, Philip M.; Kohn, Elise C.; Kotz, Herbert; McNally, Debbie; Parr, Allyson; Nguyen, Diana; Yang, Sherry X.; Steinberg, Seth M.; Venitz, Jurgen; Sparreboom, Alex; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-27</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: To det. the max.-tolerated dose (MTD) and toxicity profile of the novel anticancer agent, 2-methoxyestradiol (2ME2) administered orally, in patients with solid tumors.  Materials and methods: Twenty patients with refractory solid tumors were enrolled.  2ME2 was given orally starting at 400 mg bid with dose escalation until 3000 mg bid.  Tumor biopsies were taken before and after starting the drug to assess for microvessel d. by CD 31 and cell proliferation by Ki67 immunohistochem.  Serial plasma samples collected up to 50 h after first single oral dose for characterization of pharmacokinetics, were analyzed using liq. chromatog. tandem mass-spectrometry.  Results: Eleven men and nine women received 2ME2 at dose levels of 400 mg bid (n = 3), 800 mg bid (n = 3), 1600 mg bid (n = 6), 2200 mg bid (n = 5) and 3000 mg bid (n = 3).  There were no dose limiting toxicities, therefore the MTD was not defined.  There was one episode of grade 4 angioedema in the 1600 mg bid dose level 38 days into 2ME2 treatment.  Other toxicities were mild to moderate.  A patient with clear cell carcinoma of the ovary had a partial response at 1600 mg bid dose level lasting over three years.  Conclusion: MTD for 2ME2 was not reached at dose of 3000 mg bid.  The trial was closed due to extremely low plasma concns. of 2ME2 relative to the doses administered.  2ME2 treatment had no effect on microvessel d. (CD31 immunostaining) and cell proliferation (Ki-67 immunostaining).  A new formulation of 2ME2 with improved bioavailability is currently being developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn5SfJSuSB7Vg90H21EOLACvtfcHk0liS_3YxMPRqyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVSntro%253D&md5=4e4021491980ad34411e4637c35ebbc9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.4161%2Fcbt.5.1.2349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.5.1.2349%26sid%3Dliteratum%253Aachs%26aulast%3DDahut%26aufirst%3DW.%2BL.%26aulast%3DLakhani%26aufirst%3DN.%2BJ.%26aulast%3DGulley%26aufirst%3DJ.%2BL.%26aulast%3DArlen%26aufirst%3DP.%2BM.%26aulast%3DKohn%26aufirst%3DE.%2BC.%26aulast%3DKotz%26aufirst%3DH.%26aulast%3DMcNally%26aufirst%3DD.%26aulast%3DParr%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DSteinberg%26aufirst%3DS.%2BM.%26aulast%3DVenitz%26aufirst%3DJ.%26aulast%3DSparreboom%26aufirst%3DA.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DPhase%2520I%2520clinical%2520trial%2520of%2520oral%25202-methoxyestradiol%252C%2520an%2520antiangiogenic%2520and%2520apoptotic%2520agent%252C%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Sutherland, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuliga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziogas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. G.</span><span> </span><span class="NLM_article-title">2-Methoxyestradiol: a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">577</span> <span class="NLM_lpage">584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=577-584&author=T.+E.+Sutherlandauthor=R.+L.+Andersonauthor=R.+A.+Hughesauthor=E.+Altmannauthor=M.+Schuligaauthor=J.+Ziogasauthor=A.+G.+Stewart&title=2-Methoxyestradiol%3A+a+unique+blend+of+activities+generating+a+new+class+of+anti-tumour%2Fanti-inflammatory+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DT.%2BE.%26aulast%3DAnderson%26aufirst%3DR.%2BL.%26aulast%3DHughes%26aufirst%3DR.%2BA.%26aulast%3DAltmann%26aufirst%3DE.%26aulast%3DSchuliga%26aufirst%3DM.%26aulast%3DZiogas%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BG.%26atitle%3D2-Methoxyestradiol%253A%2520a%2520unique%2520blend%2520of%2520activities%2520generating%2520a%2520new%2520class%2520of%2520anti-tumour%252Fanti-inflammatory%2520agents%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D577%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">3,17-Disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anti-cancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">4443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4443&author=C.+Bubertauthor=M.+P.+Leeseauthor=M.+F.+Mahonauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=P.+G.+Kasprzykauthor=S.+P.+Newmanauthor=Y.+T.+Hoauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=3%2C17-Disubstituted+2-alkylestra-1%2C3%2C5%2810%29-trien-3-ol+derivatives%3A+synthesis%2C+in+vitro+and+in+vivo+anti-cancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D3%252C17-Disubstituted%25202-alkylestra-1%252C3%252C5%252810%2529-trien-3-ol%2520derivatives%253A%2520synthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520anti-cancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, N.</span><span> </span><span class="NLM_article-title">Efficient general method for sulfamoylation of a hydroxyl group</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">7047</span> <span class="NLM_lpage">7051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2FS0040-4039%2800%2901130-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtF2isLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=7047-7051&author=M.+Okadaauthor=S.+Iwashitaauthor=N.+Koizumi&title=Efficient+general+method+for+sulfamoylation+of+a+hydroxyl+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient general method for sulfamoylation of a hydroxyl group</span></div><div class="casAuthors">Okada, M.; Iwashita, S.; Koizumi, N.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">7047-7051</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The application of AcNMe2 or 1-methyl-2-pyrrolidone as solvent clearly accelerated the sulfamoylation reaction of a HO group compared with the solvents used so far.  The target sulfamates were obtained in the highest yield without a base.  Two equiv. of sulfamoyl chloride to the starting material were sufficient to complete the reaction.  This condition could be applied to extensive hydroxyl groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMkbGz4xRTMLVg90H21EOLACvtfcHk0ljcviPijaAW0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtF2isLg%253D&md5=24aeb055f809e10d10d27a703b04c65f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2901130-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252901130-8%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DIwashita%26aufirst%3DS.%26aulast%3DKoizumi%26aufirst%3DN.%26atitle%3DEfficient%2520general%2520method%2520for%2520sulfamoylation%2520of%2520a%2520hydroxyl%2520group%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D7047%26epage%3D7051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Burgess, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penton, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, E. A.</span><span> </span><span class="NLM_article-title">Synthetic applications of N-carboalkoxysulfamate esters</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1970</span> <span class="NLM_volume">92</span> <span class="NLM_fpage">5224</span> <span class="NLM_lpage">5226</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00720a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaE3cXkvFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1970&pages=5224-5226&author=E.+M.+Burgessauthor=H.+R.+Pentonauthor=E.+A.+Taylor&title=Synthetic+applications+of+N-carboalkoxysulfamate+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic applications of N-carboalkoxysulfamate esters</span></div><div class="casAuthors">Burgess, Edward M.; Penton, Harold R., Jr.; Taylor, Edward Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5224-6</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">MeCRR1OSO2N-CO2Me M+, where R is H or an alkyl group and R1 is an alkyl group or (RR1C =) cycloalkylidene group, fragment to give CH2:CRR1.  (Me3C)2C(CHMe2)OH gives Me3CC(CHMe2)(CMe:CH2)Me.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfAMPLrQ4ZlrVg90H21EOLACvtfcHk0ljcviPijaAW0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXkvFygs7g%253D&md5=5aa1e757d774f9869f2520e4e4b7b13d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja00720a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00720a041%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DE.%2BM.%26aulast%3DPenton%26aufirst%3DH.%2BR.%26aulast%3DTaylor%26aufirst%3DE.%2BA.%26atitle%3DSynthetic%2520applications%2520of%2520N-carboalkoxysulfamate%2520esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1970%26volume%3D92%26spage%3D5224%26epage%3D5226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ohira, S.</span><span> </span><span class="NLM_article-title">Methanolysis of dimethyl(1-diazo-2-oxopropyl)phosphonate. Generation of (diazomethyl) phosphonate and reaction with carbonyl compounds</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_year" style="font-weight: bold;">1989</span> <span class="NLM_volume">19</span> <span class="NLM_fpage">561</span> <span class="NLM_lpage">564</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1080%2F00397918908050700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaL1MXltlegsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1989&pages=561-564&author=S.+Ohira&title=Methanolysis+of+dimethyl%281-diazo-2-oxopropyl%29phosphonate.+Generation+of+%28diazomethyl%29+phosphonate+and+reaction+with+carbonyl+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Methanolysis of dimethyl (1-diazo-2-oxopropyl)phosphonate:  generation of dimethyl (diazomethyl)phosphonate and reaction with carbonyl compounds</span></div><div class="casAuthors">Ohira, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Treatment of MeCOC(N2)PO3Me2 with K2CO3 in MeOH afforded N2CHPO3Me2 (I), which was used in situ for the synthesis of enol ethers or alkynes.  Thus, I and cyclohexanone or decanal afforded (methoxymethylene)cyclohexane or 1-undecyne, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmw2veCJW5vbVg90H21EOLACvtfcHk0ljcviPijaAW0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltlegsLc%253D&md5=55a1aab8bf13ca7835e3609d138fe2de</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397918908050700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918908050700%26sid%3Dliteratum%253Aachs%26aulast%3DOhira%26aufirst%3DS.%26atitle%3DMethanolysis%2520of%2520dimethyl%25281-diazo-2-oxopropyl%2529phosphonate.%2520Generation%2520of%2520%2528diazomethyl%2529%2520phosphonate%2520and%2520reaction%2520with%2520carbonyl%2520compounds%26jtitle%3DSynth.%2520Commun.%26date%3D1989%26volume%3D19%26spage%3D561%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Tinley, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall-Hlubek, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cessac, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span> </span><span class="NLM_article-title">Novel 2-methoxyestradiol analogues with antitumor activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">63</span> <span class="NLM_fpage">1538</span> <span class="NLM_lpage">1549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1538-1549&author=T.+L.+Tinleyauthor=R.+M.+Lealauthor=D.+A.+Randall-Hlubekauthor=J.+W.+Cessacauthor=L.+R.+Wilkensauthor=P.+N.+Raoauthor=S.+L.+Mooberry&title=Novel+2-methoxyestradiol+analogues+with+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTinley%26aufirst%3DT.%2BL.%26aulast%3DLeal%26aufirst%3DR.%2BM.%26aulast%3DRandall-Hlubek%26aufirst%3DD.%2BA.%26aulast%3DCessac%26aufirst%3DJ.%2BW.%26aulast%3DWilkens%26aufirst%3DL.%2BR.%26aulast%3DRao%26aufirst%3DP.%2BN.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DNovel%25202-methoxyestradiol%2520analogues%2520with%2520antitumor%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D1538%26epage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span> </span><span class="NLM_article-title">Some practical consideration and applications of the National Cancer Institute <i>in vitro</i> anticancer drug discovery screen</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">91</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=91-109&author=M.+R.+Boydauthor=K.+D.+Paull&title=Some+practical+consideration+and+applications+of+the+National+Cancer+Institute+in+vitro+anticancer+drug+discovery+screen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26atitle%3DSome%2520practical%2520consideration%2520and%2520applications%2520of%2520the%2520National%2520Cancer%2520Institute%2520in%2520vitro%2520anticancer%2520drug%2520discovery%2520screen%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D34%26spage%3D91%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span> </span><span class="NLM_article-title">The NCI 60 human tumor cell line screen: An information-rich screen informing on mechanisms of toxicity</span> <span class="citation_source-journal">In Vitro Cell. Dev. Biol.: Anim.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">5A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=5A&author=R.+H.+Shoemaker&title=The+NCI+60+human+tumor+cell+line+screen%3A+An+information-rich+screen+informing+on+mechanisms+of+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26atitle%3DThe%2520NCI%252060%2520human%2520tumor%2520cell%2520line%2520screen%253A%2520An%2520information-rich%2520screen%2520informing%2520on%2520mechanisms%2520of%2520toxicity%26jtitle%3DIn%2520Vitro%2520Cell.%2520Dev.%2520Biol.%253A%2520Anim.%26date%3D2006%26volume%3D42%26spage%3D5A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raobaikady, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">97</span> <span class="NLM_fpage">1673</span> <span class="NLM_lpage">1682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fsj.bjc.6604100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=18026194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSrsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=1673-1682&author=S.+P.+Newmanauthor=P.+A.+Fosterauthor=Y.+T.+Hoauthor=J.+M.+Dayauthor=B.+Raobaikadyauthor=P.+G.+Kasprzykauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=The+therapeutic+potential+of+a+series+of+orally+bioavailable+anti-angiogenic+microtubule+disruptors+as+therapy+for+hormone-independent+prostate+and+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers</span></div><div class="casAuthors">Newman, S. P.; Foster, P. A.; Ho, Y. T.; Day, J. M.; Raobaikady, B.; Kasprzyk, P. G.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1673-1682</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Therapies for hormone-independent prostate and breast cancer are limited, with the effectiveness of the taxanes compromised by toxicity, lack of oral bioavailability and drug resistance.  This study aims to identify and characterize new microtubule disruptors, which may have improved efficacy relative to the taxanes in hormone-independent cancer.  2-Methoxy-3-O-sulfamoyl-17β-cyanomethyl-estra-1,3,5(10)-triene (STX641), 2-methoxy-3-hydroxy-17β-cyanomethyl-estra-1,3,5(10)-triene (STX640) and 2-methoxyoestradiol-3,17-O,O-bis-sulfamate (STX140) were all potent inhibitors of cell proliferation in a panel of prostate and breast cancer cell lines.  STX641 and STX640 significantly inhibited tumor growth in the MDA-MB-231 xenograft model.  STX641 inhibited both in vitro and in vivo angiogenesis.  Despite good in vivo activity, STX641 was not as potent in vivo as STX140.  Therefore, STX140 was evaluated in the prostate hormone-independent PC-3 xenograft model.  STX140 had superior efficacy to docetaxel, 2-MeOE2 and bevacizumab.  In contrast to vinorelbine, no significant toxicity was obsd.  Furthermore, STX140 could be given daily over a 60-day period leading to tumor regression and complete responses, which were maintained after the cessation of dosing.  This study demonstrates that STX641 and STX140 have considerable potential for the treatment of hormone-independent breast and prostate cancer.  In contrast to the taxanes, STX140 can be dosed orally, with no toxicity being obsd. even after prolonged daily dosing. published online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj4UzNL9Xur7Vg90H21EOLACvtfcHk0ljnuOe3WzJMPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSrsLzI&md5=68915a360f3fab3a75120ba88422a5b9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604100%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DRaobaikady%26aufirst%3DB.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520a%2520series%2520of%2520orally%2520bioavailable%2520anti-angiogenic%2520microtubule%2520disruptors%2520as%2520therapy%2520for%2520hormone-independent%2520prostate%2520and%2520breast%2520cancers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D97%26spage%3D1673%26epage%3D1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inactivation of steroid sulfatase by an active site directed inhibitor, estrone-3-O-sulfamate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">11508</span> <span class="NLM_lpage">11514</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00036a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=11508-11514&author=A.+Purohitauthor=G.+J.+Williamsauthor=N.+M.+Howarthauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inactivation+of+steroid+sulfatase+by+an+active+site+directed+inhibitor%2C+estrone-3-O-sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi00036a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00036a025%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInactivation%2520of%2520steroid%2520sulfatase%2520by%2520an%2520active%2520site%2520directed%2520inhibitor%252C%2520estrone-3-O-sulfamate%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D11508%26epage%3D11514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lloyd, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiyagarajan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">44</span> <span class="NLM_fpage">6858</span> <span class="NLM_lpage">6866</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi047692e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=6858-6866&author=M.+D.+Lloydauthor=N.+Thiyagarajanauthor=Y.+T.+Hoauthor=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=A.+Purohitauthor=M.+J.+Reedauthor=K.+R.+Acharyaauthor=B.+V.+L.+Potter&title=First+crystal+structures+of+human+carbonic+anhydrase+II+in+complex+with+dual+aromatase-steroid+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi047692e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi047692e%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThiyagarajan%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DFirst%2520crystal%2520structures%2520of%2520human%2520carbonic%2520anhydrase%2520II%2520in%2520complex%2520with%2520dual%2520aromatase-steroid%2520sulfatase%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D6858%26epage%3D6866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Appel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, G.</span><span> </span><span class="NLM_article-title">Uber das hydrazidosulfamid (On hydrazidosulfamide)</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_year" style="font-weight: bold;">1958</span> <span class="NLM_volume">91</span> <span class="NLM_fpage">1339</span> <span class="NLM_lpage">1341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1958&pages=1339-1341&author=R.+Appelauthor=G.+Berger&title=Uber+das+hydrazidosulfamid+%28On+hydrazidosulfamide%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DR.%26aulast%3DBerger%26aufirst%3DG.%26atitle%3DUber%2520das%2520hydrazidosulfamid%2520%2528On%2520hydrazidosulfamide%2529%26jtitle%3DChem.%2520Ber.%26date%3D1958%26volume%3D91%26spage%3D1339%26epage%3D1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightowler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">57</span> <span class="NLM_fpage">79</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2F0960-0760%2895%2900244-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=8645620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1996&pages=79-88&author=L.+W.+L.+Wooauthor=M.+Lightowlerauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Heteroatom-substituted+analogues+of+the+active-site+directed+inhibitor+estra-1%2C3%2C5%2810%29-trien-17-one-3-sulphamate+inhibit+estrone+sulphatase+by+a+different+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Hetero atom-substituted analogs of the active-side directed inhibitor estra-1,3,5(10)-triene-17-one-3-sulfamate inhibit estrone sulfatase by a different mechanism</span></div><div class="casAuthors">Woo, L. W. Lawrence; Lightowler, Mark; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Estrogens have a pivotal role in the growth and development of hormone-dependent breast cancers.  In postmenopausal women, the hydrolysis of the conjugate estrone sulfate (E1S) to estrone (E1) by the enzyme estrone sulfatase is the major source of breast tumor estrogen.  Inhibitors of estrone sulfatase should therefore have considerable therapeutic potential for the treatment of hormone-dependent tumors of the breast, either as the sole agent or in conjunction with aromatase inhibitors.  Several inhibitors of estrone sulfatase have now been developed of which estra-1,3,5(10)-trien-17-one-3-sulfamate (EMATE) is the most potent and also inhibits the enzyme in a time- and concn.-dependent manner, showing that it acts as an irreversible inhibitor.  Analogs of EMATE in which the 3-O-atom is replaced by other heteroatoms (S and N) were prepd. and tested for inhibition against estrone sulfatase.  3-Methoxyphenylsulfamide, 4-chlorothiophenyl-S-(N,N-dimethyl)sulfamate, estra-1,3,5(10)-trien-17-one-3-sulfamide, estra-1,3,5(10)-trien-17-one-3-S-sulfamate, and estra-1,3,5(10)-trien-17-one-3-S-(N,N-dimethyl)sulfamate inhibited estrone sulfatase weakly, but none of these compds. appears to behave as a time-dependent inhibitor.  A model of the mechanism of enzyme inhibition by EMATE is proposed and the authors conclude that the sulfamate bridging oxygen atom of EMATE is essential for active site-directed inhibition of estrone sulfatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlWZCRBBmXtLVg90H21EOLACvtfcHk0lg03nj93RfHCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D&md5=ce13a9f57587179a9d5a3a104fd67740</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900244-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900244-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLightowler%26aufirst%3DM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHeteroatom-substituted%2520analogues%2520of%2520the%2520active-site%2520directed%2520inhibitor%2520estra-1%252C3%252C5%252810%2529-trien-17-one-3-sulphamate%2520inhibit%2520estrone%2520sulphatase%2520by%2520a%2520different%2520mechanism%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D57%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Method Enzymol.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">276</span> <span class="NLM_fpage">307</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lg03nj93RfHCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethod%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Eriksson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljas, A.</span><span> </span><span class="NLM_article-title">Refined structure of human carbonic anhydrase II at 2.0Å resolution</span> <span class="citation_source-journal">Proteins</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">274</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1988&pages=274-282&author=A.+E.+Erikssonauthor=T.+A.+Jonesauthor=A.+Liljas&title=Refined+structure+of+human+carbonic+anhydrase+II+at+2.0%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DT.%2BA.%26aulast%3DLiljas%26aufirst%3DA.%26atitle%3DRefined%2520structure%2520of%2520human%2520carbonic%2520anhydrase%2520II%2520at%25202.0%25C3%2585%2520resolution%26jtitle%3DProteins%26date%3D1988%26volume%3D4%26spage%3D274%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Brunger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delano, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, G. L.</span><span> </span><span class="NLM_article-title">Crystallography & NMR system: A new software suite for macromolecular structure determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">54</span> <span class="NLM_fpage">905</span> <span class="NLM_lpage">921</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=905-921&author=A.+T.+Brungerauthor=P.+D.+Adamsauthor=G.+M.+Cloreauthor=W.+L.+Delanoauthor=P.+Grosauthor=R.+W.+Grosse-Kunstleveauthor=J.+S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+%26+NMR+system%3A+A+new+software+suite+for+macromolecular+structure+determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DDelano%26aufirst%3DW.%2BL.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%2BS.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520%2526%2520NMR%2520system%253A%2520A%2520new%2520software%2520suite%2520for%2520macromolecular%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%26date%3D1998%26volume%3D54%26spage%3D905%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Jones, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjeldgaard, M.</span><span> </span><span class="NLM_article-title">Improved methods for building protein models in electron-density maps and the location of errors in these models</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A</span><span class="NLM_year" style="font-weight: bold;">1991</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">110</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1107%2FS0108767390010224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=2025413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A280%3ADyaK3M3it1CmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1991&pages=110-119&author=T.+A.+Jonesauthor=J.+Y.+Zouauthor=S.+W.+Cowanauthor=M.+Kjeldgaard&title=Improved+methods+for+building+protein+models+in+electron-density+maps+and+the+location+of+errors+in+these+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Improved methods for building protein models in electron density maps and the location of errors in these models</span></div><div class="casAuthors">Jones T A; Zou J Y; Cowan S W; Kjeldgaard M</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section A, Foundations of crystallography</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">47 ( Pt 2)</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-9</span>
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    </div><div class="casAbstract">Map interpretation remains a critical step in solving the structure of a macromolecule.  Errors introduced at this early stage may persist throughout crystallographic refinement and result in an incorrect structure.  The normally quoted crystallographic residual is often a poor description for the quality of the model.  Strategies and tools are described that help to alleviate this problem.  These simplify the model-building process, quantify the goodness of fit of the model on a per-residue basis and locate possible errors in peptide and side-chain conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhby6yNdW8QMKL0FlyGHDofW6udTcc2eYnpl6QEEd0arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3it1CmsQ%253D%253D&md5=fd4d4a3cdb4ecb3f05bbad8b2300ef45</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0108767390010224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767390010224%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DT.%2BA.%26aulast%3DZou%26aufirst%3DJ.%2BY.%26aulast%3DCowan%26aufirst%3DS.%2BW.%26aulast%3DKjeldgaard%26aufirst%3DM.%26atitle%3DImproved%2520methods%2520for%2520building%2520protein%2520models%2520in%2520electron-density%2520maps%2520and%2520the%2520location%2520of%2520errors%2520in%2520these%2520models%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%26date%3D1991%26volume%3D47%26spage%3D110%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Laskowski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacArthur, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. M.</span><span> </span><span class="NLM_article-title">PROCHECK: a program to check the stereochemical quality of protein structures</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_year" style="font-weight: bold;">1993</span> <span class="NLM_volume">26</span> <span class="NLM_fpage">283</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1107%2FS0021889892009944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=283-291&author=R.+A.+Laskowskiauthor=M.+W.+MacArthurauthor=D.+S.+Mossauthor=J.+M.+Thornton&title=PROCHECK%3A+a+program+to+check+the+stereochemical+quality+of+protein+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">PROCHECK: a program to check the stereochemical quality of protein structures</span></div><div class="casAuthors">Laskowski, Roman A.; MacArthur, Malcolm W.; Moss, David S.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-91</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">The PROCHECK suite of programs provides a detailed check on the stereochem. of a protein structure.  Its outputs comprise a no. of plots in PostScript format and a comprehensive residue-by-residue listing.  These give an assessment of the overall quality of the structure as compared with well-refined structures of the same resoln. and also highlight regions that may need further investigation.  The PROCHECK programs are useful for assessing the quality not only of protein structures in the process of being solved but also of existing structures and of those being modeled on known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCe5FgJf4KH7Vg90H21EOLACvtfcHk0lg9wswuca88yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D&md5=fb69fc4410cd716aaaa7cc0db06b3ed2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0021889892009944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889892009944%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DMacArthur%26aufirst%3DM.%2BW.%26aulast%3DMoss%26aufirst%3DD.%2BS.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DPROCHECK%253A%2520a%2520program%2520to%2520check%2520the%2520stereochemical%2520quality%2520of%2520protein%2520structures%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D283%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jacob
T. Andring, Wolfgang Dohle, Chingkuang Tu, Barry V. L. Potter, <span class="NLM_string-name hlFld-ContribAuthor">Robert McKenna</span>. </span><span class="cited-content_cbyCitation_article-title">3,17β-Bis-sulfamoyloxy-2-methoxyestra-1,3,5(10)-triene and Nonsteroidal Sulfamate Derivatives Inhibit Carbonic Anhydrase IX: Structure–Activity Optimization for Isoform Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 2202-2212. <a href="https://doi.org/10.1021/acs.jmedchem.8b01990" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01990%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3%25252C17%2525CE%2525B2-Bis-sulfamoyloxy-2-methoxyestra-1%25252C3%25252C5%25252810%252529-triene%252Band%252BNonsteroidal%252BSulfamate%252BDerivatives%252BInhibit%252BCarbonic%252BAnhydrase%252BIX%25253A%252BStructure%2525E2%252580%252593Activity%252BOptimization%252Bfor%252BIsoform%252BSelectivity%26aulast%3DAndring%26aufirst%3DJacob%2BT.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D19122018%26date%3D18022019%26date%3D05022019%26volume%3D62%26issue%3D4%26spage%3D2202%26epage%3D2212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Grégory  Menchon</span>, <span class="hlFld-ContribAuthor ">Andrea E.  Prota</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>, <span class="hlFld-ContribAuthor ">Pascoe  Mannion</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Mark P.  Thomas</span>, <span class="hlFld-ContribAuthor ">Philip G.  Kasprzyk</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Michel O.  Steinmetz</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, and <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>  . </span><span class="cited-content_cbyCitation_article-title">Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1031-1044. <a href="https://doi.org/10.1021/acs.jmedchem.7b01474" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01474%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DQuinazolinone-Based%252BAnticancer%252BAgents%25253A%252BSynthesis%25252C%252BAntiproliferative%252BSAR%25252C%252BAntitubulin%252BActivity%25252C%252Band%252BTubulin%252BCo-crystal%252BStructure%26aulast%3DDohle%26aufirst%3DWolfgang%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D04102017%26date%3D08012018%26date%3D08022018%26date%3D11122017%26volume%3D61%26issue%3D3%26spage%3D1031%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark P.  Thomas</span> and <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women’s Health. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (19)
                                     , 7634-7658. <a href="https://doi.org/10.1021/acs.jmedchem.5b00386" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00386%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252Bthe%252BAryl%252BO-Sulfamate%252BPharmacophore%252Bfor%252BOncology%252Band%252BWomen%2525E2%252580%252599s%252BHealth%26aulast%3DThomas%26aufirst%3DMark%2BP.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10032015%26date%3D12062015%26date%3D08102015%26date%3D20052015%26volume%3D58%26issue%3D19%26spage%3D7634%26epage%3D7658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Spillane</span>  , <span class="hlFld-ContribAuthor ">Jean-Baptiste  Malaubier</span>  . </span><span class="cited-content_cbyCitation_article-title">Sulfamic Acid and Its N- and O-Substituted Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (4)
                                     , 2507-2586. <a href="https://doi.org/10.1021/cr400230c" title="DOI URL">https://doi.org/10.1021/cr400230c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr400230c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr400230c%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DSulfamic%252BAcid%252Band%252BIts%252BN-%252Band%252BO-Substituted%252BDerivatives%26aulast%3DSpillane%26aufirst%3DWilliam%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D29042013%26date%3D17122013%26date%3D26022014%26volume%3D114%26issue%3D4%26spage%3D2507%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo  Alterio</span>, <span class="hlFld-ContribAuthor ">Anna  Di Fiore</span>, <span class="hlFld-ContribAuthor ">Katia  D’Ambrosio</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, and <span class="hlFld-ContribAuthor ">Giuseppina  De Simone</span>  . </span><span class="cited-content_cbyCitation_article-title">Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2012,</strong> <em>112 </em>
                                    (8)
                                     , 4421-4468. <a href="https://doi.org/10.1021/cr200176r" title="DOI URL">https://doi.org/10.1021/cr200176r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr200176r%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DMultiple%252BBinding%252BModes%252Bof%252BInhibitors%252Bto%252BCarbonic%252BAnhydrases%25253A%252BHow%252Bto%252BDesign%252BSpecific%252BDrugs%252BTargeting%252B15%252BDifferent%252BIsoforms%25253F%26aulast%3DAlterio%26aufirst%3DVincenzo%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D18052011%26date%3D18052012%26date%3D08082012%26volume%3D112%26issue%3D8%26spage%3D4421%26epage%3D4468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Fabrice  Jourdan</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Meriel R.  Kimberley</span>, <span class="hlFld-ContribAuthor ">Mark P.  Thomas</span>, <span class="hlFld-ContribAuthor ">Ruoli  Bai</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, and <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>  . </span><span class="cited-content_cbyCitation_article-title">Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (1)
                                     , 5-9. <a href="https://doi.org/10.1021/ml200232c" title="DOI URL">https://doi.org/10.1021/ml200232c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200232c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200232c%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSteroidomimetic%252BTetrahydroisoquinolines%252Bfor%252Bthe%252BDesign%252Bof%252BNew%252BMicrotubule%252BDisruptors%26aulast%3DLeese%26aufirst%3DMathew%2BP.%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D08042011%26date%3D31102011%26date%3D07112011%26date%3D12012012%26date%3D31102011%26volume%3D3%26issue%3D1%26spage%3D5%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrice  Jourdan</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Simon P.  Newman</span>, <span class="hlFld-ContribAuthor ">Surinder  Chander</span>, <span class="hlFld-ContribAuthor ">Atul  Purohit</span>, and <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of C-17-Substituted Estratriene-3-O-sulfamates as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (13)
                                     , 4863-4879. <a href="https://doi.org/10.1021/jm200483x" title="DOI URL">https://doi.org/10.1021/jm200483x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200483x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200483x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BC-17-Substituted%252BEstratriene-3-O-sulfamates%252Bas%252BAnticancer%252BAgents%26aulast%3DJourdan%26aufirst%3DFabrice%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D21042011%26date%3D09062011%26date%3D14072011%26date%3D23052011%26volume%3D54%26issue%3D13%26spage%3D4863%26epage%3D4879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrice  Jourdan</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Simon P.  Newman</span>, <span class="hlFld-ContribAuthor ">Atul  Purohit</span>, <span class="hlFld-ContribAuthor ">Michael J.  Reed</span> and <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Antitubulin, and Antiproliferative SAR of Analogues of 2-Methoxyestradiol-3,17-O,O-bis-sulfamate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (7)
                                     , 2942-2951. <a href="https://doi.org/10.1021/jm9018806" title="DOI URL">https://doi.org/10.1021/jm9018806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9018806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9018806%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BAntitubulin%25252C%252Band%252BAntiproliferative%252BSAR%252Bof%252BAnalogues%252Bof%252B2-Methoxyestradiol-3%25252C17-O%25252CO-bis-sulfamate%26aulast%3DJourdan%26aufirst%3DFabrice%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D21122009%26date%3D12032010%26date%3D08042010%26volume%3D53%26issue%3D7%26spage%3D2942%26epage%3D2951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L. W. Lawrence  Woo</span>, <span class="hlFld-ContribAuthor ">Toby  Jackson</span>, <span class="hlFld-ContribAuthor ">Aurélien  Putey</span>, <span class="hlFld-ContribAuthor ">Gyles  Cozier</span>, <span class="hlFld-ContribAuthor ">Philip  Leonard</span>, <span class="hlFld-ContribAuthor ">K. Ravi  Acharya</span>, <span class="hlFld-ContribAuthor ">Surinder K.  Chander</span>, <span class="hlFld-ContribAuthor ">Atul  Purohit</span>, <span class="hlFld-ContribAuthor ">Michael J.  Reed</span> and <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Potent First Examples of Dual Aromatase−Steroid Sulfatase Inhibitors based on a Biphenyl Template. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2155-2170. <a href="https://doi.org/10.1021/jm901705h" title="DOI URL">https://doi.org/10.1021/jm901705h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901705h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901705h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BPotent%252BFirst%252BExamples%252Bof%252BDual%252BAromatase%2525E2%252588%252592Steroid%252BSulfatase%252BInhibitors%252Bbased%252Bon%252Ba%252BBiphenyl%252BTemplate%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BLawrence%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D17112009%26date%3D11022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2155%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anke  Löhndorf</span>, <span class="hlFld-ContribAuthor ">Leon  Hosang</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Francesca  Odoardi</span>, <span class="hlFld-ContribAuthor ">Sissy-Alina  Waschkowski</span>, <span class="hlFld-ContribAuthor ">Anette  Rosche</span>, <span class="hlFld-ContribAuthor ">Andreas  Bauche</span>, <span class="hlFld-ContribAuthor ">Riekje  Winzer</span>, <span class="hlFld-ContribAuthor ">Eva  Tolosa</span>, <span class="hlFld-ContribAuthor ">Sabine  Windhorst</span>, <span class="hlFld-ContribAuthor ">Stephen  Marry</span>, <span class="hlFld-ContribAuthor ">Alexander  Flügel</span>, <span class="hlFld-ContribAuthor ">Barry V.L.  Potter</span>, <span class="hlFld-ContribAuthor ">Björn-Philipp  Diercks</span>, <span class="hlFld-ContribAuthor ">Andreas H.  Guse</span>. </span><span class="cited-content_cbyCitation_article-title">2-Methoxyestradiol and its derivatives inhibit store-operated Ca2+ entry in T cells: Identification of a new and potent inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2021,</strong> <em>1868 </em>
                                    (6)
                                     , 118988. <a href="https://doi.org/10.1016/j.bbamcr.2021.118988" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2021.118988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2021.118988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2021.118988%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3D2-Methoxyestradiol%252Band%252Bits%252Bderivatives%252Binhibit%252Bstore-operated%252BCa2%25252B%252Bentry%252Bin%252BT%252Bcells%25253A%252BIdentification%252Bof%252Ba%252Bnew%252Band%252Bpotent%252Binhibitor%26aulast%3DL%25C3%25B6hndorf%26aufirst%3DAnke%26date%3D2021%26volume%3D1868%26issue%3D6%26spage%3D118988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I. N.  Bardasov</span>, <span class="hlFld-ContribAuthor ">A. Yu.  Alekseeva</span>, <span class="hlFld-ContribAuthor ">O. V.  Ershov</span>, <span class="hlFld-ContribAuthor ">M. A.  Mar’yasov</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative Activity of N-Substituted 2,4-Diamino-5-Aryl-5,6,7,8,9,10-Hexahydrobenzo[B][1,8]Naphthyridine-3-Carbonitriles. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Chemistry Journal</span><span> <strong>2020,</strong> <em>54 </em>
                                    (5)
                                     , 459-461. <a href="https://doi.org/10.1007/s11094-020-02236-5" title="DOI URL">https://doi.org/10.1007/s11094-020-02236-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11094-020-02236-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11094-020-02236-5%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Chemistry%2520Journal%26atitle%3DAntiproliferative%252BActivity%252Bof%252BN-Substituted%252B2%25252C4-Diamino-5-Aryl-5%25252C6%25252C7%25252C8%25252C9%25252C10-Hexahydrobenzo%25255BB%25255D%25255B1%25252C8%25255DNaphthyridine-3-Carbonitriles%26aulast%3DBardasov%26aufirst%3DI.%2BN.%26date%3D2020%26date%3D2020%26volume%3D54%26issue%3D5%26spage%3D459%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maha S.  Almutairi</span>, <span class="hlFld-ContribAuthor ">Areej N.  Al Suwayyid</span>, <span class="hlFld-ContribAuthor ">Amal  Aldarwesh</span>, <span class="hlFld-ContribAuthor ">Omaima M.  Aboulwafa</span>, <span class="hlFld-ContribAuthor ">Mohamed I.  Attia</span>. </span><span class="cited-content_cbyCitation_article-title">Antiestrogenic Activity and Possible Mode of Action of Certain New Nonsteroidal Coumarin-4-acetamides. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1553. <a href="https://doi.org/10.3390/molecules25071553" title="DOI URL">https://doi.org/10.3390/molecules25071553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071553%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAntiestrogenic%252BActivity%252Band%252BPossible%252BMode%252Bof%252BAction%252Bof%252BCertain%252BNew%252BNonsteroidal%252BCoumarin-4-acetamides%26aulast%3DAlmutairi%26aufirst%3DMaha%2BS.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Vullo</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of action of carbonic anhydrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 187-222. <a href="https://doi.org/10.1016/B978-0-12-816476-1.00009-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-816476-1.00009-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816476-1.00009-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816476-1.00009-5%26sid%3Dliteratum%253Aachs%26atitle%3DMechanisms%252Bof%252Baction%252Bof%252Bcarbonic%252Banhydrase%252Binhibitors%26aulast%3DVullo%26aufirst%3DDaniela%26date%3D2019%26spage%3D187%26epage%3D222%26pub%3DElsevier%26atitle%3DCarbonic%252BAnhydrases%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keely M  McNamara</span>, <span class="hlFld-ContribAuthor ">Fouzia  Guestini</span>, <span class="hlFld-ContribAuthor ">Torill  Sauer</span>, <span class="hlFld-ContribAuthor ">Joel  Touma</span>, <span class="hlFld-ContribAuthor ">Ida Rashida  Bukholm</span>, <span class="hlFld-ContribAuthor ">Jonas C  Lindstrøm</span>, <span class="hlFld-ContribAuthor ">Hironobu  Sasano</span>, <span class="hlFld-ContribAuthor ">Jürgen  Geisler</span>. </span><span class="cited-content_cbyCitation_article-title">In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2018,</strong> <em>118 </em>
                                    (9)
                                     , 1208-1216. <a href="https://doi.org/10.1038/s41416-018-0034-9" title="DOI URL">https://doi.org/10.1038/s41416-018-0034-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-018-0034-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-018-0034-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DIn%252Bbreast%252Bcancer%252Bsubtypes%252Bsteroid%252Bsulfatase%252B%252528STS%252529%252Bis%252Bassociated%252Bwith%252Bless%252Baggressive%252Btumour%252Bcharacteristics%26aulast%3DMcNamara%26aufirst%3DKeely%2BM%26date%3D2018%26date%3D2018%26volume%3D118%26issue%3D9%26spage%3D1208%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vaida  Linkuvienė</span>, <span class="hlFld-ContribAuthor ">Asta  Zubrienė</span>, <span class="hlFld-ContribAuthor ">Elena  Manakova</span>, <span class="hlFld-ContribAuthor ">Vytautas  Petrauskas</span>, <span class="hlFld-ContribAuthor ">Lina  Baranauskienė</span>, <span class="hlFld-ContribAuthor ">Audrius  Zakšauskas</span>, <span class="hlFld-ContribAuthor ">Alexey  Smirnov</span>, <span class="hlFld-ContribAuthor ">Saulius  Gražulis</span>, <span class="hlFld-ContribAuthor ">John E.  Ladbury</span>, <span class="hlFld-ContribAuthor ">Daumantas  Matulis</span>. </span><span class="cited-content_cbyCitation_article-title">Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design. </span><span class="cited-content_cbyCitation_journal-name">Quarterly Reviews of Biophysics</span><span> <strong>2018,</strong> <em>51 </em><a href="https://doi.org/10.1017/S0033583518000082" title="DOI URL">https://doi.org/10.1017/S0033583518000082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S0033583518000082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS0033583518000082%26sid%3Dliteratum%253Aachs%26jtitle%3DQuarterly%2520Reviews%2520of%2520Biophysics%26atitle%3DThermodynamic%25252C%252Bkinetic%25252C%252Band%252Bstructural%252Bparameterization%252Bof%252Bhuman%252Bcarbonic%252Banhydrase%252Binteractions%252Btoward%252Benhanced%252Binhibitor%252Bdesign%26aulast%3DLinkuvien%25C4%2597%26aufirst%3DVaida%26date%3D2018%26date%3D2018%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asako  Kaise</span>, <span class="hlFld-ContribAuthor ">Kiminori  Ohta</span>, <span class="hlFld-ContribAuthor ">Chinami  Shirata</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Endo</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of p-carborane-containing sulfamates as multitarget anti-breast cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6417-6426. <a href="https://doi.org/10.1016/j.bmc.2017.10.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bp-carborane-containing%252Bsulfamates%252Bas%252Bmultitarget%252Banti-breast%252Bcancer%252Bagents%26aulast%3DKaise%26aufirst%3DAsako%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6417%26epage%3D6426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Honghao  Sun</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (15)
                                     , 1765-1794. <a href="https://doi.org/10.4155/fmc-2017-0100" title="DOI URL">https://doi.org/10.4155/fmc-2017-0100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0100%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTubulin%252Binhibitors%252Btargeting%252Bthe%252Bcolchicine%252Bbinding%252Bsite%25253A%252Ba%252Bperspective%252Bof%252Bprivileged%252Bstructures%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2017%26volume%3D9%26issue%3D15%26spage%3D1765%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppina  De Simone</span>, <span class="hlFld-ContribAuthor ">Emma  Langella</span>, <span class="hlFld-ContribAuthor ">Davide  Esposito</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Simona Maria  Monti</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Winum</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Alterio</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 1002-1011. <a href="https://doi.org/10.1080/14756366.2017.1349764" title="DOI URL">https://doi.org/10.1080/14756366.2017.1349764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2017.1349764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2017.1349764%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DInsights%252Binto%252Bthe%252Bbinding%252Bmode%252Bof%252Bsulphamates%252Band%252Bsulphamides%252Bto%252BhCA%252BII%25253A%252Bcrystallographic%252Bstudies%252Band%252Bbinding%252Bfree%252Benergy%252Bcalculations%26aulast%3DDe%2BSimone%26aufirst%3DGiuseppina%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D1002%26epage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johanna  Szabó</span>, <span class="hlFld-ContribAuthor ">Zoltán  Pataki</span>, <span class="hlFld-ContribAuthor ">János  Wölfling</span>, <span class="hlFld-ContribAuthor ">Gyula  Schneider</span>, <span class="hlFld-ContribAuthor ">Noémi  Bózsity</span>, <span class="hlFld-ContribAuthor ">Renáta  Minorics</span>, <span class="hlFld-ContribAuthor ">István  Zupkó</span>, <span class="hlFld-ContribAuthor ">Erzsébet  Mernyák</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 13α-estrone derivatives as potential antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2016,</strong> <em>113 </em>, 14-21. <a href="https://doi.org/10.1016/j.steroids.2016.05.010" title="DOI URL">https://doi.org/10.1016/j.steroids.2016.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2016.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2016.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B13%2525CE%2525B1-estrone%252Bderivatives%252Bas%252Bpotential%252Bantiproliferative%252Bagents%26aulast%3DSzab%25C3%25B3%26aufirst%3DJohanna%26date%3D2016%26volume%3D113%26spage%3D14%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramanpreet  Shah</span>, <span class="hlFld-ContribAuthor ">Jatinder  Singh</span>, <span class="hlFld-ContribAuthor ">Dhandeep  Singh</span>, <span class="hlFld-ContribAuthor ">Amteshwar Singh  Jaggi</span>, <span class="hlFld-ContribAuthor ">Nirmal  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>114 </em>, 170-190. <a href="https://doi.org/10.1016/j.ejmech.2016.02.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.02.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.02.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.02.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSulfatase%252Binhibitors%252Bfor%252Brecidivist%252Bbreast%252Bcancer%252Btreatment%25253A%252BA%252Bchemical%252Breview%26aulast%3DShah%26aufirst%3DRamanpreet%26date%3D2016%26volume%3D114%26spage%3D170%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiro  Higuchi</span>, <span class="hlFld-ContribAuthor ">Hideki  Hikita</span>, <span class="hlFld-ContribAuthor ">Asumi  Murayama</span>, <span class="hlFld-ContribAuthor ">Daichi  Yuri</span>, <span class="hlFld-ContribAuthor ">Natsu  Kobayakawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Shigeru  Kojima</span>, <span class="hlFld-ContribAuthor ">Hiroko  Ueno</span>, <span class="hlFld-ContribAuthor ">Tomomi  Hatakeyama</span>, <span class="hlFld-ContribAuthor ">Airi  Kato</span>, <span class="hlFld-ContribAuthor ">Masanori  Tayu</span>, <span class="hlFld-ContribAuthor ">Etsuko  Oyama</span>, <span class="hlFld-ContribAuthor ">Shigeo  Sugiyama</span>, <span class="hlFld-ContribAuthor ">Kazuyuki  Ishii</span>, <span class="hlFld-ContribAuthor ">Hidenobu  Takahashi</span>, <span class="hlFld-ContribAuthor ">Tomomi  Kawasaki</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Non-peptide RGD Mimics for Evaluation of Their Utility as Anti-platelet Agents. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2016,</strong> <em>64 </em>
                                    (12)
                                     , 1726-1738. <a href="https://doi.org/10.1248/cpb.c16-00594" title="DOI URL">https://doi.org/10.1248/cpb.c16-00594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c16-00594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c16-00594%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNon-peptide%252BRGD%252BMimics%252Bfor%252BEvaluation%252Bof%252BTheir%252BUtility%252Bas%252BAnti-platelet%252BAgents%26aulast%3DHiguchi%26aufirst%3DKazuhiro%26date%3D2016%26volume%3D64%26issue%3D12%26spage%3D1726%26epage%3D1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle Helen  Visagie</span>, <span class="hlFld-ContribAuthor ">Lyn-Marie  Birkholtz</span>, <span class="hlFld-ContribAuthor ">Anna Margaretha  Joubert</span>. </span><span class="cited-content_cbyCitation_article-title">A 2-methoxyestradiol bis-sulphamoylated derivative induces apoptosis in breast cell lines. </span><span class="cited-content_cbyCitation_journal-name">Cell & Bioscience</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13578-015-0010-5" title="DOI URL">https://doi.org/10.1186/s13578-015-0010-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13578-015-0010-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13578-015-0010-5%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520%2526%2520Bioscience%26atitle%3DA%252B2-methoxyestradiol%252Bbis-sulphamoylated%252Bderivative%252Binduces%252Bapoptosis%252Bin%252Bbreast%252Bcell%252Blines%26aulast%3DVisagie%26aufirst%3DMichelle%2BHelen%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. A.  Zefirov</span>, <span class="hlFld-ContribAuthor ">O. N.  Zefirova</span>. </span><span class="cited-content_cbyCitation_article-title">2-Methoxyestradiol and its analogs. Synthesis and structure—antiproliferative activity relationship. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>51 </em>
                                    (9)
                                     , 1207-1216. <a href="https://doi.org/10.1134/S1070428015090018" title="DOI URL">https://doi.org/10.1134/S1070428015090018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428015090018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428015090018%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D2-Methoxyestradiol%252Band%252Bits%252Banalogs.%252BSynthesis%252Band%252Bstructure%2525E2%252580%252594antiproliferative%252Bactivity%252Brelationship%26aulast%3DZefirov%26aufirst%3DN.%2BA.%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D9%26spage%3D1207%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erzsébet  Mernyák</span>, <span class="hlFld-ContribAuthor ">Ida  Kovács</span>, <span class="hlFld-ContribAuthor ">Renáta  Minorics</span>, <span class="hlFld-ContribAuthor ">Péter  Sere</span>, <span class="hlFld-ContribAuthor ">Dóra  Czégány</span>, <span class="hlFld-ContribAuthor ">Izabella  Sinka</span>, <span class="hlFld-ContribAuthor ">János  Wölfling</span>, <span class="hlFld-ContribAuthor ">Gyula  Schneider</span>, <span class="hlFld-ContribAuthor ">Zsuzsanna  Újfaludi</span>, <span class="hlFld-ContribAuthor ">Imre  Boros</span>, <span class="hlFld-ContribAuthor ">Imre  Ocsovszki</span>, <span class="hlFld-ContribAuthor ">Mónika  Varga</span>, <span class="hlFld-ContribAuthor ">István  Zupkó</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of trans-16-triazolyl-13α-methyl-17-estradiol diastereomers and the effects of structural modifications on their in vitro antiproliferative activities. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2015,</strong> <em>150 </em>, 123-134. <a href="https://doi.org/10.1016/j.jsbmb.2015.04.001" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2015.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2015.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2015.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DSynthesis%252Bof%252Btrans-16-triazolyl-13%2525CE%2525B1-methyl-17-estradiol%252Bdiastereomers%252Band%252Bthe%252Beffects%252Bof%252Bstructural%252Bmodifications%252Bon%252Btheir%252Bin%252Bvitro%252Bantiproliferative%252Bactivities%26aulast%3DMerny%25C3%25A1k%26aufirst%3DErzs%25C3%25A9bet%26date%3D2015%26volume%3D150%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea R.  Nikolić</span>, <span class="hlFld-ContribAuthor ">Edward T.  Petri</span>, <span class="hlFld-ContribAuthor ">Olivera R.  Klisurić</span>, <span class="hlFld-ContribAuthor ">Andjelka S.  Ćelić</span>, <span class="hlFld-ContribAuthor ">Dimitar S.  Jakimov</span>, <span class="hlFld-ContribAuthor ">Evgenija A.  Djurendić</span>, <span class="hlFld-ContribAuthor ">Katarina M.  Penov Gaši</span>, <span class="hlFld-ContribAuthor ">Marija N.  Sakač</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer cell potential of steroidal 16,17-seco-16,17a-dinitriles: Identification of a selective inhibitor of hormone-independent breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (4)
                                     , 703-711. <a href="https://doi.org/10.1016/j.bmc.2014.12.069" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.12.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.12.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.12.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bcell%252Bpotential%252Bof%252Bsteroidal%252B16%25252C17-seco-16%25252C17a-dinitriles%25253A%252BIdentification%252Bof%252Ba%252Bselective%252Binhibitor%252Bof%252Bhormone-independent%252Bbreast%252Bcancer%252Bcells%26aulast%3DNikoli%25C4%2587%26aufirst%3DAndrea%2BR.%26date%3D2015%26volume%3D23%26issue%3D4%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sven  Sommerwerk</span>, <span class="hlFld-ContribAuthor ">Lucie  Heller</span>, <span class="hlFld-ContribAuthor ">René  Csuk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxic Activity of Pentacyclic Triterpenoid Sulfamates. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (1)
                                     , 46-54. <a href="https://doi.org/10.1002/ardp.201400297" title="DOI URL">https://doi.org/10.1002/ardp.201400297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201400297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201400297%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BCytotoxic%252BActivity%252Bof%252BPentacyclic%252BTriterpenoid%252BSulfamates%26aulast%3DSommerwerk%26aufirst%3DSven%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D1%26spage%3D46%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Chapman</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Optimisation of Tetrahydroisoquinoline-Based Chimeric Microtubule Disruptors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>132 </em>, n/a-n/a. <a href="https://doi.org/10.1002/cmdc.201402025" title="DOI URL">https://doi.org/10.1002/cmdc.201402025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402025%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DOptimisation%252Bof%252BTetrahydroisoquinoline-Based%252BChimeric%252BMicrotubule%252BDisruptors%26aulast%3DDohle%26aufirst%3DWolfgang%26date%3D2014%26date%3D2014%26volume%3D132%26spage%3Dn%252Fa%26epage%3Dn%252Fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Meriel R.  Major</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Mark P.  Thomas</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Mary F.  Mahon</span>, <span class="hlFld-ContribAuthor ">Simon P.  Newman</span>, <span class="hlFld-ContribAuthor ">Atul  Purohit</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Anti-tubulin and Antiproliferative SAR of Steroidomimetic Dihydroisoquinolinones. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (4)
                                     , 798-812. <a href="https://doi.org/10.1002/cmdc.201400017" title="DOI URL">https://doi.org/10.1002/cmdc.201400017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201400017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201400017%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%25252C%252BAnti-tubulin%252Band%252BAntiproliferative%252BSAR%252Bof%252BSteroidomimetic%252BDihydroisoquinolinones%26aulast%3DLeese%26aufirst%3DMathew%2BP.%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3D798%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veerappan  Jeyachandran</span>, <span class="hlFld-ContribAuthor ">Sundaravel  Vivek Kumar</span>, <span class="hlFld-ContribAuthor ">Raju  Ranjith Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 16-spiro steroids: 7-(Aryl)tetrahydro-1H-pyrrolo[1,2-c][1,3]thiazolo estrone hybrid heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2014,</strong> <em>82 </em>, 29-37. <a href="https://doi.org/10.1016/j.steroids.2014.01.003" title="DOI URL">https://doi.org/10.1016/j.steroids.2014.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2014.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2014.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSynthesis%252Bof%252Bnovel%252B16-spiro%252Bsteroids%25253A%252B7-%252528Aryl%252529tetrahydro-1H-pyrrolo%25255B1%25252C2-c%25255D%25255B1%25252C3%25255Dthiazolo%252Bestrone%252Bhybrid%252Bheterocycles%26aulast%3DJeyachandran%26aufirst%3DVeerappan%26date%3D2014%26volume%3D82%26spage%3D29%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle Helen  Visagie</span>, <span class="hlFld-ContribAuthor ">Lynn-Marie  Birkholtz</span>, <span class="hlFld-ContribAuthor ">Anna Margaretha  Joubert</span>. </span><span class="cited-content_cbyCitation_article-title">17-beta-estradiol analog inhibits cell proliferation by induction of apoptosis in breast cell lines. </span><span class="cited-content_cbyCitation_journal-name">Microscopy Research and Technique</span><span> <strong>2014,</strong> <em>77 </em>
                                    (3)
                                     , 236-242. <a href="https://doi.org/10.1002/jemt.22334" title="DOI URL">https://doi.org/10.1002/jemt.22334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jemt.22334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjemt.22334%26sid%3Dliteratum%253Aachs%26jtitle%3DMicroscopy%2520Research%2520and%2520Technique%26atitle%3D17-beta-estradiol%252Banalog%252Binhibits%252Bcell%252Bproliferation%252Bby%252Binduction%252Bof%252Bapoptosis%252Bin%252Bbreast%252Bcell%252Blines%26aulast%3DVisagie%26aufirst%3DMichelle%2BHelen%26date%3D2014%26date%3D2014%26volume%3D77%26issue%3D3%26spage%3D236%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Meriel R.  Major</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Ann  Fiore</span>, <span class="hlFld-ContribAuthor ">Philip G.  Kasprzyk</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (1)
                                     , 85-108. <a href="https://doi.org/10.1002/cmdc.201300261" title="DOI URL">https://doi.org/10.1002/cmdc.201300261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300261%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTetrahydroisoquinolinone-Based%252BSteroidomimetic%252Band%252BChimeric%252BMicrotubule%252BDisruptors%26aulast%3DLeese%26aufirst%3DMathew%2BP.%26date%3D2014%26date%3D2013%26volume%3D9%26issue%3D1%26spage%3D85%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucas C.  Kopel</span>, <span class="hlFld-ContribAuthor ">Mahmoud S.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Fathi T.  Halaweish</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel estrone analogs by incorporation of thiophenols via conjugate addition to an enone side chain. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2013,</strong> <em>78 </em>
                                    (11)
                                     , 1119-1125. <a href="https://doi.org/10.1016/j.steroids.2013.07.005" title="DOI URL">https://doi.org/10.1016/j.steroids.2013.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2013.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2013.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSynthesis%252Bof%252Bnovel%252Bestrone%252Banalogs%252Bby%252Bincorporation%252Bof%252Bthiophenols%252Bvia%252Bconjugate%252Baddition%252Bto%252Ban%252Benone%252Bside%252Bchain%26aulast%3DKopel%26aufirst%3DLucas%2BC.%26date%3D2013%26volume%3D78%26issue%3D11%26spage%3D1119%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaser A.  Mostafa</span>, <span class="hlFld-ContribAuthor ">Scott D.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Steroid derivatives as inhibitors of steroid sulfatase. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2013,</strong> <em>137 </em>, 183-198. <a href="https://doi.org/10.1016/j.jsbmb.2013.01.013" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2013.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2013.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2013.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DSteroid%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bsteroid%252Bsulfatase%26aulast%3DMostafa%26aufirst%3DYaser%2BA.%26date%3D2013%26volume%3D137%26spage%3D183%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Éva  Frank</span>, <span class="hlFld-ContribAuthor ">Gyula  Schneider</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of sex hormone-derived modified steroids possessing antiproliferative activity. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2013,</strong> <em>137 </em>, 301-315. <a href="https://doi.org/10.1016/j.jsbmb.2013.02.018" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2013.02.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2013.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2013.02.018%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DSynthesis%252Bof%252Bsex%252Bhormone-derived%252Bmodified%252Bsteroids%252Bpossessing%252Bantiproliferative%252Bactivity%26aulast%3DFrank%26aufirst%3D%25C3%2589va%26date%3D2013%26volume%3D137%26spage%3D301%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atul  Gupta</span>, <span class="hlFld-ContribAuthor ">B.  Sathish Kumar</span>, <span class="hlFld-ContribAuthor ">Arvind S.  Negi</span>. </span><span class="cited-content_cbyCitation_article-title">Current status on development of steroids as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2013,</strong> <em>137 </em>, 242-270. <a href="https://doi.org/10.1016/j.jsbmb.2013.05.011" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2013.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2013.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2013.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DCurrent%252Bstatus%252Bon%252Bdevelopment%252Bof%252Bsteroids%252Bas%252Banticancer%252Bagents%26aulast%3DGupta%26aufirst%3DAtul%26date%3D2013%26volume%3D137%26spage%3D242%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle H  Visagie</span>, <span class="hlFld-ContribAuthor ">Anna M  Joubert</span>. </span><span class="cited-content_cbyCitation_article-title">2-Methoxyestradiol-bis-sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell line. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell International</span><span> <strong>2012,</strong> <em>12 </em>
                                    (1)
                                     , 37. <a href="https://doi.org/10.1186/1475-2867-12-37" title="DOI URL">https://doi.org/10.1186/1475-2867-12-37</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1475-2867-12-37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1475-2867-12-37%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%2520International%26atitle%3D2-Methoxyestradiol-bis-sulphamate%252Brefrains%252Bfrom%252Binducing%252Bapoptosis%252Band%252Bautophagy%252Bin%252Ba%252Bnon-tumorigenic%252Bbreast%252Bcell%252Bline%26aulast%3DVisagie%26aufirst%3DMichelle%2BH%26date%3D2012%26volume%3D12%26issue%3D1%26spage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ganapathy  Panchapakesan</span>, <span class="hlFld-ContribAuthor ">Vasudevan  Dhayalan</span>, <span class="hlFld-ContribAuthor ">Nachiappan  Dhatchana Moorthy</span>, <span class="hlFld-ContribAuthor ">Nidhyanandan  Saranya</span>, <span class="hlFld-ContribAuthor ">Arasambattu K.  Mohanakrishnan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-substituted 17β-hydroxy/17-methylene estratrienes and their in vitro cytotoxicity in human cancer cell cultures. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2011,</strong> <em>76 </em>
                                    (13)
                                     , 1491-1504. <a href="https://doi.org/10.1016/j.steroids.2011.08.004" title="DOI URL">https://doi.org/10.1016/j.steroids.2011.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2011.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2011.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSynthesis%252Bof%252B2-substituted%252B17%2525CE%2525B2-hydroxy%25252F17-methylene%252Bestratrienes%252Band%252Btheir%252Bin%252Bvitro%252Bcytotoxicity%252Bin%252Bhuman%252Bcancer%252Bcell%252Bcultures%26aulast%3DPanchapakesan%26aufirst%3DGanapathy%26date%3D2011%26volume%3D76%26issue%3D13%26spage%3D1491%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Guo</span>, <span class="hlFld-ContribAuthor ">Guolan  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Xianran  He</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Wu</span>, <span class="hlFld-ContribAuthor ">Yuling  Xiao</span>, <span class="hlFld-ContribAuthor ">Yuanhu  Pan</span>, <span class="hlFld-ContribAuthor ">Guofu  Qiu</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Xianming  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (9)
                                     , 3662-3674. <a href="https://doi.org/10.1016/j.ejmech.2011.05.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.05.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.05.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252B16%2525CE%2525B2-azolyl-3%2525CE%2525B2-amino-5%2525CE%2525B1-androstane%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DGuo%26aufirst%3DHao%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D3662%26epage%3D3674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">René  Maltais</span>, <span class="hlFld-ContribAuthor ">Donald  Poirier</span>. </span><span class="cited-content_cbyCitation_article-title">Steroid sulfatase inhibitors: A review covering the promising 2000–2010 decade. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2011,</strong> <em>76 </em>
                                    (10-11)
                                     , 929-948. <a href="https://doi.org/10.1016/j.steroids.2011.03.010" title="DOI URL">https://doi.org/10.1016/j.steroids.2011.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2011.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2011.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSteroid%252Bsulfatase%252Binhibitors%25253A%252BA%252Breview%252Bcovering%252Bthe%252Bpromising%252B2000%2525E2%252580%2525932010%252Bdecade%26aulast%3DMaltais%26aufirst%3DRen%25C3%25A9%26date%3D2011%26volume%3D76%26issue%3D10-11%26spage%3D929%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James R.  Hanson</span>. </span><span class="cited-content_cbyCitation_article-title">Steroids: partial synthesis in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2010,</strong> <em>27 </em>
                                    (6)
                                     , 887. <a href="https://doi.org/10.1039/c001262a" title="DOI URL">https://doi.org/10.1039/c001262a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c001262a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc001262a%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DSteroids%25253A%252Bpartial%252Bsynthesis%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DHanson%26aufirst%3DJames%2BR.%26date%3D2010%26volume%3D27%26issue%3D6%26spage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">René  Maltais</span>, <span class="hlFld-ContribAuthor ">Diane  Fournier</span>, <span class="hlFld-ContribAuthor ">Donald  Poirier</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Structure-Activity Relationship (QSAR) Study with a Series of 17α-Derivatives of Estradiol: Model for the Development of Reversible Steroid Sulfatase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">QSAR & Combinatorial Science</span><span> <strong>2009,</strong> <em>28 </em>
                                    (11-12)
                                     , 1284-1299. <a href="https://doi.org/10.1002/qsar.200960028" title="DOI URL">https://doi.org/10.1002/qsar.200960028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qsar.200960028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqsar.200960028%26sid%3Dliteratum%253Aachs%26jtitle%3DQSAR%2520%2526%2520Combinatorial%2520Science%26atitle%3DQuantitative%252BStructure-Activity%252BRelationship%252B%252528QSAR%252529%252BStudy%252Bwith%252Ba%252BSeries%252Bof%252B17%2525CE%2525B1-Derivatives%252Bof%252BEstradiol%25253A%252BModel%252Bfor%252Bthe%252BDevelopment%252Bof%252BReversible%252BSteroid%252BSulfatase%252BInhibitors%26aulast%3DMaltais%26aufirst%3DRen%25C3%25A9%26date%3D2009%26date%3D2009%26volume%3D28%26issue%3D11-12%26spage%3D1284%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J M  Day</span>, <span class="hlFld-ContribAuthor ">P A  Foster</span>, <span class="hlFld-ContribAuthor ">H J  Tutill</span>, <span class="hlFld-ContribAuthor ">S P  Newman</span>, <span class="hlFld-ContribAuthor ">Y T  Ho</span>, <span class="hlFld-ContribAuthor ">M P  Leese</span>, <span class="hlFld-ContribAuthor ">B V L  Potter</span>, <span class="hlFld-ContribAuthor ">M J  Reed</span>, <span class="hlFld-ContribAuthor ">A  Purohit</span>. </span><span class="cited-content_cbyCitation_article-title">BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2009,</strong> <em>100 </em>
                                    (3)
                                     , 476-486. <a href="https://doi.org/10.1038/sj.bjc.6604873" title="DOI URL">https://doi.org/10.1038/sj.bjc.6604873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/sj.bjc.6604873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsj.bjc.6604873%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DBCRP%252Bexpression%252Bdoes%252Bnot%252Bresult%252Bin%252Bresistance%252Bto%252BSTX140%252Bin%252Bvivo%25252C%252Bdespite%252Bthe%252Bincreased%252Bexpression%252Bof%252BBCRP%252Bin%252BA2780%252Bcells%252Bin%252Bvitro%252Bafter%252Blong-term%252BSTX140%252Bexposure%26aulast%3DDay%26aufirst%3DJ%2BM%26date%3D2009%26date%3D2009%26volume%3D100%26issue%3D3%26spage%3D476%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.W. Lawrence  Woo</span>, <span class="hlFld-ContribAuthor ">Delphine S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Sharland</span>, <span class="hlFld-ContribAuthor ">Melanie  Trusselle</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>, <span class="hlFld-ContribAuthor ">Surinder K.  Chander</span>, <span class="hlFld-ContribAuthor ">Anna  Di Fiore</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Giuseppina  De Simone</span>, <span class="hlFld-ContribAuthor ">Atul  Purohit</span>, <span class="hlFld-ContribAuthor ">Michael J.  Reed</span>, <span class="hlFld-ContribAuthor ">Barry V.L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent,
              in vitro
              and
              in vivo
              activities, molecular modeling, and protein crystallography. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2008,</strong> <em>7 </em>
                                    (8)
                                     , 2435-2444. <a href="https://doi.org/10.1158/1535-7163.MCT-08-0195" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-08-0195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-08-0195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-08-0195%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DAnticancer%252Bsteroid%252Bsulfatase%252Binhibitors%25253A%252Bsynthesis%252Bof%252Ba%252Bpotent%252Bfluorinated%252Bsecond-generation%252Bagent%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bactivities%25252C%252Bmolecular%252Bmodeling%25252C%252Band%252Bprotein%252Bcrystallography%26aulast%3DWoo%26aufirst%3DL.W.%2BLawrence%26date%3D2008%26date%3D2008%26volume%3D7%26issue%3D8%26spage%3D2435%26epage%3D2444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrice  Jourdan</span>, <span class="hlFld-ContribAuthor ">Christian  Bubert</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Andrew  Smith</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Sandra  Regis-Lydi</span>, <span class="hlFld-ContribAuthor ">Simon P.  Newman</span>, <span class="hlFld-ContribAuthor ">Atul  Purohit</span>, <span class="hlFld-ContribAuthor ">Michael J.  Reed</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2008,</strong> <em>6 </em>
                                    (22)
                                     , 4108. <a href="https://doi.org/10.1039/b810300c" title="DOI URL">https://doi.org/10.1039/b810300c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b810300c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb810300c%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DEffects%252Bof%252BC-17%252Bheterocyclic%252Bsubstituents%252Bon%252Bthe%252Banticancer%252Bactivity%252Bof%252B2-ethylestra-1%25252C3%25252C5%25252810%252529-triene-3-O-sulfamates%25253A%252Bsynthesis%25252C%252Bin%252Bvitro%252Bevaluation%252Band%252Bcomputational%252Bmodelling%26aulast%3DJourdan%26aufirst%3DFabrice%26date%3D2008%26volume%3D6%26issue%3D22%26spage%3D4108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of 2-methoxyestradiol <b>1</b>, 2-MeOE2MATE <b>2</b>, and 2-MeOE2bisMATE <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Computational overlay of minimal energy conformations of 17-<i>O</i>-sulfamoyl <b>3</b> and 17-cyanomethyl <b>15</b> functionalized estra-1,3,5[10]-triene derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0003.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 17-Cyanomethyl and 17-Cyanomethylene Estra-1,3,5(10)-triene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (EtO)<sub>2</sub>POCH<sub>2</sub>CN, NaH, THF; (ii) H<sub>2</sub>, Pd/C, THF/EtOH; (iii) TBAF, THF; (iv) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of <b>15</b> displaying the intermolecular hydrogen bonding through the sulfamate <i>NH</i> to the nitrile of the neighboring <b>15</b> and also to the carbonyl oxygen in the solvent of crystallization (acetone). Ellipsoids are represented at 30% probability. Primed labeled atoms were generated via the –1 + <i>x</i>, <i>y</i>, 1 + <i>z</i> symmetry operation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0005.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 17-(1,1-Dicyano)methyl Estra-1,3,5(10)-triene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) CH<sub>2</sub>(CN)<sub>2</sub>, β-alanine, PhMe; (ii) TBAF, THF; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA; (iv) NaBH<sub>4</sub>, THF/MeOH.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0006.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 1-(Cyano)ethyl Side Chains at C-17<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LDA, THF, MeI, −78 °C to rt; (ii) EtCN, LDA, THF, −78 °C; (iii) MsOH, Et<sub>3</sub>N, DCM, or Burgess reagent, DMF; (iv) H<sub>2</sub>, Pd/C, THF/EtOH; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0007.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-prop-2-ynyl Estra-1,3,5(10)-triene<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIBALH, PhMe/CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt; (ii) (MeO)<sub>2</sub>POC(N<sub>2</sub>)COMe, MeOH, K<sub>2</sub>CO<sub>3</sub>; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0008.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 17-Cyano Estra-1,3,5(10)-triene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) KCN, AcOH, MeOH; (ii) SOCl<sub>2</sub>, pyridine, reflux; (iii) H<sub>2</sub>, Pd/C, THF/MeOH; (iv) NaHCO<sub>3</sub>, MeOH/acetone; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA.</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activity of <b>8</b> in an in vitro model of angiogenesis. (a) Plot of quantified tubule length per well in control, VEGF stimulated and <b>8</b> treated wells at 20 and 40 nM. Treated wells are stimulated by 2 ng/mL VEGF. (b) Images of the control, stimulated, and treated wells in this assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>8</b> disrupts microtubule dynamics. The ability of compound <b>8</b> to inhibit paclitaxel-stimulated tubulin stabilization was assessed. In vitro tubulin assembly was measured by turbidity at 350 nm. Tubulin was preincubated with or without compound <b>8</b> (10 µM) for 5 min at 37 °C. Tubulin assembly was then stimulated by adding paclitaxel (10 µM). The change in the absorbance was continuously monitored at 350 nm for 15 min at 37 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Ribbon diagram of the <b>15</b>−hCAII complex obtained by X-ray crystallography. The inhibitor molecule, metal coordinating residues His94, His96, and His119, and the zinc ion are represented in ball and stick format. (b) Detailed schematic representation of <b>15</b> within the hCAII active site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/medium/jm-2007-01319c_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of daily oral administration of <b>14</b> and <b>15</b> on the growth of MDA-MB-231 xenografts in athymic female nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701319c/production/images/large/jm-2007-01319c_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701319c&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiatt, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshaw, E.</span><span> </span><span class="NLM_article-title">Tumor angiogenesis: therapeutic implications</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_year" style="font-weight: bold;">1971</span> <span class="NLM_volume">285</span> <span class="NLM_fpage">1182</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1056%2FNEJM197108122850711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=4938153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1971&pages=1182-1186&author=J.+Folkmanauthor=M.+Bachauthor=J.+W.+Roweauthor=F.+Davidoffauthor=P.+Lambertauthor=C.+Hirschauthor=A.+Goldbergauthor=H.+H.+Hiattauthor=J.+Glassauthor=E.+Henshaw&title=Tumor+angiogenesis%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor angiogenesis: therapeutic implications</span></div><div class="casAuthors">Folkman J</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1182-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA0C6odtE1LPxQvRxYU81tfW6udTcc2eZEZ_yqsjhDrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D&md5=efdddcba0c04be542edd51fef2ef27b9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM197108122850711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197108122850711%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DM.%26aulast%3DRowe%26aufirst%3DJ.%2BW.%26aulast%3DDavidoff%26aufirst%3DF.%26aulast%3DLambert%26aufirst%3DP.%26aulast%3DHirsch%26aufirst%3DC.%26aulast%3DGoldberg%26aufirst%3DA.%26aulast%3DHiatt%26aufirst%3DH.%2BH.%26aulast%3DGlass%26aufirst%3DJ.%26aulast%3DHenshaw%26aufirst%3DE.%26atitle%3DTumor%2520angiogenesis%253A%2520therapeutic%2520implications%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26spage%3D1182%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerbel, R. S.</span><span> </span><span class="NLM_article-title">Angiogenesis as a therapeutic target</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">438</span> <span class="NLM_fpage">967</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fnature04483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=16355214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSksrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=967-974&author=N.+Ferraraauthor=R.+S.+Kerbel&title=Angiogenesis+as+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis as a therapeutic target</span></div><div class="casAuthors">Ferrara, Napoleone; Kerbel, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">7070</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inhibiting angiogenesis is a promising strategy for treatment of cancer and several other disorders, including age-related macular degeneration.  Major progress towards a treatment has been achieved over the past few years, and the first antiangiogenic agents have been recently approved for use in several countries.  Therapeutic angiogenesis (promoting new vessel growth to treat ischemic disorders) is an exciting frontier of cardiovascular medicine, but further understanding of the mechanisms of vascular morphogenesis is needed first.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdP_T905faXLVg90H21EOLACvtfcHk0ljzmygOFEYT7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSksrnI&md5=05a90bd29a0fb34f9c20a825f899d04c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature04483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04483%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DKerbel%26aufirst%3DR.%2BS.%26atitle%3DAngiogenesis%2520as%2520a%2520therapeutic%2520target%26jtitle%3DNature%26date%3D2005%26volume%3D438%26spage%3D967%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">391</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fnrd1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=15136787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=391-400&author=N.+Ferraraauthor=K.+J.+Hillanauthor=H.+P.+Gerberauthor=W.+Novotny&title=Discovery+and+development+of+bevacizumab%2C+an+anti-VEGF+antibody+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span></div><div class="casAuthors">Ferrara, Napoleone; Hillan, Kenneth J.; Gerber, Hans-Peter; Novotny, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular supply to nourish a growing tumor, was postulated many decades ago, although the identification and isolation of these factors proved elusive.  Now, vascular endothelial growth factor (VEGF), which was identified in the 1980s, is recognized as an essential regulator of normal and abnormal blood vessel growth.  In 1993, it was shown that a monoclonal antibody that targeted VEGF results in a dramatic suppression of tumor growth in vivo, which led to the development of bevacizumab (Avastin; Genentech), a humanized variant of this anti-VEGF antibody, as an anticancer agent.  The recent approval of bevacizumab by the US FDA as a first-line therapy for metastatic colorectal cancer validates the ideas that VEGF is a key mediator of tumor angiogenesis and that blocking angiogenesis is an effective strategy to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaLbfhdBKOLVg90H21EOLACvtfcHk0ljzmygOFEYT7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D&md5=4b1f647db4dfe2a24449cdf59b874e7c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1381%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DGerber%26aufirst%3DH.%2BP.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DDiscovery%2520and%2520development%2520of%2520bevacizumab%252C%2520an%2520anti-VEGF%2520antibody%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hurwitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehrenbacher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartwright, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabbinavar, F.</span><span> </span><span class="NLM_article-title">Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">350</span> <span class="NLM_fpage">2335</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1056%2FNEJMoa032691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=15175435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2335-2342&author=H.+Hurwitzauthor=L.+Fehrenbacherauthor=W.+Novotnyauthor=T.+Cartwrightauthor=J.+Hainsworthauthor=W.+Heimauthor=J.+Berlinauthor=A.+Baronauthor=S.+Griffingauthor=E.+Holmgrenauthor=N.+Ferraraauthor=G.+Fyfeauthor=B.+Rogersauthor=R.+Rossauthor=F.+Kabbinavar&title=Bevacizumab+plus+irinotecan%2C+fluorouracil%2C+and+leucovorin+for+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer</span></div><div class="casAuthors">Hurwitz, Herbert; Fehrenbacher, Louis; Novotny, William; Cartwright, Thomas; Hainsworth, John; Heim, William; Berlin, Jordan; Baron, Ari; Griffing, Susan; Holmgren, Eric; Ferrara, Napoleone; Fyfe, Gwen; Rogers, Beth; Ross, Robert; Kabbinavar, Fairooz</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2335-2342</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclin. and clin. activity against metastatic colorectal cancer, particularly in combination with chemotherapy.  Of 813 patients with previously untreated metastatic colorectal cancer, we randomly assigned 402 to receive irinotecan, bolus fluorouracil, and leucovorin (IFL) plus bevacizumab (5 mg per kg of body wt. every two weeks) and 411 to receive IFL plus placebo.  The primary end point was overall survival.  Secondary end points were progression-free survival, the response rate, the duration of the response, safety, and the quality of life.  The median duration of survival was 20.3 mo in the group given IFL plus bevacizumab, as compared with 15.6 mo in the group given IFL plus placebo, corresponding to a hazard ratio for death of 0.66 (P<0.001).  The median duration of progression-free survival was 10.6 mo in the group given IFL plus bevacizumab, as compared with 6.2 mo in the group given IFL plus placebo (hazard ratio for disease progression, 0.54; P<0.001); the corresponding rates of response were 44.8 % and 34.8 % (P = 0.004).  The median duration of the response was 10.4 mo in the group given IFL plus bevacizumab, as compared with 7.1 mo in the group given IFL plus placebo (hazard ratio for progression, 0.62; P = 0.001).  Grade 3 hypertension was more common during treatment with IFL plus bevacizumab than with IFL plus placebo (11.0 % vs. 2.3 %) but was easily managed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5r6uP5oxZU7Vg90H21EOLACvtfcHk0liCAQerQQXN4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gjt74%253D&md5=6a1289cdbf1501f121eb0482e5a1f536</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa032691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa032691%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DH.%26aulast%3DFehrenbacher%26aufirst%3DL.%26aulast%3DNovotny%26aufirst%3DW.%26aulast%3DCartwright%26aufirst%3DT.%26aulast%3DHainsworth%26aufirst%3DJ.%26aulast%3DHeim%26aufirst%3DW.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DA.%26aulast%3DGriffing%26aufirst%3DS.%26aulast%3DHolmgren%26aufirst%3DE.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DFyfe%26aufirst%3DG.%26aulast%3DRogers%26aufirst%3DB.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DKabbinavar%26aufirst%3DF.%26atitle%3DBevacizumab%2520plus%2520irinotecan%252C%2520fluorouracil%252C%2520and%2520leucovorin%2520for%2520metastatic%2520colorectal%2520cancer%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D2335%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, J. S.</span><span> </span><span class="NLM_article-title">Lessons from phase III clinical trials on anti-VEGF therapy for cancer</span> <span class="citation_source-journal">Nat Clin. Pract. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">24</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fncponc0403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=16407877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVynsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=24-40&author=R.+K.+Jainauthor=D.+G.+Dudaauthor=J.+W.+Clarkauthor=J.+S.+Loeffler&title=Lessons+from+phase+III+clinical+trials+on+anti-VEGF+therapy+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from phase III clinical trials on anti-VEGF therapy for cancer</span></div><div class="casAuthors">Jain, Rakesh K.; Duda, Dan G.; Clark, Jeffrey W.; Loeffler, Jay S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-40</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In randomized phase III trials two anti-vascular endothelial growth factor (VEGF) approaches have yielded survival benefit in patients with metastatic cancer.  In one approach, the addn. of bevacizumab, a VEGF-specific antibody, to std. chemotherapy improved overall survival in colorectal and lung cancer patients and progression-free survival in breast cancer patients.  In the second approach, multitargeted tyrosine kinase inhibitors that block VEGF receptor and other kinases in both endothelial and cancer cells, demonstrated survival benefit in gastrointestinal stromal tumor and renal-cell-carcinoma patients.  By contrast, adding bevacizumab to chemotherapy failed to increase survival in patients with previously treated and refractory metastatic breast cancer.  Furthermore, addn. of vatalanib, a kinase inhibitor developed as a VEGF receptor-selective agent, to chemotherapy did not show a similar benefit in metastatic colorectal cancer patients.  These contrasting responses raise crit. questions about how these agents work and how to combine them optimally.  We summarize three of the many potential mechanisms of action of anti-VEGF agents, and also discuss progress relating to the identification of potential biomarkers for anti-VEGF-agent efficacy in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzdONgbUWNUrVg90H21EOLACvtfcHk0liCAQerQQXN4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVynsL0%253D&md5=dfcfbf8ab8060df6b65c359b0bf8ef77</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fncponc0403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc0403%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DDuda%26aufirst%3DD.%2BG.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DLoeffler%26aufirst%3DJ.%2BS.%26atitle%3DLessons%2520from%2520phase%2520III%2520clinical%2520trials%2520on%2520anti-VEGF%2520therapy%2520for%2520cancer%26jtitle%3DNat%2520Clin.%2520Pract.%2520Oncol.%26date%3D2006%26volume%3D3%26spage%3D24%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">A-ring substituted estrogen sulfamates: Potent multi-targeted anti-cancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">48</span> <span class="NLM_fpage">5243</span> <span class="NLM_lpage">5256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5243-5256&author=M.+P.+Leeseauthor=H.+A.+M.+Hejazauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+Reedauthor=B.+V.+L.+Potter&title=A-ring+substituted+estrogen+sulfamates%3A+Potent+multi-targeted+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm050066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050066a%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DA-ring%2520substituted%2520estrogen%2520sulfamates%253A%2520Potent%2520multi-targeted%2520anti-cancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5243%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumor agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">3135</span> <span class="NLM_lpage">3138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3135-3138&author=M.+P.+Leeseauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Alkylsulfanyl+estrogen+derivatives%3A+synthesis+of+a+novel+class+of+multi-targeted+anti-tumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Alkylsulfanyl%2520estrogen%2520derivatives%253A%2520synthesis%2520of%2520a%2520novel%2520class%2520of%2520multi-targeted%2520anti-tumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3135%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-<i>O</i>-sulfamates</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">94</span> <span class="NLM_fpage">239</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2Fj.jsbmb.2005.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=15862971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=239-251&author=M.+P.+Leeseauthor=B.+Leblondauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Anti-cancer+activities+of+novel+D-ring+modified+2-substituted+estrogen-3-O-sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates</span></div><div class="casAuthors">Leese, Mathew P.; Leblond, Bertrand; Newman, Simon P.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">239-251</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulfamoylated derivs. of the endogenous estrogen metabolite 2-methoxyestradiol [2-MeOE2 (I)], such as 2-methoxy-3-O-sulfamoylestrone [2-MeOEMATE (II)], display greatly enhanced activity against the proliferation of human cancer cells and inhibit steroid sulfatase (STS), another current oncol. target.  We explore here the effects of steroidal D-ring modification on the activity of such 2-substituted estrogen-3-O-sulfamates in respect of inhibition of tumor cell proliferation and steroid sulfatase.  The novel 17-deoxy analogs of 2-MeOEMATE and the related 2-Et and 2-methylsulfanyl compds. showed greatly reduced inhibition of MCF-7 proliferation.  Introduction of a 17α-benzyl substituent to such 2-substituted estrogen sulfamates also proved deleterious to anti-proliferative activity but could, in one case, enhance STS inhibition with respect to the parent substituted estrone sulfamate.  In contrast, selected 17-oxime derivs. of 2-MeOEMATE displayed an enhanced anti-proliferative activity.  These results illustrate that enhanced in vitro anti-cancer activity can be achieved in the 2-substituted estrogen sulfamate series and highlight, in particular, the importance of potential hydrogen bonding effects around the steroidal D-ring in the activity of these mols.  The SAR parameters established herein will assist the future design of anti-proliferative and anti-endocrine agents as potential therapeutics for both hormone dependent and independent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC4Cz4Pgw94bVg90H21EOLACvtfcHk0liCAQerQQXN4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLs%253D&md5=0bc448776d6e96d5ee9f562de51eabb4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2005.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2005.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DAnti-cancer%2520activities%2520of%2520novel%2520D-ring%2520modified%25202-substituted%2520estrogen-3-O-sulfamates%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D94%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography, and in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">7683</span> <span class="NLM_lpage">7696</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060705x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7683-7696&author=M.+P.+Leeseauthor=B.+Leblondauthor=A.+Smithauthor=S.+P.+Newmanauthor=A.+Di+Fioreauthor=G.+de+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-substituted+estradiol+bis-sulfamates%2C+multitargeted+antitumor+agents%3A+Synthesis%2C+in+vitro+SAR%2C+protein+crystallography%2C+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm060705x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060705x%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3Dde%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-substituted%2520estradiol%2520bis-sulfamates%252C%2520multitargeted%2520antitumor%2520agents%253A%2520Synthesis%252C%2520in%2520vitro%2520SAR%252C%2520protein%2520crystallography%252C%2520and%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7683%26epage%3D7696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effect of 2-methoxyoestrone-3-<i>O</i>-sulphamate on the growth of breast cancer cells and induced mammary tumours</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">85</span> <span class="NLM_fpage">584</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=10699934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=584-589&author=A.+Purohitauthor=H.+A.+M.+Hejazauthor=L.+Waldenauthor=L.+MacCarthy-Morroghauthor=G.+Packhamauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effect+of+2-methoxyoestrone-3-O-sulphamate+on+the+growth+of+breast+cancer+cells+and+induced+mammary+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours</span></div><div class="casAuthors">Purohit A; Hejaz H A; Walden L; MacCarthy-Morrogh L; Packham G; Potter B V; Reed M J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">584-9</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">2-Methoxyoestrogens are emerging as a new class of drug that can inhibit tumour growth and angiogenesis.  As sulphamoylation of oestrogens enhances their potency and bioavailability we have synthesized 2-methoxyoestrone-3-O-sulphamate (2-MeOEMATE) and compared its ability to inhibit the proliferation of breast cancer cells with that of 2-methoxyoestrone (2-MeOE1). 2-MeOEMATE (1 microM) inhibited the growth of oestrogen receptor positive MCF-7 breast cancer cells by 52% whereas 2-MeOE1 had little effect at this concentration. 2-MeOEMATE also inhibited the growth of oestrogen receptor negative MDA-MB-231 breast cancer cells.  Exposure of cells to 2-MeOEMATE caused them to round up and become detached suggesting that this compound may induce cells to undergo apoptosis.  Cell cycle analysis revealed that 2-MeOEMATE caused cells to arrest in the G(2)/M phase with the increase in G(2)/M arrested cells being detectable by 12 hr.  Exposure of MCF-7 cells to 2 L-MeOEMATE for 24 hr followed by culture in drug-free medium for 24 hr did not reverse the arrest of cells in the G(2)/M phase.  TUNEL analysis confirmed that 2-MeOEMATE induced apoptosis in a significant proportion of treated MCF-7 cells.  In an in vivo study, employing nitrosomethylurea-induced mammary tumours in intact rats, 2-MeOE1 (20mg/kg/d, p.o. for 11 days) had little effect on tumour growth.  In contrast, the same dose of 2-MeOEMATE resulted in the almost complete regression of 2/3 tumours over an 11-day period.  We conclude that 2-MeOEMATE should have considerable therapeutic potential for the treatment of breast tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqkhlCxw4mrynGiHuhFGv8fW6udTcc2eZIeQJOB4G-V7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D&md5=75a9c5a896a1a00886a9c17cf2cbe241</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000215%252985%253A4%253C584%253A%253AAID-IJC22%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DWalden%26aufirst%3DL.%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effect%2520of%25202-methoxyoestrone-3-O-sulphamate%2520on%2520the%2520growth%2520of%2520breast%2520cancer%2520cells%2520and%2520induced%2520mammary%2520tumours%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26spage%3D584%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">Differential effects of estrone and estrone-3-<i>O</i>-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">60</span> <span class="NLM_fpage">5441</span> <span class="NLM_lpage">5450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=11034086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1ehtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5441-5450&author=L.+MacCarthy-Morroghauthor=P.+A.+Townsendauthor=A.+Purohitauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=Differential+effects+of+estrone+and+estrone-3-O-sulfamate+derivatives+on+mitotic+arrest%2C+apoptosis%2C+and+microtubule+assembly+in+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span></div><div class="casAuthors">MacCarthy-Morrogh, Lucy; Townsend, Paul A.; Purohit, Atul; Hejaz, Hatem A. M.; Potter, Barry V. L.; Reed, Michael J.; Packham, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5441-5450</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">There is considerable interest in the potential use of estrogen derivs. for the treatment and prevention of breast cancer.  We demonstrated previously that the sulfamoylated estrone deriv. 2-methoxyestrone-3-O-sulfamate (2-MeOEMATE) induced G2-M cell cycle arrest and modest levels of apoptosis in breast cancer cells in vitro, whereas the parent estrone deriv., 2-methoxyestrone, did not, 2-MeOEMATE also induced breast tumor regression in vivo in intact rats.  To further explore the significance of sulfamoylation on the anticancer activity of estrone derivs. and to elucidate their mechanism of action, we synthesized two addnl. agents, 2-ethylestrone and 2-ethylestrone-3-O-sulfamate (2-EtEMATE).  2-MeOEMATE and 2-EtEMATE inhibited the growth of a panel of estrogen receptor-neg. and -pos. breast cancer cell lines in vitro, induced mitotic arrest and apoptosis, and suppressed the long-term clonogenic potential of MCF7 and CAL51 breast cancer cells.  In each assay, the sulfamoylated estrone derivs. were > 10-fold more potent than their parent compds.  The sulfamoylated estrone derivs. were also significantly more potent inhibitors of cell growth than the previously studied endogenous estradiol metabolite 2-methoxyestradiol.  2-MeOEMATE and 2-EtEMATE functioned as antimicrotubule agents and inhibited the ability of paclitaxel to promote tubulin assembly in vitro.  Like other antimicrotubule agents, the sulfamoylated estrone derivs. induced BCL-2 and BCL-XL phosphorylation and increased p53 expression.  2-MeOEMATE and 2-EtEMATE are novel antimicrotubule agents that have potent anticancer activity in breast cancer cells in vitro and may be beneficial as anticancer agents in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwuuBiQck6dLVg90H21EOLACvtfcHk0lgdGMTU3phzuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1ehtr8%253D&md5=07ffe177df9adffa388318cc283891ff</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DTownsend%26aufirst%3DP.%2BA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3DDifferential%2520effects%2520of%2520estrone%2520and%2520estrone-3-O-sulfamate%2520derivatives%2520on%2520mitotic%2520arrest%252C%2520apoptosis%252C%2520and%2520microtubule%2520assembly%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5441%26epage%3D5450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of <i>in vitro</i> angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">109</span> <span class="NLM_fpage">533</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1002%2Fijc.20045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=14991574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXislCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=533-540&author=S.+P.+Newmanauthor=M.+P.+Leeseauthor=A.+Purohitauthor=D.+R.+C.+Jamesauthor=C.+E.+Rennieauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+in+vitro+angiogenesis+by+2-methoxy-+and+2-ethyl-estrogen+sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates</span></div><div class="casAuthors">Newman, Simon P.; Leese, Mathew P.; Purohit, Atul; James, David. R. C.; Rennie, Catherine E.; Potter, Barry V. L.; Reed, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-540</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Sulfamoylation of 2-methoxyestrone (2-MeOE1) was shown previously to enhance its potency as an anti-proliferative agent against breast cancer cells.  We have examd. the ability of a series of 2-methoxyestradiol (2-MeOE2) and 2-ethylestradiol (2-EtE2) sulfamates to inhibit angiogenesis in vitro.  2-MeOE2 bis-sulfamate and 2-EtE2 sulfamate were potent inhibitors of human umbilical vein endothelial cell (HUVEC) proliferation with IC50 values of 0.05 μM and 0.01 μM, resp.  A novel co-culture system, in which endothelial cells were cultured in a matrix of human dermal fibroblasts, was also used to assess the anti-angiogenic potential of these drugs.  In this system endothelial cells proliferate and migrate through the culture matrix to form tubule structures.  Whereas 2-MeOE2 (1.0 μM) caused a small redn. in tubule formation, both 2-MeOE2 bis-sulfamate (0.1 μM) and 2-EtE2 sulfamate (0.1 μM) almost completely abolished tubule formation.  2-MeOE2 bis-sulfamate and 2-EtE2 sulfamate both induced BCL-2 phosphorylation, p53 protein expression and apoptosis in HUVECs.  Microarray anal. of a limited no. of genes known to be involved in the angiogenic process did not show any gross changes in cells treated with the 2-substituted estrogens.  The sulfamoylated derivs. of 2-MeOE2 and 2-EtE2 are potent inhibitors of in vitro angiogenesis and both compds. should have therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjobqvR13TBLVg90H21EOLACvtfcHk0lgzIwCmj8nKvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXislCisro%253D&md5=483da21487f348462926eb1b2b11caad</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fijc.20045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20045%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DD.%2BR.%2BC.%26aulast%3DRennie%26aufirst%3DC.%2BE.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520in%2520vitro%2520angiogenesis%2520by%25202-methoxy-%2520and%25202-ethyl-estrogen%2520sulfamates%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D109%26spage%3D533%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">1368</span> <span class="NLM_lpage">1376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=17426705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1368-1376&author=S.+K.+Chanderauthor=P.+A.+Fosterauthor=M.+P.+Leeseauthor=S.+P.+Newmanauthor=B.+V.+L.+Potterauthor=A.+Purohitauthor=M.+J.+Reed&title=In+vivo+inhibition+of+angiogenesis+by+sulphamoylated+derivatives+of+2-methoxyoestradiol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol</span></div><div class="casAuthors">Chander, S. K.; Foster, P. A.; Leese, M. P.; Newman, S. P.; Potter, B. V. L.; Purohit, A.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1368-1376</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs that inhibit growth of tumors and their blood supply could have considerable therapeutic potential.  2-Methoxyestradiol-3,17-O,O-bis-sulfamate (2-MeOE2bisMATE) has been shown to inhibit the proliferation of MCF-7 (ER+) breast cancer cells and angiogenesis in vitro.  2-MeOE2bisMATE and its analog, 17-Cym-2-MeOE2MATE, were investigated for their ability to inhibit in vivo angiogenesis and tumor growth.  The mouse Matrigel plug assay for angiogenesis was used to investigate the effect of compds. on neovascularization and was quantified using a FITC-dextran injection technique.  Nude mice bearing tumors derived from MCF-7 cells were used to assess efficacy on tumor growth.  Tumor sections were stained for VEGFR-2 and Ki67 to assess tumor angiogenesis and cell proliferation resp.  Matrigel plugs supplemented with basic fibroblast growth factor resulted in increased neovascularization over 7 days.  Oral administration of 2-MeOE2bisMATE for 7 days at 10 or 50 mg kg-1 significantly reduced neovascularization to or below control levels resp.  17-Cym-2-MeOE2MATE at 20 mg kg-1 was equally effective.  2-MeOE2bisMATE, dosed daily for 21 days, caused a 52% redn. in tumor growth at 5 mg kg-1 and 38% regression at 20 mg kg-1.  17-Cym-2-MeOE2MATE (20 mg kg-1) reduced tumor growth by 92%.  Immunohistochem. revealed a redn. in angiogenesis and proliferation.  Matrigel plug and tumor imaging after FITC-dextran injection indicated that 2-MeOE2bisMATE caused a marked disruption of vasculature.  These sulfamoylated estrogen derivs. have been shown to be potent inhibitors of angiogenesis in vivo.  This, together with their ability to inhibit tumor growth, indicates the potential of this new class of drugs for further development for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqermbvXLYR8LVg90H21EOLACvtfcHk0lgzIwCmj8nKvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslyisro%253D&md5=a589de69ba3adc8e5ca93cff2cda1ede</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520angiogenesis%2520by%2520sulphamoylated%2520derivatives%2520of%25202-methoxyoestradiol%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D1368%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wood, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouzakiti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">323</span> <span class="NLM_lpage">332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=323-332&author=L.+Woodauthor=M.+P.+Leeseauthor=A.+Mouzakitiauthor=A.+Purohitauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=2-MeOE2bisMATE+induces+caspase-dependent+apoptosis+in+CAL51+breast+cancer+cells+and+overcomes+resistance+to+TRAIL+via+cooperative+activation+of+caspases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DL.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMouzakiti%26aufirst%3DA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3D2-MeOE2bisMATE%2520induces%2520caspase-dependent%2520apoptosis%2520in%2520CAL51%2520breast%2520cancer%2520cells%2520and%2520overcomes%2520resistance%2520to%2520TRAIL%2520via%2520cooperative%2520activation%2520of%2520caspases%26jtitle%3DApoptosis%26date%3D2004%26volume%3D9%26spage%3D323%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutill, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">The role of 17β-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">324</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=324-330&author=S.+P.+Newmanauthor=C.+R.+Iresonauthor=H.+J.+Tutillauthor=J.+M.+Dayauthor=M.+F.+C.+Parsonsauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=The+role+of+17%CE%B2-hydroxysteroid+dehydrogenases+in+modulating+the+activity+of+2-methoxyestradiol+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DTutill%26aufirst%3DH.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DParsons%26aufirst%3DM.%2BF.%2BC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%252017%25CE%25B2-hydroxysteroid%2520dehydrogenases%2520in%2520modulating%2520the%2520activity%2520of%25202-methoxyestradiol%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D324%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-<i>bis</i>-sulphamate <i>in vivo</i> in rodents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">90</span> <span class="NLM_fpage">932</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fsj.bjc.6601591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=14970876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=932-937&author=C.+R.+Iresonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=S.+Pereraauthor=S.+P.+Newmanauthor=D.+Parishauthor=M.+P.+Leeseauthor=A.+C.+Smithauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Pharmacokinetics+and+efficacy+of+2-methoxyoestradiol+and+2-methoxyoestradiol-bis-sulphamate+in+vivo+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span></div><div class="casAuthors">Ireson, C. R.; Chander, S. K.; Purohit, A.; Perera, S.; Newman, S. P.; Parish, D.; Leese, M. P.; Smith, A. C.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">932-937</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Methoxyoestradiol (2-MeOE2) is an endogenous estrogen metabolite that inhibits the proliferation of cancer cells in vitro, and it is also antiangiogenic.  In vivo 2-MeOE2, when administered at relatively high doses, inhibits the growth of tumors derived from breast cancer cells, sarcomas and melanomas.  Sulphamoylated derivs. of 2-MeOE2 are more potent inhibitors of in vitro breast cancer cell growth than 2-MeOE2.  In the present study, the authors have compared the pharmacokinetic profiles and metab. of 2-MeOE2 and its sulfamoylated deriv., 2-methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE), in adult female rats.  Their ability to inhibit tumor growth was compared in nude mice bearing xenografts derived from MDA-MB-435 (estrogen receptor neg.) melanoma cancer cells.  After a single oral 10 mg kg-1 dose of 2-MeOE2bisMATE, significant concns. of this compd. were still detectable at 24 h.  In contrast, no 2-MeOE2 or metabolites were detected in plasma at any time after a 10 mg kg-1 oral dose.  Thus, the bioavailability of 2-MeOE2 is very low, whereas for 2-MeOE2bisMATE it was 85%.  No significant metabolites of 2-MeOE2bisMATE were detected in plasma after oral or i.v. dosing, showing that this drug is resistant to metab.  In the tumor efficacy model, oral administration of 2-MeOE2bisMATE, at 20 mg kg-1 day-1 daily for 28 days, almost completely inhibited tumor growth.  Inhibition of tumor growth was maintained for a further 28 days after the cessation of dosing.  At this dose level, 2-MeOE2 did not inhibit tumor growth.  The resistance to metab. shown by 2-MeOE2bisMATE and its ability to inhibit tumor growth in vivo suggest that this compd. should have considerable potential for development as a novel anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogMoiaDGhPlLVg90H21EOLACvtfcHk0li3yskr-1sMWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D&md5=e92f1f7f94f9d2fdb3afad25cc41903d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601591%26sid%3Dliteratum%253Aachs%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520efficacy%2520of%25202-methoxyoestradiol%2520and%25202-methoxyoestradiol-bis-sulphamate%2520in%2520vivo%2520in%2520rodents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26spage%3D932%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: Molecular biology, regulation and inhibition</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">26</span> <span class="NLM_fpage">171</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1210%2Fer.2004-0003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=15561802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=171-202&author=M.+J.+Reedauthor=A.+Purohitauthor=S.+P.+Newmanauthor=B.+V.+L.+Potter&title=Steroid+sulfatase%3A+Molecular+biology%2C+regulation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulfatase: Molecular biology, regulation, and inhibition</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Woo, L. W. L.; Newman, S. P.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-202</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Steroid sulfatase (STS) is responsible for the hydrolysis of aryl and alkyl steroid sulfates and therefore has a pivotal role in regulating the formation of biol. active steroids.  STS is widely distributed throughout the body, and its action is implicated in physiol. processes and pathol. conditions.  The crystal structure of STS has been resolved, but relatively little is known about what regulates its expression or activity.  Research into the control and inhibition of this enzyme has been stimulated by its important role in supporting the growth of hormone-dependent tumors of the breast and prostate.  STS is responsible for the hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate to estrone and dehydroepiandrosterone, resp., both of which can be converted to steroids with estrogenic properties (i.e., estradiol and androstenediol) that can stimulate tumor growth.  STS expression is increased in breast tumors and has prognostic significance.  The role of STS in supporting tumor growth prompted the development of potent STS inhibitors.  Several steroidal and nonsteroidal STS inhibitors are now available, with the irreversible type of inhibitor having a phenol sulfamate ester as its active pharmacophore.  One such inhibitor, 667 COUMATE, has now entered a phase I trial in postmenopausal women with breast cancer.  The skin is also an important site of STS activity, and deficiency of this enzyme is assocd. with X-linked ichthyosis.  STS may also be involved in regulating part of the immune response and some aspects of cognitive function.  The development of potent STS inhibitors will allow investigation of the role of this enzyme in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvDkv9jdOyZ7Vg90H21EOLACvtfcHk0li3yskr-1sMWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D&md5=5ea6cff3a5f23b3f31d08506c724df06</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0003%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulfatase%253A%2520Molecular%2520biology%252C%2520regulation%2520and%2520inhibition%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D171%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">The development of steroid sulphatase inhibitors</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">9</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=9-23&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potter&title=The+development+of+steroid+sulphatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DThe%2520development%2520of%2520steroid%2520sulphatase%2520inhibitors%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D1996%26volume%3D3%26spage%3D9%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">305</span> <span class="NLM_fpage">909</span> <span class="NLM_lpage">914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=909-914&author=Y.+T.+Hoauthor=A.+Purohitauthor=N.+Vickerauthor=S.+P.+Newmanauthor=J.+J.+Robinsonauthor=M.+P.+Leeseauthor=D.+Ganeshapillaiauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+carbonic+anhydrase+II+by+steroidal+and+non-steroidal+sulphamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVicker%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DJ.%2BJ.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520carbonic%2520anhydrase%2520II%2520by%2520steroidal%2520and%2520non-steroidal%2520sulphamates%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D305%26spage%3D909%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Stanway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sufi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigushin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczyk, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulinkaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, R. C.</span><span> </span><span class="NLM_article-title">Phase I study of STX64 (667 Coumate) in breast cancer patients: The first study of a steroid sulfatase inhibitor</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">1585</span> <span class="NLM_lpage">1592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1158%2F1078-0432.CCR-05-1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=16533785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1585-1592&author=S.+J.+Stanwayauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=S.+Sufiauthor=D.+Vigushinauthor=R.+Wardauthor=R.+Wilsonauthor=F.+Z.+Stanczykauthor=N.+Dobbsauthor=E.+Kulinkayaauthor=M.+Elliottauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=R.+C.+Coombs&title=Phase+I+study+of+STX64+%28667+Coumate%29+in+breast+cancer+patients%3A+The+first+study+of+a+steroid+sulfatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: the First Study of a Steroid Sulfatase Inhibitor</span></div><div class="casAuthors">Stanway, Susannah J.; Purohit, Atul; Woo, L. W. Lawrence; Sufi, Saulat; Vigushin, David; Ward, Rebecca; Wilson, Richard H.; Stanczyk, Frank Z.; Dobbs, Nicola; Kulinskaya, Elena; Elliott, Moira; Potter, Barry V. L.; Reed, Michael J.; Coombes, R. Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1585-1592</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Inhibition of steroid sulfatase (STS), the enzyme responsible for the hydrolysis of steroid sulfates, represents a potential novel treatment for postmenopausal women with hormone-dependent breast cancer.  Estrone and DHEA are formed by this sulfatase pathway and can be converted to steroids (estradiol and androstenediol, resp.), which have potent estrogenic properties.  Exptl. Design: STX64 (667 Coumate), a tricylic coumarin-based sulfamate that irreversibly inhibits STS activity, was selected for entry into the first phase I trial of a STS inhibitor in postmenopausal women with breast cancer.  STX64 was administered orally (nine patients at 5 mg and five patients at 20 mg) as an initial dose followed 1 wk later by 3 x 2 weekly cycles, with each cycle comprising daily dosing for 5 days followed by 9 days off treatment.  Blood and tumor tissue samples were collected for the assessment of STS activity and serum was obtained for steroid hormone measurements before and after treatment.  Results: The median inhibition of STS activity by STX64 was 98% in peripheral blood lymphocytes (PBL) and 99% in breast tumor tissue at the end of the 5-day dosing period.  As expected, serum concns. of estrone, estradiol, androstenediol, and DHEA all decreased significantly from pretreatment levels.  Unexpectedly, androstenedione and testosterone concns. also decreased.  Four patients, all of whom had previously progressed on aromatase inhibitors, showed evidence of stable disease for 2.75 to 7 mo.  The drug was well tolerated with only minor drug-related adverse events recorded.  Conclusion: STX64 is a potent, well-tolerated STS inhibitor.  It inhibits STS activity in PBLs and tumor tissues and causes significant decreases in serum concns. of steroids with estrogenic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvfOgizqc5GLVg90H21EOLACvtfcHk0lhYl-MMlFjTrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGmsL0%253D&md5=91b2349eac6d0b3f27073e7b894b7b6d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1996%26sid%3Dliteratum%253Aachs%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSufi%26aufirst%3DS.%26aulast%3DVigushin%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DStanczyk%26aufirst%3DF.%2BZ.%26aulast%3DDobbs%26aufirst%3DN.%26aulast%3DKulinkaya%26aufirst%3DE.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DCoombs%26aufirst%3DR.%2BC.%26atitle%3DPhase%2520I%2520study%2520of%2520STX64%2520%2528667%2520Coumate%2529%2520in%2520breast%2520cancer%2520patients%253A%2520The%2520first%2520study%2520of%2520a%2520steroid%2520sulfatase%2520inhibitor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1585%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Stanway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delavault, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurieau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: a new target for the endocrine therapy of breast cancer</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">370</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=370-374&author=S.+J.+Stanwayauthor=P.+Delavaultauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=C.+Thurieauauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Steroid+sulfatase%3A+a+new+target+for+the+endocrine+therapy+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DDelavault%26aufirst%3DP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DThurieau%26aufirst%3DC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DSteroid%2520sulfatase%253A%2520a%2520new%2520target%2520for%2520the%2520endocrine%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D370%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hussain, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perunovic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, D. H.</span><span> </span><span class="NLM_article-title">Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">104</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fsj.bjc.6603530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=17213826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1KnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=104-109&author=S.+A.+Hussainauthor=R.+Ganesanauthor=G.+Reynoldsauthor=L.+Grossauthor=A.+Stevensauthor=J.+Pastorekauthor=P.+G.+Murrayauthor=B.+Perunovicauthor=M.+S.+Anwarauthor=L.+Billinghamauthor=N.+D.+Jamesauthor=D.+Spoonerauthor=C.+J.+Pooleauthor=D.+W.+Reaauthor=D.+H.+Palmer&title=Hypoxia-regulated+carbonic+anhydrase+IX+expression+is+associated+with+poor+survival+in+patients+with+invasive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer</span></div><div class="casAuthors">Hussain, S. A.; Ganesan, R.; Reynolds, G.; Gross, L.; Stevens, A.; Pastorek, J.; Murray, P. G.; Perunovic, B.; Anwar, M. S.; Billingham, L.; James, N. D.; Spooner, D.; Poole, C. J.; Rea, D. W.; Palmer, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-109</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor hypoxia is a microenvironmental factor related to poor response to radiation, chemotherapy, genetic instability, selection for resistance to apoptosis, and increased risk of invasion and metastasis.  Hypoxia-regulated carbonic anhydrase IX (CA IX) has been studied in various tumor sites and its expression has been correlated with the clin. outcome.  The purpose of this study was to investigate the correlation of CA IX expression with outcome in patients with invasive breast cancer.  We conducted a retrospective study examg. the effects of carbonic anhydrase IX (CA IX) on survival in patients with breast cancer.  To facilitate the screening of multiple tissue blocks from each patient, tissue microarrays were prepd. contg. between two and five representative samples of tumor per patient.  Immunohistochem. was used to examine expression of CA IX in patients with breast cancer.  The study includes a cohort of 144 unselected patients with early invasive breast cancer who underwent surgery, and had CA IX expression and follow-up data available for anal.  At the time of anal., there were 28 deaths and median follow-up of 48 mo with 96% of patients having at least 2 years of follow-up.  CA IX was neg. for 107 patients (17 deaths) and pos. for 37 patients (11 deaths).  Kaplan-Meier survival curves show that survival was superior in the CA IX-neg. group with a 2-yr survival of 97% for negatives and 83% for positives (log-rank test P=0.01).  Allowing for potential prognostic variables in a Cox regression anal., CA IX remained a significant independent predictor of survival (P=0.035).  This study showed in both univariate and multivariate anal. that survival is significantly inferior in patients with tumor expressing CA IX.  Prospective studies are underway to investigate this correlation in clin. trial setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIslWBGCU0lbVg90H21EOLACvtfcHk0lhf-yrQd9RHxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1KnsQ%253D%253D&md5=4bf6d73ab8551ce706272ebed8d33aa4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603530%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DS.%2BA.%26aulast%3DGanesan%26aufirst%3DR.%26aulast%3DReynolds%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DL.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DPastorek%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DP.%2BG.%26aulast%3DPerunovic%26aufirst%3DB.%26aulast%3DAnwar%26aufirst%3DM.%2BS.%26aulast%3DBillingham%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DN.%2BD.%26aulast%3DSpooner%26aufirst%3DD.%26aulast%3DPoole%26aufirst%3DC.%2BJ.%26aulast%3DRea%26aufirst%3DD.%2BW.%26aulast%3DPalmer%26aufirst%3DD.%2BH.%26atitle%3DHypoxia-regulated%2520carbonic%2520anhydrase%2520IX%2520expression%2520is%2520associated%2520with%2520poor%2520survival%2520in%2520patients%2520with%2520invasive%2520breast%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D104%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachdeva, Y. P.</span><span> </span><span class="NLM_article-title">Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">40</span> <span class="NLM_fpage">2323</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9700833" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2323-2334&author=M.+Cushmanauthor=H.+M.+Heauthor=J.+A.+Katzenellenbogenauthor=R.+K.+Varmaauthor=E.+Hamelauthor=C.+M.+Linauthor=S.+Ramauthor=Y.+P.+Sachdeva&title=Synthesis+of+analogs+of+2-methoxyestradiol+with+enhanced+inhibitory+effects+on+tubulin+polymerization+and+cancer+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9700833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9700833%26sid%3Dliteratum%253Aachs%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DH.%2BM.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DVarma%26aufirst%3DR.%2BK.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DRam%26aufirst%3DS.%26aulast%3DSachdeva%26aufirst%3DY.%2BP.%26atitle%3DSynthesis%2520of%2520analogs%2520of%25202-methoxyestradiol%2520with%2520enhanced%2520inhibitory%2520effects%2520on%2520tubulin%2520polymerization%2520and%2520cancer%2520cell%2520growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2323%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Klauber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parangi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DʼAmato, R. J.</span><span> </span><span class="NLM_article-title">Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">57</span> <span class="NLM_fpage">81</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=8988045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK2sXjvFOmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=81-86&author=N.+Klauberauthor=S.+Parangiauthor=E.+Flynnauthor=E.+Hamelauthor=R.+J.+D%CA%BCAmato&title=Inhibition+of+angiogenesis+and+breast+cancer+in+mice+by+the+microtubule+inhibitors+2-methoxyestradiol+and+taxol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol</span></div><div class="casAuthors">Klauber, Nancy; Parangi, Sareh; Flynn, Evelyn; Hamel, Ernest; D'Amato, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-86</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">2-Methoxyestradiol (2-ME), an endogenous estrogen metabolite which disrupts microtubule function, has been shown to inhibit proliferating cells in vitro and suppress certain murine tumors in vivo.  In vitro screening has detd. that breast cancer cell lines are most sensitive to inhibition by 2-ME.  Addnl., 2-ME has been shown to inhibit angiogenesis in vitro.  We tested whether 2-ME suppresses cytokine-induced angiogenesis in vivo and inhibits growth of a human breast carcinoma in severe combined immunodeficient mice.  A model of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF)-induced corneal neovascularization in C57BL/6 mice was used to evaluate the antiangiogenic effects of 2-ME and other microtubule inhibitors such as Taxol, vincristine, and colchicine.  2-ME (150 mg/kg p.o.) inhibited bFGF and VEGF-induced neovascularization by 39% and 54%, resp.  Taxol (6 mg/kg i.p.) inhibited bFGF and VEGF-induced neovascularization by 45% and 37%, resp.  Vincristine (0.2 mg/kg i.p.) and colchicine (0.25 mg/kg i.p.) had no effect.  Treatment with 2-ME (75 mg/kg p.o.) for 1 mo suppressed the growth of a human breast carcinoma in mice by 60% without toxicity.  Recognition of the antiangiogenic and antitumor properties of 2-ME and taxol may be crucial in planning clin. applications to angiogenesis-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbq_DgfUImq7Vg90H21EOLACvtfcHk0ljCiZJ2DyB8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvFOmtw%253D%253D&md5=88fbe8611dfdb66530160abe5318c2d7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlauber%26aufirst%3DN.%26aulast%3DParangi%26aufirst%3DS.%26aulast%3DFlynn%26aufirst%3DE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DD%25CA%25BCAmato%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520angiogenesis%2520and%2520breast%2520cancer%2520in%2520mice%2520by%2520the%2520microtubule%2520inhibitors%25202-methoxyestradiol%2520and%2520taxol%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D81%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">38</span> <span class="NLM_fpage">2041</span> <span class="NLM_lpage">2049</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00012a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=2041-2049&author=M.+Cushmanauthor=H.+M.+Heauthor=J.+A.+Katzenellenbogenauthor=C.+M.+Linauthor=E.+Hamel&title=Synthesis%2C+antitubulin+and+antimitotic+activity%2C+and+cytotoxicity+of+analogs+of+2-methoxyestradiol%2C+an+endogenous+mammalian+metabolite+of+estradiol+that+inhibits+tubulin+polymerization+by+binding+to+the+colchicine+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00012a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00012a003%26sid%3Dliteratum%253Aachs%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DH.%2BM.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DSynthesis%252C%2520antitubulin%2520and%2520antimitotic%2520activity%252C%2520and%2520cytotoxicity%2520of%2520analogs%2520of%25202-methoxyestradiol%252C%2520an%2520endogenous%2520mammalian%2520metabolite%2520of%2520estradiol%2520that%2520inhibits%2520tubulin%2520polymerization%2520by%2520binding%2520to%2520the%2520colchicine%2520binding%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D2041%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Abbate, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">231</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=231-234&author=F.+Abbateauthor=J.+Y.+Winumauthor=B.+V.+L.+Potterauthor=A.+Casiniauthor=J.+L.+Monteroauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors%3A+X-ray+crystallographic+structure+of+the+adduct+of+human+isozyme+II+with+EMATE%2C+a+dual+inhibitor+of+carbonic+anhydrases+and+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbate%26aufirst%3DF.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DJ.%2BL.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors%253A%2520X-ray%2520crystallographic%2520structure%2520of%2520the%2520adduct%2520of%2520human%2520isozyme%2520II%2520with%2520EMATE%252C%2520a%2520dual%2520inhibitor%2520of%2520carbonic%2520anhydrases%2520and%2520steroid%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D231%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddersen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B.</span><span> </span><span class="NLM_article-title">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">55</span> <span class="NLM_fpage">395</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2F0960-0760%2895%2900214-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=8541236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=395-403&author=W.+Elgerauthor=S.+Schwarzauthor=A.+M.+Heddenauthor=G.+Reddersenauthor=B.+Schneider&title=Sulfamates+of+various+estrogens+are+prodrugs+with+increased+systemic+and+reduced+hepatic+estrogenicity+at+oral+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span></div><div class="casAuthors">Elger, Walter; Schwarz, Sigfrid; Hedden, Annemarie; Reddersen, Gudrun; Schneider, Birgitt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">395-403</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oral therapy with natural or synthetic estrogens, like ethinylestradiol, suffers from low, suboptimally defined bioavailability and excess hepatic estrogen actions.  N,N-alkylated and non-alkylated sulfamates of ethinylestradiol, estradiol and estrone overcome these deficiencies.  Ovariectomized Wistar rats (-7/group) were orally treated for 7 days, and killed on day 8, plasma was gained on days 0, 4, and 8.  Systemic estrogenicity was quantified by assessment of uterine wt., vaginal cornification, and measurement of gonadotropins by homologous RIA.  Estrogenicity in the liver was analyzed.  Angiotensinogen was estd. by RIA of angiotensin-I after incubation of EDTA-plasma with porcine renin.  Total and high-d. cholesterol were measured by enzymic methods.  Preliminary biotransformation studies were performed after oral administration of 10 μg, 5 μ Ci [2,4,6,7-3H]estradiol sulfonate.  Ethinylestradiol led to distinct elevation of angiotensin-I and dramatic depression of cholesterol fractions, reflecting hepatic estrogen effects, already at doses with marginal systemic effects.  Estradiol and estrone had systemic and hepatic estrogenic activity at much higher doses only.  Estrogen sulfamates had systemic estrogen activity 10-90-fold above that of their parent estrogen.  Non-alkylated sulfamates of given estrogens were more active than N-alkylated ones.  Elevation of systemic estrogen activity was always combined with a dramatic redn. of hepatic estrogenicity.  Estradiol sulfamate had a 90-fold elevated systemic estrogen activity vs. estradiol, but lacked hepatic activity including the 30-fold dose inducing vaginal response.  Three hours after administration no unchanged estradiol sulfamate was detectable in plasma.  Rather peaks, probably representing estradiol and estrone, were found.  Estrogen sulfamates are considered prodrugs of their parent estrogen, which do not interact with any liver function during the first-pass.  They represent a new strategy of oral hormone administration.  Their main potential seems to be the systemic generation of natural estrogen when used in oral contraceptives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq93WhQsNTWFbVg90H21EOLACvtfcHk0ljCiZJ2DyB8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D&md5=60ff9ba569eb4001a4a023073e8737e0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900214-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900214-6%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DHedden%26aufirst%3DA.%2BM.%26aulast%3DReddersen%26aufirst%3DG.%26aulast%3DSchneider%26aufirst%3DB.%26atitle%3DSulfamates%2520of%2520various%2520estrogens%2520are%2520prodrugs%2520with%2520increased%2520systemic%2520and%2520reduced%2520hepatic%2520estrogenicity%2520at%2520oral%2520application%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D55%26spage%3D395%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dahut, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparreboom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span> </span><span class="NLM_article-title">Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">22</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.4161%2Fcbt.5.1.2349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=16357512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVSntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=22-27&author=W.+L.+Dahutauthor=N.+J.+Lakhaniauthor=J.+L.+Gulleyauthor=P.+M.+Arlenauthor=E.+C.+Kohnauthor=H.+Kotzauthor=D.+McNallyauthor=A.+Parrauthor=D.+Nguyenauthor=S.+X.+Yangauthor=S.+M.+Steinbergauthor=J.+Venitzauthor=A.+Sparreboomauthor=W.+D.+Figg&title=Phase+I+clinical+trial+of+oral+2-methoxyestradiol%2C+an+antiangiogenic+and+apoptotic+agent%2C+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors</span></div><div class="casAuthors">Dahut, William L.; Lakhani, Nehal J.; Gulley, James L.; Arlen, Philip M.; Kohn, Elise C.; Kotz, Herbert; McNally, Debbie; Parr, Allyson; Nguyen, Diana; Yang, Sherry X.; Steinberg, Seth M.; Venitz, Jurgen; Sparreboom, Alex; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-27</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: To det. the max.-tolerated dose (MTD) and toxicity profile of the novel anticancer agent, 2-methoxyestradiol (2ME2) administered orally, in patients with solid tumors.  Materials and methods: Twenty patients with refractory solid tumors were enrolled.  2ME2 was given orally starting at 400 mg bid with dose escalation until 3000 mg bid.  Tumor biopsies were taken before and after starting the drug to assess for microvessel d. by CD 31 and cell proliferation by Ki67 immunohistochem.  Serial plasma samples collected up to 50 h after first single oral dose for characterization of pharmacokinetics, were analyzed using liq. chromatog. tandem mass-spectrometry.  Results: Eleven men and nine women received 2ME2 at dose levels of 400 mg bid (n = 3), 800 mg bid (n = 3), 1600 mg bid (n = 6), 2200 mg bid (n = 5) and 3000 mg bid (n = 3).  There were no dose limiting toxicities, therefore the MTD was not defined.  There was one episode of grade 4 angioedema in the 1600 mg bid dose level 38 days into 2ME2 treatment.  Other toxicities were mild to moderate.  A patient with clear cell carcinoma of the ovary had a partial response at 1600 mg bid dose level lasting over three years.  Conclusion: MTD for 2ME2 was not reached at dose of 3000 mg bid.  The trial was closed due to extremely low plasma concns. of 2ME2 relative to the doses administered.  2ME2 treatment had no effect on microvessel d. (CD31 immunostaining) and cell proliferation (Ki-67 immunostaining).  A new formulation of 2ME2 with improved bioavailability is currently being developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn5SfJSuSB7Vg90H21EOLACvtfcHk0lhtC4zfRZCGlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVSntro%253D&md5=4e4021491980ad34411e4637c35ebbc9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.4161%2Fcbt.5.1.2349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.5.1.2349%26sid%3Dliteratum%253Aachs%26aulast%3DDahut%26aufirst%3DW.%2BL.%26aulast%3DLakhani%26aufirst%3DN.%2BJ.%26aulast%3DGulley%26aufirst%3DJ.%2BL.%26aulast%3DArlen%26aufirst%3DP.%2BM.%26aulast%3DKohn%26aufirst%3DE.%2BC.%26aulast%3DKotz%26aufirst%3DH.%26aulast%3DMcNally%26aufirst%3DD.%26aulast%3DParr%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DSteinberg%26aufirst%3DS.%2BM.%26aulast%3DVenitz%26aufirst%3DJ.%26aulast%3DSparreboom%26aufirst%3DA.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DPhase%2520I%2520clinical%2520trial%2520of%2520oral%25202-methoxyestradiol%252C%2520an%2520antiangiogenic%2520and%2520apoptotic%2520agent%252C%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Sutherland, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuliga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziogas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. G.</span><span> </span><span class="NLM_article-title">2-Methoxyestradiol: a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">577</span> <span class="NLM_lpage">584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=577-584&author=T.+E.+Sutherlandauthor=R.+L.+Andersonauthor=R.+A.+Hughesauthor=E.+Altmannauthor=M.+Schuligaauthor=J.+Ziogasauthor=A.+G.+Stewart&title=2-Methoxyestradiol%3A+a+unique+blend+of+activities+generating+a+new+class+of+anti-tumour%2Fanti-inflammatory+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DT.%2BE.%26aulast%3DAnderson%26aufirst%3DR.%2BL.%26aulast%3DHughes%26aufirst%3DR.%2BA.%26aulast%3DAltmann%26aufirst%3DE.%26aulast%3DSchuliga%26aufirst%3DM.%26aulast%3DZiogas%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BG.%26atitle%3D2-Methoxyestradiol%253A%2520a%2520unique%2520blend%2520of%2520activities%2520generating%2520a%2520new%2520class%2520of%2520anti-tumour%252Fanti-inflammatory%2520agents%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D577%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">3,17-Disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anti-cancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">4443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4443&author=C.+Bubertauthor=M.+P.+Leeseauthor=M.+F.+Mahonauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=P.+G.+Kasprzykauthor=S.+P.+Newmanauthor=Y.+T.+Hoauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=3%2C17-Disubstituted+2-alkylestra-1%2C3%2C5%2810%29-trien-3-ol+derivatives%3A+synthesis%2C+in+vitro+and+in+vivo+anti-cancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D3%252C17-Disubstituted%25202-alkylestra-1%252C3%252C5%252810%2529-trien-3-ol%2520derivatives%253A%2520synthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520anti-cancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, N.</span><span> </span><span class="NLM_article-title">Efficient general method for sulfamoylation of a hydroxyl group</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">7047</span> <span class="NLM_lpage">7051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2FS0040-4039%2800%2901130-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtF2isLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=7047-7051&author=M.+Okadaauthor=S.+Iwashitaauthor=N.+Koizumi&title=Efficient+general+method+for+sulfamoylation+of+a+hydroxyl+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient general method for sulfamoylation of a hydroxyl group</span></div><div class="casAuthors">Okada, M.; Iwashita, S.; Koizumi, N.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">7047-7051</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The application of AcNMe2 or 1-methyl-2-pyrrolidone as solvent clearly accelerated the sulfamoylation reaction of a HO group compared with the solvents used so far.  The target sulfamates were obtained in the highest yield without a base.  Two equiv. of sulfamoyl chloride to the starting material were sufficient to complete the reaction.  This condition could be applied to extensive hydroxyl groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMkbGz4xRTMLVg90H21EOLACvtfcHk0lhtC4zfRZCGlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtF2isLg%253D&md5=24aeb055f809e10d10d27a703b04c65f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2901130-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252901130-8%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DIwashita%26aufirst%3DS.%26aulast%3DKoizumi%26aufirst%3DN.%26atitle%3DEfficient%2520general%2520method%2520for%2520sulfamoylation%2520of%2520a%2520hydroxyl%2520group%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D7047%26epage%3D7051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Burgess, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penton, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, E. A.</span><span> </span><span class="NLM_article-title">Synthetic applications of N-carboalkoxysulfamate esters</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1970</span> <span class="NLM_volume">92</span> <span class="NLM_fpage">5224</span> <span class="NLM_lpage">5226</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00720a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaE3cXkvFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1970&pages=5224-5226&author=E.+M.+Burgessauthor=H.+R.+Pentonauthor=E.+A.+Taylor&title=Synthetic+applications+of+N-carboalkoxysulfamate+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic applications of N-carboalkoxysulfamate esters</span></div><div class="casAuthors">Burgess, Edward M.; Penton, Harold R., Jr.; Taylor, Edward Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5224-6</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">MeCRR1OSO2N-CO2Me M+, where R is H or an alkyl group and R1 is an alkyl group or (RR1C =) cycloalkylidene group, fragment to give CH2:CRR1.  (Me3C)2C(CHMe2)OH gives Me3CC(CHMe2)(CMe:CH2)Me.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfAMPLrQ4ZlrVg90H21EOLACvtfcHk0lixoskl4Ggx7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXkvFygs7g%253D&md5=5aa1e757d774f9869f2520e4e4b7b13d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja00720a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00720a041%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DE.%2BM.%26aulast%3DPenton%26aufirst%3DH.%2BR.%26aulast%3DTaylor%26aufirst%3DE.%2BA.%26atitle%3DSynthetic%2520applications%2520of%2520N-carboalkoxysulfamate%2520esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1970%26volume%3D92%26spage%3D5224%26epage%3D5226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ohira, S.</span><span> </span><span class="NLM_article-title">Methanolysis of dimethyl(1-diazo-2-oxopropyl)phosphonate. Generation of (diazomethyl) phosphonate and reaction with carbonyl compounds</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_year" style="font-weight: bold;">1989</span> <span class="NLM_volume">19</span> <span class="NLM_fpage">561</span> <span class="NLM_lpage">564</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1080%2F00397918908050700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaL1MXltlegsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1989&pages=561-564&author=S.+Ohira&title=Methanolysis+of+dimethyl%281-diazo-2-oxopropyl%29phosphonate.+Generation+of+%28diazomethyl%29+phosphonate+and+reaction+with+carbonyl+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Methanolysis of dimethyl (1-diazo-2-oxopropyl)phosphonate:  generation of dimethyl (diazomethyl)phosphonate and reaction with carbonyl compounds</span></div><div class="casAuthors">Ohira, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Treatment of MeCOC(N2)PO3Me2 with K2CO3 in MeOH afforded N2CHPO3Me2 (I), which was used in situ for the synthesis of enol ethers or alkynes.  Thus, I and cyclohexanone or decanal afforded (methoxymethylene)cyclohexane or 1-undecyne, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmw2veCJW5vbVg90H21EOLACvtfcHk0lixoskl4Ggx7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltlegsLc%253D&md5=55a1aab8bf13ca7835e3609d138fe2de</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397918908050700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918908050700%26sid%3Dliteratum%253Aachs%26aulast%3DOhira%26aufirst%3DS.%26atitle%3DMethanolysis%2520of%2520dimethyl%25281-diazo-2-oxopropyl%2529phosphonate.%2520Generation%2520of%2520%2528diazomethyl%2529%2520phosphonate%2520and%2520reaction%2520with%2520carbonyl%2520compounds%26jtitle%3DSynth.%2520Commun.%26date%3D1989%26volume%3D19%26spage%3D561%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Tinley, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall-Hlubek, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cessac, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span> </span><span class="NLM_article-title">Novel 2-methoxyestradiol analogues with antitumor activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">63</span> <span class="NLM_fpage">1538</span> <span class="NLM_lpage">1549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1538-1549&author=T.+L.+Tinleyauthor=R.+M.+Lealauthor=D.+A.+Randall-Hlubekauthor=J.+W.+Cessacauthor=L.+R.+Wilkensauthor=P.+N.+Raoauthor=S.+L.+Mooberry&title=Novel+2-methoxyestradiol+analogues+with+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTinley%26aufirst%3DT.%2BL.%26aulast%3DLeal%26aufirst%3DR.%2BM.%26aulast%3DRandall-Hlubek%26aufirst%3DD.%2BA.%26aulast%3DCessac%26aufirst%3DJ.%2BW.%26aulast%3DWilkens%26aufirst%3DL.%2BR.%26aulast%3DRao%26aufirst%3DP.%2BN.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DNovel%25202-methoxyestradiol%2520analogues%2520with%2520antitumor%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D1538%26epage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span> </span><span class="NLM_article-title">Some practical consideration and applications of the National Cancer Institute <i>in vitro</i> anticancer drug discovery screen</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">91</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=91-109&author=M.+R.+Boydauthor=K.+D.+Paull&title=Some+practical+consideration+and+applications+of+the+National+Cancer+Institute+in+vitro+anticancer+drug+discovery+screen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26atitle%3DSome%2520practical%2520consideration%2520and%2520applications%2520of%2520the%2520National%2520Cancer%2520Institute%2520in%2520vitro%2520anticancer%2520drug%2520discovery%2520screen%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D34%26spage%3D91%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span> </span><span class="NLM_article-title">The NCI 60 human tumor cell line screen: An information-rich screen informing on mechanisms of toxicity</span> <span class="citation_source-journal">In Vitro Cell. Dev. Biol.: Anim.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">5A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=5A&author=R.+H.+Shoemaker&title=The+NCI+60+human+tumor+cell+line+screen%3A+An+information-rich+screen+informing+on+mechanisms+of+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26atitle%3DThe%2520NCI%252060%2520human%2520tumor%2520cell%2520line%2520screen%253A%2520An%2520information-rich%2520screen%2520informing%2520on%2520mechanisms%2520of%2520toxicity%26jtitle%3DIn%2520Vitro%2520Cell.%2520Dev.%2520Biol.%253A%2520Anim.%26date%3D2006%26volume%3D42%26spage%3D5A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raobaikady, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">97</span> <span class="NLM_fpage">1673</span> <span class="NLM_lpage">1682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1038%2Fsj.bjc.6604100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=18026194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSrsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=1673-1682&author=S.+P.+Newmanauthor=P.+A.+Fosterauthor=Y.+T.+Hoauthor=J.+M.+Dayauthor=B.+Raobaikadyauthor=P.+G.+Kasprzykauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=The+therapeutic+potential+of+a+series+of+orally+bioavailable+anti-angiogenic+microtubule+disruptors+as+therapy+for+hormone-independent+prostate+and+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers</span></div><div class="casAuthors">Newman, S. P.; Foster, P. A.; Ho, Y. T.; Day, J. M.; Raobaikady, B.; Kasprzyk, P. G.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1673-1682</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Therapies for hormone-independent prostate and breast cancer are limited, with the effectiveness of the taxanes compromised by toxicity, lack of oral bioavailability and drug resistance.  This study aims to identify and characterize new microtubule disruptors, which may have improved efficacy relative to the taxanes in hormone-independent cancer.  2-Methoxy-3-O-sulfamoyl-17β-cyanomethyl-estra-1,3,5(10)-triene (STX641), 2-methoxy-3-hydroxy-17β-cyanomethyl-estra-1,3,5(10)-triene (STX640) and 2-methoxyoestradiol-3,17-O,O-bis-sulfamate (STX140) were all potent inhibitors of cell proliferation in a panel of prostate and breast cancer cell lines.  STX641 and STX640 significantly inhibited tumor growth in the MDA-MB-231 xenograft model.  STX641 inhibited both in vitro and in vivo angiogenesis.  Despite good in vivo activity, STX641 was not as potent in vivo as STX140.  Therefore, STX140 was evaluated in the prostate hormone-independent PC-3 xenograft model.  STX140 had superior efficacy to docetaxel, 2-MeOE2 and bevacizumab.  In contrast to vinorelbine, no significant toxicity was obsd.  Furthermore, STX140 could be given daily over a 60-day period leading to tumor regression and complete responses, which were maintained after the cessation of dosing.  This study demonstrates that STX641 and STX140 have considerable potential for the treatment of hormone-independent breast and prostate cancer.  In contrast to the taxanes, STX140 can be dosed orally, with no toxicity being obsd. even after prolonged daily dosing. published online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj4UzNL9Xur7Vg90H21EOLACvtfcHk0lhSC6eSY3MTAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSrsLzI&md5=68915a360f3fab3a75120ba88422a5b9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604100%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DRaobaikady%26aufirst%3DB.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520a%2520series%2520of%2520orally%2520bioavailable%2520anti-angiogenic%2520microtubule%2520disruptors%2520as%2520therapy%2520for%2520hormone-independent%2520prostate%2520and%2520breast%2520cancers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D97%26spage%3D1673%26epage%3D1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inactivation of steroid sulfatase by an active site directed inhibitor, estrone-3-O-sulfamate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">11508</span> <span class="NLM_lpage">11514</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00036a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=11508-11514&author=A.+Purohitauthor=G.+J.+Williamsauthor=N.+M.+Howarthauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inactivation+of+steroid+sulfatase+by+an+active+site+directed+inhibitor%2C+estrone-3-O-sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi00036a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00036a025%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInactivation%2520of%2520steroid%2520sulfatase%2520by%2520an%2520active%2520site%2520directed%2520inhibitor%252C%2520estrone-3-O-sulfamate%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D11508%26epage%3D11514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lloyd, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiyagarajan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">44</span> <span class="NLM_fpage">6858</span> <span class="NLM_lpage">6866</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi047692e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=6858-6866&author=M.+D.+Lloydauthor=N.+Thiyagarajanauthor=Y.+T.+Hoauthor=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=A.+Purohitauthor=M.+J.+Reedauthor=K.+R.+Acharyaauthor=B.+V.+L.+Potter&title=First+crystal+structures+of+human+carbonic+anhydrase+II+in+complex+with+dual+aromatase-steroid+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi047692e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi047692e%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThiyagarajan%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DFirst%2520crystal%2520structures%2520of%2520human%2520carbonic%2520anhydrase%2520II%2520in%2520complex%2520with%2520dual%2520aromatase-steroid%2520sulfatase%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D6858%26epage%3D6866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Appel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, G.</span><span> </span><span class="NLM_article-title">Uber das hydrazidosulfamid (On hydrazidosulfamide)</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_year" style="font-weight: bold;">1958</span> <span class="NLM_volume">91</span> <span class="NLM_fpage">1339</span> <span class="NLM_lpage">1341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1958&pages=1339-1341&author=R.+Appelauthor=G.+Berger&title=Uber+das+hydrazidosulfamid+%28On+hydrazidosulfamide%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DR.%26aulast%3DBerger%26aufirst%3DG.%26atitle%3DUber%2520das%2520hydrazidosulfamid%2520%2528On%2520hydrazidosulfamide%2529%26jtitle%3DChem.%2520Ber.%26date%3D1958%26volume%3D91%26spage%3D1339%26epage%3D1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightowler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">57</span> <span class="NLM_fpage">79</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2F0960-0760%2895%2900244-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=8645620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1996&pages=79-88&author=L.+W.+L.+Wooauthor=M.+Lightowlerauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Heteroatom-substituted+analogues+of+the+active-site+directed+inhibitor+estra-1%2C3%2C5%2810%29-trien-17-one-3-sulphamate+inhibit+estrone+sulphatase+by+a+different+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Hetero atom-substituted analogs of the active-side directed inhibitor estra-1,3,5(10)-triene-17-one-3-sulfamate inhibit estrone sulfatase by a different mechanism</span></div><div class="casAuthors">Woo, L. W. Lawrence; Lightowler, Mark; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Estrogens have a pivotal role in the growth and development of hormone-dependent breast cancers.  In postmenopausal women, the hydrolysis of the conjugate estrone sulfate (E1S) to estrone (E1) by the enzyme estrone sulfatase is the major source of breast tumor estrogen.  Inhibitors of estrone sulfatase should therefore have considerable therapeutic potential for the treatment of hormone-dependent tumors of the breast, either as the sole agent or in conjunction with aromatase inhibitors.  Several inhibitors of estrone sulfatase have now been developed of which estra-1,3,5(10)-trien-17-one-3-sulfamate (EMATE) is the most potent and also inhibits the enzyme in a time- and concn.-dependent manner, showing that it acts as an irreversible inhibitor.  Analogs of EMATE in which the 3-O-atom is replaced by other heteroatoms (S and N) were prepd. and tested for inhibition against estrone sulfatase.  3-Methoxyphenylsulfamide, 4-chlorothiophenyl-S-(N,N-dimethyl)sulfamate, estra-1,3,5(10)-trien-17-one-3-sulfamide, estra-1,3,5(10)-trien-17-one-3-S-sulfamate, and estra-1,3,5(10)-trien-17-one-3-S-(N,N-dimethyl)sulfamate inhibited estrone sulfatase weakly, but none of these compds. appears to behave as a time-dependent inhibitor.  A model of the mechanism of enzyme inhibition by EMATE is proposed and the authors conclude that the sulfamate bridging oxygen atom of EMATE is essential for active site-directed inhibition of estrone sulfatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlWZCRBBmXtLVg90H21EOLACvtfcHk0lhSC6eSY3MTAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D&md5=ce13a9f57587179a9d5a3a104fd67740</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900244-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900244-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLightowler%26aufirst%3DM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHeteroatom-substituted%2520analogues%2520of%2520the%2520active-site%2520directed%2520inhibitor%2520estra-1%252C3%252C5%252810%2529-trien-17-one-3-sulphamate%2520inhibit%2520estrone%2520sulphatase%2520by%2520a%2520different%2520mechanism%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D57%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Method Enzymol.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">276</span> <span class="NLM_fpage">307</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0liT7o3uGF5yuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethod%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Eriksson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljas, A.</span><span> </span><span class="NLM_article-title">Refined structure of human carbonic anhydrase II at 2.0Å resolution</span> <span class="citation_source-journal">Proteins</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">274</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1988&pages=274-282&author=A.+E.+Erikssonauthor=T.+A.+Jonesauthor=A.+Liljas&title=Refined+structure+of+human+carbonic+anhydrase+II+at+2.0%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DT.%2BA.%26aulast%3DLiljas%26aufirst%3DA.%26atitle%3DRefined%2520structure%2520of%2520human%2520carbonic%2520anhydrase%2520II%2520at%25202.0%25C3%2585%2520resolution%26jtitle%3DProteins%26date%3D1988%26volume%3D4%26spage%3D274%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Brunger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delano, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, G. L.</span><span> </span><span class="NLM_article-title">Crystallography & NMR system: A new software suite for macromolecular structure determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">54</span> <span class="NLM_fpage">905</span> <span class="NLM_lpage">921</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=905-921&author=A.+T.+Brungerauthor=P.+D.+Adamsauthor=G.+M.+Cloreauthor=W.+L.+Delanoauthor=P.+Grosauthor=R.+W.+Grosse-Kunstleveauthor=J.+S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+%26+NMR+system%3A+A+new+software+suite+for+macromolecular+structure+determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DDelano%26aufirst%3DW.%2BL.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%2BS.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520%2526%2520NMR%2520system%253A%2520A%2520new%2520software%2520suite%2520for%2520macromolecular%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%26date%3D1998%26volume%3D54%26spage%3D905%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Jones, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjeldgaard, M.</span><span> </span><span class="NLM_article-title">Improved methods for building protein models in electron-density maps and the location of errors in these models</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A</span><span class="NLM_year" style="font-weight: bold;">1991</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">110</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1107%2FS0108767390010224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm701319c&amp;key=2025413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A280%3ADyaK3M3it1CmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1991&pages=110-119&author=T.+A.+Jonesauthor=J.+Y.+Zouauthor=S.+W.+Cowanauthor=M.+Kjeldgaard&title=Improved+methods+for+building+protein+models+in+electron-density+maps+and+the+location+of+errors+in+these+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Improved methods for building protein models in electron density maps and the location of errors in these models</span></div><div class="casAuthors">Jones T A; Zou J Y; Cowan S W; Kjeldgaard M</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section A, Foundations of crystallography</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">47 ( Pt 2)</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-9</span>
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    </div><div class="casAbstract">Map interpretation remains a critical step in solving the structure of a macromolecule.  Errors introduced at this early stage may persist throughout crystallographic refinement and result in an incorrect structure.  The normally quoted crystallographic residual is often a poor description for the quality of the model.  Strategies and tools are described that help to alleviate this problem.  These simplify the model-building process, quantify the goodness of fit of the model on a per-residue basis and locate possible errors in peptide and side-chain conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhby6yNdW8QMKL0FlyGHDofW6udTcc2eYndY53e9iXPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3it1CmsQ%253D%253D&md5=fd4d4a3cdb4ecb3f05bbad8b2300ef45</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0108767390010224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767390010224%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DT.%2BA.%26aulast%3DZou%26aufirst%3DJ.%2BY.%26aulast%3DCowan%26aufirst%3DS.%2BW.%26aulast%3DKjeldgaard%26aufirst%3DM.%26atitle%3DImproved%2520methods%2520for%2520building%2520protein%2520models%2520in%2520electron-density%2520maps%2520and%2520the%2520location%2520of%2520errors%2520in%2520these%2520models%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%26date%3D1991%26volume%3D47%26spage%3D110%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Laskowski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacArthur, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. M.</span><span> </span><span class="NLM_article-title">PROCHECK: a program to check the stereochemical quality of protein structures</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_year" style="font-weight: bold;">1993</span> <span class="NLM_volume">26</span> <span class="NLM_fpage">283</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm701319c&amp;key=10.1107%2FS0021889892009944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm701319c&amp;key=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=283-291&author=R.+A.+Laskowskiauthor=M.+W.+MacArthurauthor=D.+S.+Mossauthor=J.+M.+Thornton&title=PROCHECK%3A+a+program+to+check+the+stereochemical+quality+of+protein+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">PROCHECK: a program to check the stereochemical quality of protein structures</span></div><div class="casAuthors">Laskowski, Roman A.; MacArthur, Malcolm W.; Moss, David S.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-91</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">The PROCHECK suite of programs provides a detailed check on the stereochem. of a protein structure.  Its outputs comprise a no. of plots in PostScript format and a comprehensive residue-by-residue listing.  These give an assessment of the overall quality of the structure as compared with well-refined structures of the same resoln. and also highlight regions that may need further investigation.  The PROCHECK programs are useful for assessing the quality not only of protein structures in the process of being solved but also of existing structures and of those being modeled on known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCe5FgJf4KH7Vg90H21EOLACvtfcHk0ljd-UeIZ1HMiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D&md5=fb69fc4410cd716aaaa7cc0db06b3ed2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0021889892009944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889892009944%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DMacArthur%26aufirst%3DM.%2BW.%26aulast%3DMoss%26aufirst%3DD.%2BS.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DPROCHECK%253A%2520a%2520program%2520to%2520check%2520the%2520stereochemical%2520quality%2520of%2520protein%2520structures%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D283%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CA2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CA2','PDB','1CA2'); return false;">PDB: 1CA2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BET" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BET','PDB','3BET'); return false;">PDB: 3BET</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i57"><a href="/doi/suppl/10.1021/jm701319c">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51101"></div></div></div></div></div><hr /></hr><p class="last">Table of elemental analyses, 13C NMR data and crystallographic data for the hCA II/<b>15</b> complex. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701319c/suppl_file/jm701319c-file001.pdf">jm701319c-file001.pdf (334.32 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701319c&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm701319c" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701319c" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998f70ba703c6a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
